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Abstract
The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a neglected
infectious disease that is becoming a world health concern. This obligate intracellular parasite employs a
diversity of molecules and strategies to successfully invade a wide variety of mammalian cells and
modulate host immune responses, which are essential features for completion of its life cycle in the host.
The

major

plasma

membrane

antigens

of

T.

cruzi

infective

trypomastigote

forms

are

glycosylphosphatidylinositol (tGPI)-anchored mucin-like glycoproteins. Although previous studies
demonstrated that the proinflammatory responses induced by tGPIs are mediated by Toll-like receptor
(TLR) 2, the involvement of other TLRs and coreceptors has not been investigated yet. The focus of the
first part of this dissertation was to investigate the molecular events involved in the interaction between T.
cruzi and host cells and particularly, the upstream molecules implicated in tGPIs recognition by the innate
immune system and the influence of the tGPI structural features on the biological activity and
receptor/coreceptor requirement. To overcome the limitations related to heterogeneity and quantity of
native GPI anchors, chemically synthesized tGPIs (stGPIs) were used. The stGPIs were preferentially
recognized by the TLR2 and TLR6 heterodimer while co-expression of CD14 and CD36 accessory
molecules induced a significant enhancement in cellular responses as assessed by NF-κB activation and
IL-8 production. Further insights into the influence of the tGPI structural features on the biological
activity and receptor/coreceptor requirement were also revealed. Intriguingly, in contrast to the well
established role of TLR2 as one of the primary sensor of the innate immune defense against pathogens,
activation of host cell TLR2 signaling by trypomastigote-released, GPI-containing vesicles was shown to
facilitate T. cruzi invasion. This unanticipated role of TLR2 in host cell invasion by T. cruzi was further
investigated. Clearly, TLR2-specific ligands significantly increased parasite infection in distinct cell
types. In line with these findings, silencing of TLR2 by RNA interference significantly decreased
infection. Moreover, the participation of host cell actin and intracellular calcium in TLR2-mediated
invasion was assessed. Taken together, these results suggest that activation of host cell TLR2 by T. cruzi
vii

molecules may play a dual, paradoxical role during the infection by stimulating microbicidal responses
and increasing the parasite infectivity. It also begins to reveal previously unrecognized mechanisms of
host cell signaling subversion that may be exploited by other intracellular pathogens.
In the second part of this research, a novel and improved approach to study in vitro models of
host cell-parasite interaction and more specifically, T. cruzi infection, was developed. Conventional
manual counting of parasite infection rate is extremely time-consuming and subjective. Hence, an
approach based on high-content imaging and automated analysis in a multiwell plate format was
developed to generate multiparametric data on a cell-by-cell basis which was further explored to precisely
and quickly determine several parameters associated to in vitro infection of host cells. Statistical analysis
confirmed that there was substantial agreement between the data acquired manually and by applying the
automated analysis. Moreover, to further assess the applicability of this novel methodology, the effects of
specific compounds on T. cruzi intracellular proliferation were evaluated. The results not only
demonstrated the potential of the tested compounds as anti-T. cruzi agents, but also confirmed the
effectiveness and uniqueness of high-content imaging in the determination of cytotoxic effects of the
tested compounds as well as changes in T. cruzi infection rates and intracellular proliferation in a single
experiment. Notably, this novel automated method may contribute to accelerate the discovery of potential
drugs as well as the elucidation of molecular events related to the interaction between host cell and human
intracellular pathogens.
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Chapter 1: General Introduction

1.1.

Chagas disease and Trypanosoma cruzi

Trypanosoma cruzi is the etiologic agent of Chagas disease or American trypanosomiasis, which
is the most significant parasitic pathology of the Americas and, contradictorily, it is also considered a
neglected infectious disease (Tarleton et al., 2007). In Latin America, it is estimated that 8 to 11 million
people are infected and 120 million are at risk of acquiring the disease (Schmunis, 2007). Moreover,
13,000-50,000 people may die every year due to progress to debilitating chronic digestive-tract
abnormalities such as megacolon and megaoesophagous as well as cardiomyopathy (WHO, 2002). The
latter is regarded as the leading cause of cardiovascular death in endemic areas (Rassi Jr et al., 2009).
The main routes of T. cruzi transmission to humans are through contaminated triatomine insect
vector excrements, congenital contagion, and organ transplantation or blood transfusion from infected
donors, as well as parasite-tainted food and juices (Tarleton et al., 2007, Pereira et al., 2009). Although
the disease is prevalent in Latin America, lately it has also threatened Europe, Asia and North America
due to the rising migration from endemic countries (Schmunis et al., 2009, Yadon et al., 2009). A recent
study estimated that more than 300,000 chronically infected migrants are living in the United States (US)
(Bern et al., 2009). Moreover, in the US, widespread blood donation screening for T. cruzi has began in
January 2007 (CDC, 2007) and since then, 1,168 confirmed seropositive donations have been detected in
42 states, with the largest numbers found in California, Florida, and Texas (AABB, 2010) including 2
cases in El Paso (Tobler et al., 2007). In addition to blood donations positive for T. cruzi antibodies,
vector-borne cases of infection, transfusion-associated transmissions as well as T. cruzi infection related
to transplantation of organs have been documented in the US in recent years (Young et al., 2007, CDC,
2007, CDC, 2002, Bern et al., 2009).
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Currently, there are only two drugs (Benznidazole and Nifurtimox) available for the treatment of
Chagas disease, and both are highly toxic and only partially effective (Urbina, 2009). Notably, there is no
effective drug treatment for the established chronic phase of the disease (Croft et al., 2005, Tarleton et al.,
2007) as well as vaccine for the prevention or treatment of Chagas disease (Dumonteil, 2007, Garg et al.,
2005). Moreover, an increasing number of drug-resistant T. cruzi strains have been reported (Wilkinson et
al., 2008). Therefore, there is an urgent need to develop new chemotherapies against T. cruzi.
Vector-mediated transmission of T. cruzi to a mammalian host is initiated after a bloodmeal,
when the triatomine insect defecates and releases infective metacyclic trypomastigotes that enter the host
bloodstream through the bite wound or exposed mucosal membrane (Figure 1.1). Metacyclic
trypomastigotes then invade a variety of nucleated cells and enter the cell in a membrane-bound vacuole
from which they subsequently escape to the cytosol and differentiate into replicative amastigote forms.
After several cycles of binary fission, the amastigotes differentiate into trypomastigotes and, upon host
cell rupture, a large number of infective forms are released into the extracellular milieu where they can
infect adjacent cells or go to the bloodstream to infect other tissues, or be ingested by a triatomine insect
(Tyler et al., 2001).
In the vertebrate host, T. cruzi infection is characterized by a short acute phase with high
parasitemia and mild symptoms such as fever, swollen lymph glands, and inflammatory reaction at the
bite site. Subsequently, the host immune response against the parasite effectively control both parasitemia
and tissue parasitism but is unable to eradicate the infection resulting in a chronic phase which is
generally asymptomatic. Besides promoting host resistance to T. cruzi infection, the immune system
appears to play a fundamental role in the pathogenesis of Chagas disease by maintaining a continuous
inflammatory reaction. This response was proposed to underlie the progressive damage of the heart and
gastrointestinal tract, leading to the symptomatic chronic forms of the disease in 30–40% of patients
(Teixeira et al., 2006). Furthermore, exacerbation of the infection and manifestations of the disease can
occur due to immunosuppression by several factors including human immunodeficiency virus (HIV)
infection (Tarleton et al., 2007). Therefore, a fine balance between the development of immune responses
2

to control the infection and regulation of this response to avoid tissue damage appears to be essential
during T. cruzi infection.
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Figure 1.1. Trypanosoma cruzi life cycle.
Vector-mediated transmission of T. cruzi to a mammalian host is initiated after a bloodmeal, when the
triatomine insect defecates and releases infective metacyclic trypomastigotes that enter the host
bloodstream through the bite wound or exposed mucosal membrane (1). Metacyclic trypomastigotes then
invade a variety of nucleated cells (2) and enter the cell in a membrane-bound vacuole from which they
subsequently escape to the cytosol and differentiate into replicative amastigote forms (3). After several
cycles of binary replication, the amastigotes differentiate into trypomastigotes (4) and, upon host cell
rupture, a large number of infective forms are released into the extracellular milieu (5) where they can
infect adjacent cells or go to the bloodstream to infect other tissues (6), or be ingested by a triatomine
insect. If ingested, trypomastigotes differentiate into non-infective epimastigotes (7) that replicate in the
midgut of the insect (8-9). In the distal portion of the insect gut, epimastigotes transform into infective
metacyclic trypomastigotes (10), which are eventually excreted with the feces during a new blood uptake
by the insect vector (1). Modified from Almeida I.C. (unpublished). Field emission electron microscopy
of the interaction between the trypomastigote and host cell was taken from Barrias et al. (2010).
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1.2.

Molecular aspects of T. cruzi-host cell interaction during cell invasion

T. cruzi is an obligate intracellular parasite, and its ability to successfully infect, survive and
replicate within a cell is an essential feature for completion of its life cycle in the mammalian host cell.
The infective trypomastigote forms are capable of invading a large variety of phagocytic and nonphagocytic cell types (Andrade et al., 2005, Dias et al., 2008) including macrophages, smooth and striated
muscle cells, fibroblasts (Andrade et al., 2005), and endothelial cells (Dias et al., 2008). Since the
pathology of the disease is mainly related to persistence of the parasite in non-phagocytic cells, studies
have greatly focused on the invasion processes in these cells. To gain access to the intracellular
environment of host cells, T. cruzi has evolved unique invasion strategies by actively manipulating
multiple host cell surface receptors and signaling pathways (Villalta et al., 2009, Burleigh et al., 2002).
The best characterized signaling event related to host cell invasion is the remarkable subversion
of a calcium-regulated lysosomal exocytosis pathway involved in the general mechanism of mammalian
cell plasma membrane repair (Andrews, 2002, Reddy et al., 2001). Trypomastigote-induced host cell
intracellular calcium mobilization leads to a transient reorganization of the host cell cortical actin
cytoskeleton and lysosome recruitment to the site of parasite entry, resulting in the formation of a
parasitophorous vacuole with lysosomal properties (Figure 1.2) (Burleigh et al., 2002, Tardieux et al.,
1992). Subsequently, an unexpected second strategy that involves the invagination of host cell plasma
membrane and formation of parasitophorous vacuoles, which gradually fuses to lysosomes was described
(Woolsey et al., 2003, Burleigh, 2005) (Figure 1.2).
Additionally, a number of other host cell signaling pathways in different cell types were shown to
be modulated by the parasite (Burleigh et al., 2002). It has been demonstrated that T. cruzi stimulates host
cell signaling pathways involving PI3K (Woolsey et al., 2003), Rac1 (Dutra et al., 2005), Rab5
(Maganto-Garcia et al., 2008), adenylyl cyclase (Rodriguez et al., 1999), and Rho GTPase (Woolsey et
al., 2004), among other signaling components. It has also been reported that T. cruzi and its molecules
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stimulate protein phosphorylation in host cells (Ruta et al., 1996, Magdesian et al., 2007) and that
mitogen-activated protein (MAP) kinase and tyrosine kinase inhibitors affect parasite entry in a cell typedependent manner (Vieira et al., 1994, Villalta et al., 1998). Furthermore, T. cruzi inhibits programmed
cell death in fibroblasts, neurons, and cardiomyocytes to promote its survival and growth, whereas it
triggers apoptosis in other cell types (Carmen et al., 2007, Petersen et al., 2006). Notably, activation of
host cell receptors such as transforming growth factor-β (Hall et al., 2000), bradykinin B2 (Scharfstein et
al., 2000), and nerve growth factor TrKA (de Melo-Jorge et al., 2007) receptors were implicated in
increased invasion by this parasite. Collectively, these findings highlight the enormous complexity of the
mechanisms required for establishment of infection by T. cruzi and the ability of the parasite to exploit
multiple host cell surface receptors and signaling pathways to enter the cell.
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Figure 1.2. Major mechanisms of non-phagocytic cell invasion exploited by T. cruzi trypomastigotes.
Lysosome/calcium mediated pathway. Proteolytically generated trypomastigote factor (PGTF) is an
inactive precursor present only in infective trypomastigotes which is processed by a serine peptidase,
oligopeptidase B (OpdB), from the parasite generating an active calcium agonist. Host cell intracellular
calcium elevation induced by processed PGTF is mediated by G-protein coupled receptor (GPCR) that
promotes the activation of phospholipase C (PLC) leading to inositol 1,4,5-triphosphate (IP3) formation
and activation of the endoplasmic reticulum calcium ATPase (ER Ca+2 ATPase). The resulting increase in
intracellular free calcium induces a transient reorganization of the host cell cortical actin cytoskeleton and
lysosomes recruitment to the site of parasite entry in the plasma membrane leading to formation of a
parasitophorous vacuole with lysosomal properties. Plasma membrane invagination pathway.
Trypomastigotes enter host cells enveloped in a cell plasma membrane-derived vacuole devoid of
lysosomal markers. Subsequently, the parasitophorous vacuoles containing plasma membrane markers
gradually fuse to lysosomes.
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1.3.

Host immunity against T. cruzi and Toll-like receptor activation

In addition to the numerous mechanisms of invasion exploited by the parasite, T. cruzi employs a
diversity of molecules and strategies to modulate the host immune responses and ultimately establish a
life-long infection in immunocompetent hosts. At the onset of infection, the innate recognition of T. cruzi
plays a crucial role in host resistance to infection by stimulating the production of cytokines, limiting the
infection, and generating signals required for the development of appropriate adaptive immune response.
Numerous studies demonstrated that T. cruzi and its molecules strongly elicit the synthesis of
proinflammatory cytokines such as interleukin (IL)-12 and tumor necrosis factor (TNF)-α in
macrophages, and induce dendritic cell (DC) maturation. These processes are essential for the generation
of humoral and cellular effector mechanisms against the parasite (Ropert et al., 2002, Ouaissi et al., 2002,
Tarleton, 2007).
Macrophages and DCs are key innate immunity cells that express various pattern-recognition
receptors (PRRs) which recognize specific molecules of microbial pathogens, the pathogen-associated
molecular patterns (PAMPs). Several classes of PRRs including Toll-like receptors (TLRs) have been
identified. To date, 12 members of the TLR family have been described in mammalian cells (Kumar et
al., 2009). Each TLR recognizes specific PAMPs. For instance, TLR4 recognizes lipopolysaccharide
(LPS), TLR9 recognizes genomic DNA rich in unmethylated CpG DNA, whereas TLR2 recognizes the
largest variety of PAMPs including peptidoglycan, lipoteichoic acid, lipoproteins, lipoarabinomannan,
zymosan, certain glycolipids, non-enterobacterial LPS, and porins (Kumar et al., 2009, Akira et al.,
2004). It is proposed that TLR2 recognizes this wide range of microbial products through functional
cooperation with several other receptors and coreceptors/accessory molecules. Efficient signal
transduction and differential ligand recognition by TLR2 requires its heterodimerization with either TLR1
or TLR6 as well as the presence of distinct coreceptors/accessory molecules including CD14 (Drage et
al., 2009, Nakata et al., 2006, Henneke et al., 2001, Manukyan et al., 2005) and CD36 (Triantafilou et al.,
2006, Drage et al., 2009, Areschoug et al., 2009, Akashi-Takamura et al., 2008, Hoebe et al., 2005, Stuart
8

et al., 2005). These accessory molecules are proposed to deliver or present more appropriately the ligands
to TLR2, and some may also contribute to cytoplasmic signaling.
TLR-dependent signaling pathways were shown to play an essential role in the immune responses
against protozoan parasites (Gazzinelli et al., 2006) by ultimately eliciting the production of cytokines
and antimicrobial responses. In the last few years, several protozoan-derived molecules were shown to
activate TLRs. For instance, T. brucei genomic DNA is recognized by TLR9, Leishmania spp.
lipophosphoglycan (LPG) is recognized by TLR2, and Plasmodium falciparum and Toxoplasma gondii
glycosylphosphatidylinositol (GPI) anchors are recognized by TLR2 and TLR4, respectively (Gazzinelli
et al., 2006, Kumar et al., 2009). In T. cruzi, it was first demonstrated that GPI-anchors highly purified
from infective trypomastigote mucins (tGPI-mucins) activate TLR2, with subsequent induction of MAPkinases and NF-κB signaling pathways (Camargo et al., 1997, Almeida et al., 2000, Ropert et al., 2002).
More recently, it has been shown that T. cruzi genomic DNA activates TLR9 (Bafica et al., 2006), and
noninfective epimastigote-derived glycoinositolphospholipids (GIPLs) activate TLR4 (Oliveira et al.,
2004). Although initial parasite recognition occurs mainly through TLRs, recent studies suggest that
TLR-independent responses also account for host resistance against T. cruzi infection (Chessler et al.,
2008, Kayama et al., 2009, Silva et al., 2010).
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1.4.

T. cruzi glycosylphosphatidylinositol anchors and trypomastigote-released vesicles

Glycosylphosphatidylinositol (GPI) anchor is a posttranslational modification found in numerous
eukaryotic proteins and its primary role is to insert the modified protein to the plasma membrane (Paulick
et al., 2008). GPI-anchored molecules are the major antigens expressed on the plasma membrane of
parasitic protozoa and they densely coat the cell surface of T. cruzi, T. brucei, Plasmodium species, and
Leishmania species (Ferguson, 1999, Guha-Niyogi et al., 2001). Parasite-derived GPI-anchored
molecules are involved not only in the activation of the innate immunity during protozoan infections but
also in the generation of reactive nitrogen intermediates such as nitric oxide, and the expression of
adhesion molecules by host macrophages and endothelial cells (Almeida et al., 2001).
Most GPIs share a conserved core structure composed of a highly hydrophilic glycan core
containing Manα1-2Manα1-6Manα1-4GlcNα1-6myo-inositol-1-PO4-, which is attached through the myoinositol-linked phosphate residue to a hydrophobic moiety containing a glycerolipid or a ceramide. The
C-terminus of the protein is linked to the GPI by an ethanolaminephosphate (EtNP) or 2aminoethylphosphonate (AEP) at the third mannose residue distal from the glucosamine. Interestingly,
depending on the organism, cell type or developmental stage, a wide variety of substituents can be found
in the glycan core, myo-inositol or lipid moiety generating an extensive diversity of GPI structures that
ensues a great variation in the potency of their biological activity (Paulick et al., 2008, Almeida et al.,
2001).
In line with these observations, in T. cruzi, subtle structural features between distinct
developmental stages have been implicated in their differential proinflammatory activities (Almeida et al.,
2001, Almeida et al., 2000). Structural analysis of the GPI anchors purified from mucin-like
glycoproteins revealed that the lipid moiety of the infective trypomastigote-derived GPIs (tGPIs) is
mainly composed of unsaturated fatty acids (C18:1 or C18:2) at the sn-2 position, whereas noninfective
epimastigote-derived GPIs (eGPIs) contain exclusively saturated fatty acids (C16:0 or C18:0) (Figure
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1.3). Moreover, tGPIs contain additional galactose residues along the glycan core (Almeida et al., 2000,
Buscaglia et al., 2004). These particular differences were suggested to be essential for the higher potency
of tGPI as compared to eGPIs in the induction of proinflammatory cytokines and nitric oxide by
macrophages (Camargo et al., 1997, Almeida et al., 2000, Campos et al., 2001). However, further study
of the relationship between GPI anchor structure and its biological activity has been hampered due to the
heterogeneity and limited quantities of GPI anchors from natural sources. Recently, to clearly elucidate
the structural characteristics that determine the potency of GPIs in the induction of proinflammatory
activity, synthetic tGPIs (stGPIs) containing sn1-O-(C16:0)alkyl-2-O-(C18:1, C18:2, or C16:0)acylglycerol lipid and the parasite-specific substituent AEP at the O6 position of the glucosamine moiety
were produced (Yashunsky et al., 2006).
Although several evidences clearly demonstrated that T. cruzi tGPIs are able to induce activation
of host cell signaling pathways, the mechanisms by which these membrane-anchored molecules are
presented to the cognate receptor(s) remained poorly understood. Our group has recently demonstrated
that in addition to the release of surface molecules in soluble form, mammalian cell-derived T. cruzi
trypomastigote forms shed vesicles (Figure 1.4) containing molecules known to play important roles in
host cell immune response, adhesion and invasion by the parasite (Torrecilhas et al., unpublished data)
(Goncalves et al., 1991, Ouaissi et al., 1992, Pinho et al., 2002). Accordingly, T. cruzi vesicles elicited a
TLR2-dependent proinflammatory response in macrophages as well as significant enhancement of
parasite infectivity (Torrecilhas et al., unpublished data). Further in vivo studies confirmed these findings
by demonstrating that treatment of mice with vesicles prior to T. cruzi infection results in exacerbation of
inflammation and tissue parasitism (Trocoli Torrecilhas et al., 2009). Intriguingly, the vesicle-induced
enhancement of T. cruzi host cell invasion was shown to be mediated by TLR2 (Torrecilhas et al.,
unpublished data).
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stGPI

Figure 1.3. Structure of glycosylphosphatidylinositols (GPIs) from T. cruzi.
Detailed structure of the noninfective epimastigote-derived GPI (eGPI), the infective trypomastigotederived GPI (tGPI), and the synthetic tGPI (stGPI). m-Ins, myo-inositol; Gal, galactose; GlcN,
glucosamine; Man, mannose; AEP, 2-aminoethylphosphonate; EtNP, ethanolaminephosphate; AAG,
alkylacylglycerol. Modified from Almeida et al., 2001.
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A

1 µm

0.3 µm

B

1 µm

Figure 1.4. T. cruzi trypomastigote vesicles.
A and B. Scanning electron microscopy of trypomastigotes; arrows indicate vesicles being formed or
released by the parasite. Inset shows the white square delimited area on the parasite surface were the
vesicles can be visualized in more detail. Scale bars are indicated. Modified from Torrecilhas et al.,
unpublished data.
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1.5.

Conventional approaches to determine parameters linked to in vitro T. cruzi-host

cell interaction and high-content imaging analysis

To gain insights into the molecular mechanisms that regulate T. cruzi host cell invasion,
intracellular proliferation and other events during parasite-host cell interactions as well as for
identification of compounds with anti-parasitic effects, studies based on in vitro T. cruzi infection have
largely relied on the application of labor-intensive manual counting of host cells and parasites by light or
fluorescence microscopy. Typically, these assays are performed in individual coverslips and parasites are
detected by Giemsa staining (Barrias et al., 2010, Hoff, 1975), DNA labeling with fluorescent dyes, or by
immunostaining using anti-T. cruzi antibodies followed by a fluorescent secondary antibody (Woolsey et
al., 2004, Andrade et al., 2004). The analysis then involves the visual counting of intracellular parasites in
each of the one hundred to five hundred cells per sample. In addition, compounds against T. cruzi have
been evaluated by manually counting the parasites released into the supernatant of infected cells and by
assays using extracellular parasites (Rowland et al., 2003). These methods based on visual scoring and
manual annotation are time-consuming, potentially biased by the user, and unsuitable for the analysis of
larger number of biological samples.
To date, only few reports have tried to address these concerns. Buckner et al. (1996) engineered
parasites expressing β-galactosidase for colorimetric assays (Buckner et al., 1996). Alternatively, an assay
based on the selective incorporation of radioactive uracil by parasite-infected cells has been described
(Yan et al., 1998). More recently, Hyland et al. (2008) engineered T. cruzi expressing firefly luciferase for
bioluminescent determination of infection rates (Hyland et al., 2008), These approaches have been
applied for screening of compounds against T. cruzi (Mezencev et al., 2009, Kraus et al., 2009).
However, in addition to other disadvantages, these methods require separate assays for assessment of
mammalian cell toxicity and the results are an average of the biological responses of thousands of cells.
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Conversely, current new technologies offer numerous advantages when compared to conventional
procedures. Developments in high-content imaging, which is based on automated fluorescence image
acquisition, processing and analysis, have provided unique and powerful tools to quantitatively determine
spatiotemporal events in complex biological systems (Zanella et al., 2010). This technology allows the
precise, efficient and simultaneous assessment of multiple cellular parameters relevant for evaluating the
potential of novel compounds and dissecting signaling pathways and it is based on single-cell analysis in
large cell populations. Recent reports have confirmed the potential of image-based cellular screening to
monitor and quantify several cellular events such as protein nuclear translocation (Link et al., 2009, Agler
et al., 2007), G-protein coupled receptor activity (Ross et al., 2008), microtubule dynamics (De Rycker et
al., 2009) in addition to aid in the identification of compounds that interfere with these biological
processes. This technology has also been successfully applied for screening of RNA interference libraries
(Conrad et al., 2010) and identification of host kinases and respective inhibitors that prevent bacterial
intracellular growth (Kuijl et al., 2007). However, so far, this approach has not been applied for the study
of intracellular parasites such as T. cruzi.
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1.6.

Significance and Aims

Chagas disease is a neglected infectious disease that is becoming a world health concern due to
extensive migration of chronically infected people from endemic areas to developed countries in North
America and Europe. The silent character of the disease at its chronic stage maintains the infection largely
unnoticed, contributing to the transmission and progression of the disease. Alarmingly, only two highly
toxic drugs are commercially available and there is no effective treatment for the established chronic
phase of the disease, which highlights the urgent need to develop new chemotherapies against T. cruzi.
At the molecular level, compelling evidence indicates that the T. cruzi-host cell interplay is highly
complex and involves a multitude of host cell signaling pathways that are exploited by the parasite.
Further elucidation of the molecular aspects of how the parasite interacts with the host cell may contribute
to better understand the mechanisms regulating the establishment of T. cruzi infection and the
pathogenesis of Chagas disease. Importantly, the development of novel methodologies to study in vitro
models of host cell-parasite interaction and, more specifically infection, are essential to accelerate the
elucidation of the molecular basis of these interactions and the discovery of potential anti-parasitic drugs.
This accumulated knowledge may eventually result in the development of efficacious therapies for the
treatment of Chagas disease.
The aims of this dissertation are twofold: (1) the investigation of the host cell-T. cruzi interaction
at the molecular level, particularly the upstream molecules involved in TLR2 recognition of tGPIs by
innate immune system and the role of TLR2 signaling in the invasion process, and (2) the development
and evaluation of a novel method for the analysis of in vitro T. cruzi infection.
Previous studies demonstrated that the strong proinflammatory responses elicited by tGPIs are
mediated by TLR2. However, the participation of other TLRs and putative coreceptors has not been
evaluated yet. In addition, slight variations in the structure of GPI are known to significantly affect their
potency. Therefore, the focus of the Chapter 2 is to determine whether TLR2 heterodimerization with
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TLR1 or TLR6 is critical for sensing of tGPIs as well as to evaluate the involvement of accessory
molecules in efficient recognition of T. cruzi GPIs. Moreover, the influence of the tGPI structural features
on the biological activity and receptor/coreceptor requirement is assessed.
Paradoxically, it was revealed that activation of TLR2 signaling by trypomastigote-released
vesicles facilitate T. cruzi invasion. Conversely, neither the mechanism nor the extension of this
unexpected event has been investigated yet. Hence, the aim of Chapter 3 is to evaluate the effects of
distinct TLR ligands in addition to parasite-released vesicles on T. cruzi invasion of distinct cell types,
confirm the participation of TLR2 in infection and assess the role of host cell intracellular calcium and
actin cytoskeleton in this process.
Furthermore, during the studies on the molecular events involved in T. cruzi invasion, hundreds
of in vitro infection assays are performed in order to determine the number of parasites per cell and the
percentage of infected cells. These quantifications are usually carried out by direct counting and analysis
of the infected host cells under the microscope. This manual counting is extremely time-consuming and
subjective. Therefore, the objective of Chapter 4, section 4.1, is to develop an accurate and more
efficient approach for determination of the infection rate by this intracellular parasite based on highcontent imaging and automated analysis in addition to statistically compare the manual and automated
counting. In Chapter 4, section 4.2, the effects of specific compounds on T. cruzi intracellular
proliferation are evaluated to further assess the applicability of this novel methodology. Importantly, by
applying this newly developed automated method, several parameters linked to host cell infection by this
parasite can be determined in a dramatically reduced time as compared to manual counting. Moreover, it
provides a potent tool for analyzing the efficacy of compounds against T. cruzi based on disease-causing
intracellular parasite forms.
Taken together, the studies described here provide greater understanding of the molecular events
implicated in the sensing of T. cruzi GPIs by the innate immune system. They also begin to reveal the
mechanisms involved in TLR2-mediated T. cruzi invasion as well as to provide evidence of host cell
signaling subversion that may be exploited by other intracellular pathogens. In addition, the high-content
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imaging-based approach may significantly contribute to accelerate the research based on in vitro studies
of the molecular components of the interplay between host cells and intracellular pathogens as well as the
discovery of novel lead compounds in the critical search for more efficient and less toxic drugs against T.
cruzi.
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Chapter 2: Activation of Toll-Like Receptors 2 and 6 Heterodimer by Synthetic
Trypanosoma cruzi Trypomastigote Glycosylphosphatidylinositols Is Enhanced by
Coexpression of CD14 and CD36 *

2.1.

Introduction

Trypanosoma cruzi is the etiologic agent of Chagas disease or American trypanosomiasis, which
is the most significant parasitic disease of the Americas. It is estimated that about 11 million people are
infected and up to 50,000 people may die every year due to progress to debilitating chronic
cardiomyopathy, heart failure, and digestive-tract abnormalities such as megacolon and megaoesophagous
(WHO, 2002, Dias et al., 2002). The main routes of T. cruzi transmission to humans are through
contaminated vector excrements, congenital contagion, and organ transplantation or blood transfusion
from infected donors (Tarleton et al., 2007). Although the disease is prevalent in Latin America, lately it
has also threatened North America and Europe due to the rising migration from endemic countries
(Schmunis et al., 2009, Yadon et al., 2009). Currently, there is no effective drug treatment for the
established chronic phase of the disease (Croft et al., 2005, Tarleton et al., 2007).
T. cruzi infection begins with a short acute phase characterized by high parasitemia which is
followed by a life-long chronic condition, when the host immune response against the parasite limits the
proliferation but is unable to eradicate the infection. In addition to controlling parasite replication, the
activation of the immune system during infection promotes a persistent inflammatory reaction in host
tissues. The resulting inflammatory response is considered to be the major cause of tissue damage and

* Note: This chapter is the basis for the manuscript 8 (see list of publications and manuscripts): Nohara, L.L., Yashunsky, D.Y.,
Marques, A.F., Torrecillhas, A.C.T., Ferguson, M.A.J., D.Y., Nikolaev, A.V. and Almeida, I.C. Preferential activation of TLR2/6
heterodimer by synthetic Trypanosoma cruzi trypomastigote glycosylphosphatidylinositols is enhanced by coexpression of CD14
and CD36. In preparation.
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subsequent organ dysfunction that underlies the development of the symptomatic chronic forms of the
disease in 30–40% of patients, which is mainly characterized by cardiomyopathy and gastrointestinal
disorders (Teixeira et al., 2006). Therefore, the amplitude and quality of the immune responses against T.
cruzi may determine not only the efficiency in the control of infection but also the severity of the
pathology. This highlights the importance of better understanding the initial interaction of T. cruzi and the
immune system.
At the onset of infection, the innate recognition of T. cruzi plays a crucial role in host resistance
or susceptibility to infection (Tarleton, 2007). It ensures the sensing and destruction of parasites by cells
of the innate immune system such as macrophages and dendritic cells, activation of these cells to generate
appropriate adaptive immune response and the sensing of infection by the primary targets of invasion by
the parasite, the nonimmune cells. It has been demonstrated that activation of macrophages by T. cruzi
strongly elicits the synthesis of proinflammatory cytokines, such as IL-12 and TNF-α. The main parasite
molecules responsible for this potent host proinflammatory response are the glycosylphosphatidylinositol
(GPI)-anchors highly purified from mucins of mammalian cell-derived T. cruzi trypomastigotes (tGPImucins) (Camargo et al., 1997, Almeida et al., 2000, Ropert et al., 2001).
GPI-anchored molecules are the major antigens expressed on the plasma membrane of parasitic
protozoa, such as T. cruzi, T. brucei, Plasmodium spp., and Leishmania spp. (Ferguson, 1999, GuhaNiyogi et al., 2001). Besides their role on the activation of the innate immunity during protozoan
infections, GPI-anchored molecules derived from these parasites are involved in the generation of reactive
nitrogen intermediates such as nitric oxide (NO), and the expression of adhesion molecules by host
macrophages and endothelial cells (Almeida et al., 2001).
Free or protein-associated GPIs of protozoan parasites are composed of a hydrophilic glycan core,
Manα1-2Manα1-6Manα1-4GlcNα1-6myo-inositol-1-PO4- (or Manα1-3Manα1-4GlcNα1-6myo-inositol-1PO4- , as in some Leishmania spp.(McConville et al., 1993)), which is further attached through the myoinositol-linked phosphate residue to a hydrophobic moiety containing a glycerolipid or a ceramide. An
extensive diversity of GPI structures and consequent variation in potency of their biological activity is
20

generated by the: (a) addition of carbohydrate residues, phosphorylated substituents such as
ethanolaminephosphate (EtNP) and 2- aminoethylphosphonate (AEP), and/or glucose (Glc)-1-PO4 on the
conserved glycan core (Man2-3GlcN), (b) acylation of the myo-inositol ring, and (c) different lipid
components on the hydrophobic moiety (Almeida et al., 2001, Guha-Niyogi et al., 2001, Ferguson, 1999,
McConville et al., 1993).
In T. cruzi, prominent differences in the GPI structure between distinct developmental stages are
observed and an initial correlation between their structure and proinflammatory activity has been reported
(Almeida et al., 2000, Campos et al., 2001).While the relatively inactive GPI anchors from noninfective
insect-derived epimastigotes (eGPIs) have a lipid moiety composed exclusively of saturated fatty acids
(C16:0 or C18:0) at the sn-2 position, the highly proinflammatory infective trypomastigote-derived GPIs
(tGPIs) contain mainly unsaturated fatty acids (C18:1 or C18:2) at this position besides additional
galactose residues along the glycan core (Almeida et al., 2000, Buscaglia et al., 2004). Although the
importance of the latter feature in the tGPI activity is still unclear, the presence of the unsaturated fatty
acid was proposed to be essential for the potency of tGPI in the induction of proinflammatory cytokines
and NO by macrophages (Camargo et al., 1997, Almeida et al., 2000, Campos et al., 2001). Thus far, it
has been shown that these inflammatory responses induced by T. cruzi GPIs are mediated by Toll-like
receptor 2 with subsequent activation of signaling pathways involving mitogen-activated protein (MAP)
kinase and NF-κB (Campos et al., 2001, Ropert et al., 2001).
Toll-like receptors (TLRs) are pattern-recognition receptors by which the innate immune system
senses pathogenic microorganisms through recognition of microbial components, the pathogen-associated
molecular patterns (PAMPs), which are structurally distinct from host molecules. TLRs play a key role in
the stimulation of innate immune response as well as the subsequent development of adaptive immunity.
Among the 12 mammalian TLRs described to date, TLR2 recognizes the largest variety of PAMPs
including peptidoglycan, lipoteichoic acid (LTA), lipoproteins and lipopeptides (e.g., FSL-1,
Pam3CSK4), lipoarabinomannan, zymosan, certain glycolipids, nonenterobacterial lipopolysaccharide
(LPS), and porins (Kumar et al., 2009, Akira et al., 2004). It is proposed that TLR2 recognizes this wide
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range of microbial products through functional cooperation with several other receptors and
coreceptors/accessory molecules.
Efficient signal transduction by TLR2 requires its heterodimerization with either TLR1 or TLR6.
TLR1/2 and TLR2/6 can discriminate triacylated (e.g, PAM3CSK4) and diacylated (e.g, FSL-1)
lipopeptides, respectively. TLR2 microbial recognition, signaling, and modulation of responses are also
known to require the presence of coreceptors/accessory molecules including lipopolysaccharide (LPS)binding protein (LPB) (Schroder et al., 2004), CD11b-CD18 integrin (Hajishengallis et al., 2005),
ganglioside GD1a (Liang et al., 2007), vitronectin (Gerold et al., 2008), CD14 (Drage et al., 2009, Nakata
et al., 2006, Henneke et al., 2001, Manukyan et al., 2005) and CD36 (Triantafilou et al., 2006, Drage et
al., 2009, Areschoug et al., 2009, Akashi-Takamura et al., 2008, Hoebe et al., 2005, Stuart et al., 2005).
These molecules are proposed to deliver the ligands to TLR2, and some may additionally contribute to
cytoplasmic signaling. CD14 is a GPI-anchored protein that is expressed on the cell surface. The role of
CD14 has been first described in LPS responsiveness by binding LPS and facilitating LPS transfer to
TLR4/MD-2 (Triantafilou et al., 2005). Later, it was demonstrated that CD14 also enhances many TLR2specific responses (Drage et al., 2009, Nakata et al., 2006, Henneke et al., 2001, Manukyan et al., 2005).
It has also been recently demonstrated that sensing of TLR2/TLR6 ligands such as LTA, FSL-1 and
lipomannan is impaired in primary macrophages isolated from mice with non-functional CD14 (JimenezDalmaroni et al., 2009). Furthermore, CD36, a transmembrane glycoprotein and one of three members of
the class B scavenger receptor family, was recently shown to cooperate with TLR2/6 in the sensing of
intact bacteria including Staphylococcus aureus (Stuart et al., 2005), E. coli (Baranova et al., 2008) as
well as bacterial ligands such as S. aureus LTA (Stuart et al., 2005, Hoebe et al., 2005), macrophageactivating lipopeptide-2 (Hoebe et al., 2005) and LPS (Baranova et al., 2008). Additionally, CD36 was
shown to interact with TLR2/1 (Triantafilou et al., 2006). In contrast to the interaction of CD14 and
TLR2, the associations of TLR2/TLR6 or TLR2/TLR1 with CD36 are not preformed and are ligandinduced (Triantafilou et al., 2006).

22

Interestingly, Krishnegowda et al. (2005) demonstrated that P. falciparum GPIs with distinct
structures differentially activate the TLR2/1 and TLR2/6 heterodimers. P. falciparum GPIs, which are
structurally distinct from T. cruzi GPIs, contain a diacylated glycerol moiety and an extra fatty acid at
position 2 of the myo-inositol ring. P. falciparum GPIs with three fatty acids were mainly recognized by
the TLR2/1 heterodimer, whereas those with two fatty acids interacted with TLR2/6 (Krishnegowda et
al., 2005). In addition, it has been shown that CD36 cooperates with TLR2 in pro-inflammatory cytokine
responses to P. falciparum GPIs (Patel et al., 2007).
Although previous studies demonstrated that TLR2 is essential in the sensing of T. cruzi GPIs, the
involvement of other receptors and coreceptors has not been investigated yet. Furthermore, it has been
proposed that T. cruzi GPI recognition requires TLR2 and TLR6 in addition to CD14 (Gazzinelli et al.,
2006); however, no experimental evidence has been provided so far. On the other hand, further studies on
the relationship between GPI anchor structure and its biological activity has been hampered due to the
heterogeneity and limited quantities of GPI anchors from natural sources. Recently, to clearly elucidate
the structural traits responsible for the tGPI proinflammatory activity as well as to determine whether
structural differences result in a differential receptor/coreceptor requirement, tGPIs containing sn1-O(C16:0)alkyl-2-O-(C18:1, C18:2, or C16:0)-acylglycerol lipid were chemically synthesized (Yashunsky et
al., 2006). Two major structural features were included in these GPIs, a 2-aminoethylphosphonate (AEP)
at the O6 position of the glucosamine moiety, which is a parasite-specific substituent, and unsaturated
fatty acids (C18:1 or C18:2) in the lipid moiety.
Here we provide the first clear evidence that T. cruzi synthetic tGPIs are preferentially recognized
by the TLR2/6 heterodimer and that CD14 expression leads to enhanced responses assessed as NF-κB
activation and IL-8 production by cells transfected with constructs encoding distinct TLRs and
coreceptors. Additionally, coexpression of CD14 and CD36 with TLR2/6 was able to further increase the
proinflammatory responses by tGPIs. We also demonstrate that stGPIs containing unsaturated fatty acids
in the sn-2 position of the alkylacylglycerophosphate moiety are more active than GPIs containing a
saturated fatty acid confirming previous predictions that the presence of unsaturated fatty acid is one of
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the traits responsible for the higher activity induced by GPIs derived from infective trypomastigote forms.
Moreover, we show that , surprisingly, GPI-mucins purified from T. cruzi trypomastigotes and their GPI
moieties are differentially recognized by TLR2/1 and TLR2/6 heterodimers.
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2.2.

Materials and Methods

Parasite and mammalian cell cultures
HEK293A (human embryonic kidney cells), kindly provided by Dr. German Rosas-Acosta (University of
Texas at El Paso), and LLC-MK2 (green monkey kidney epithelial cells) (ATCC) cells were cultured in
high glucose Dulbecco’s modified eagle medium (DMEM) supplemented with 10% fetal bovine serum
(FBS) at 37 oC, under 5% CO2 atmosphere. Tissue culture cell-derived trypomastigote forms of T. cruzi
(Y strain) (ATCC) were obtained 5 to 9 days after infection of LLC-MK2 monolayers as previously
described (Andrews et al., 1982). Cell cultures were regularly tested for Mycoplasma by polymerase
chain reaction (Uphoff et al., 2005).

Analysis of TLRs mRNA expression by reverse transcription-polymerase chain reaction (RT-PCR)
To determine the level of TLR mRNA expression in HEK293A, total RNA was isolated using TRIzol
Reagent (Invitrogen) according to the manufacturer’s recommendations and treated with RQ1 RNAsefree DNase (Promega) to degrade contaminant genomic DNA. The integrity of the total RNA was
evaluated by agarose gel electrophoresis. The presence of sharp bands corresponding to 28S and 18S
ribosomal RNAs was considered as an indicative of RNA integrity. Total RNA was quantitated and 0.5
µg of RNA was reverse transcribed using the First-Strand cDNA Synthesis Kit and oligo dT primer
(Fermentas) according to the manufacturer’s recommendations. A control reaction was performed in the
absence of reverse transcriptase. Human TLR1 to TLR10 specific primers from the TLR RT-Primer Set
(InvivoGen) were used for the amplification of TLRs mRNAs and the following human glyceraldehyde 3phosphate dehydrogenase (GAPDH) primers were used as control: GAPDH forward 5’TCCTGCACCACCAACTGC-3’

and

reverse

5’-GAGGGGCCATCCACAGTCTTCT-3’.

PCR

amplification was performed on a Mastecycler Thermal Cycler (Eppendorf) for 30 cycles using the
following cycling conditions for TLR primers: 95 °C for 2 min, followed by 35 cycles of 95 °C for 30
sec, 55 °C for 30 sec, 72 °C for 2 min, and then a final extension of 72 °C for 5 min. For GAPDH primers
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the annealing temperature was 65 °C. Lack of DNA contamination in the RNA preparations was verified
by PCR amplification of the cDNA synthesis control prepared in the absence of reverse transcriptase. A
positive control double stranded DNA provided in the kit was used to ensure proper amplification and to
visualize the following expected PCR fragments: TLR1 706 base pairs (bp), TLR2 657bp, TLR3 602bp,
TLR4 550bp, TLR5 493bp, TLR6 435bp, TLR7 387bp, TLR8 335bp, TLR9 312bp and TLR10 214bp.
The expected PCR fragment sizes were confirmed by running the PCR products on a 1.5% agarose gel.

TLR ligands
The following stimuli were used in the experiments as positive controls: Pam3Cys-SKKKK (P3C) and
FSL-1 (FSL) (EMC Microcollections) and, ultra pure lipopolysaccharide (LPS) from Escherichia coli
0111:B4 strain (InvivoGen).

Synthetic trypomastigote GPIs
Synthetic tGPIs containing sn1-O-(C16:0)alkyl-2-O-(C18:1, C18:2 or C16:0)acylglycerol (Yashunsky et
al., 2006) were provided by Dr. Andrei Nikolaev (Division of Biological Chemistry and Drug Discovery,
University of Dundee, UK).

Extraction of T. cruzi trypomastigote GPI-mucin and isolation of GPIs
Trypomastigotes were harvested from the supernatant of infected LLC-MK2 cells, washed twice in
phosphate-buffered saline (PBS), pH 7.4, and centrifuged at 2,000 g for 10 min at 4 °C. The parasite
pellet was then store at -80 oC until use. GPI-anchored trypomastigote mucins (tGPI-mucins) were
extracted as described previously (Almeida et al., 2000), with minor modifications. Briefly, the parasite
pellet was delipidated three times with a solution of chloroform:methanol:water (C:M:W, 1:2:0.8, v/v/v)
followed by chloroform:methanol (C:M, 2:1, v/v). Between extractions, the organic phase was separated
from the pellet by centrifugation at 2,000 g for 20 min, at room temperature. The resulting delipidated
parasite pellet was dried under nitrogen stream and extracted three times with 9% n-butanol. The aqueous
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phase, enriched with GPI-anchored proteins, was dried in a vacuum centrifuge and stored at -80 oC until
use. The sample was resuspended in 5% n-propanol and applied onto a POROS R2/10 column (0.46 × 10
cm, PerSeptive Biosystems, Framingham, MA) on a Waters Alliance 2695 HPLC system. The column
was eluted using a 5-80% n-propanol gradient, at a flow rate of 1 mL/min. To detect the trypomastigote
mucin-containing fractions, collected HPLC-fractions were screened by chemiluminescent enzyme-linked
immunosorbent assay (CL-ELISA) with anti-α-galactosyl (α-Gal) antibodies purified from the serum of
patients with chronic Chagas disease, as previously described (Almeida et al., 1994). The α-Gal-positive
fractions were pooled and dried in a vacuum centrifuge. To isolate the GPI moieties from
glycopolypeptide cores, tGPI-mucins were digested for 18 h at 37 oC with proteinase K (from
Tritirachium album, lyophilized powder, ≥30 units/mg protein, Sigma) at 1:5 enzyme:protein ratio in 100
mM ammonium bicarbonate, pH 8.0. After the incubation, the sample was heated at 100 oC for 5 min to
inactivate the enzymatic activity. Then, the released GPI anchors were extracted by n-butanol/water
partition essentially as described (Almeida et al., 2000). The butanolic phase (91% n-butanol, 9% water)
was dried in a vacuum centrifuge. Then, the GPI sample was further purified in reverse phase ziptip, built
in 200-µL micropipette tips with a small piece of glass-fiber filter and POROS R1 (C4) 50 resin (50-µm
average particle size, Applied Biosystems) (Whitney et al., 1998) in n-propanol. The ziptip was washed
with methanol and equilibrated with 5% n-propanol. The sample was resuspended in 5% n-propanol and
loaded onto the column. The column was sequentially washed with 5% n-propanol and 20% n-propanol
and then eluted with 80% n-propanol. The eluate was dried in a vacuum centrifuge.

Electrospray ionization-mass spectrometry (ESI-MS) analysis of GPIs
Synthetic and purified GPIs were resuspended in 50% n-propanol/10 mM ammonium acetate and
analyzed in an ESI-QTOF-MS (Qtof-1, Micromass, Waters). Spectra were collected in the negative-ion
mode at 50-2000 mass-to-charge (m/z) range. The nanospray source was set at 1.5-2.5 kV, and the source
and desolvation temperatures at 110 and 150 °C, respectively. Each GPI species was subjected to
fragmentation with collision energy from 30 to 50 eV.
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Quantification of myo-inositol content by gas chromatography-mass spectrometry (GC-MS) analysis
The myo-inositol content in the sample was determined by GC-MS as described (Ferguson, 1992).
Briefly, twenty pmol of scyllo-inositol (Sigma-Aldrich) internal standard was added to each sample in a
heat-cleaned (500 oC, 2 h), one-end flame-sealed borosilicate 250-µl capillary microtube (Sigma-Aldrich).
An external standard containing 20 pmol of myo-inositol (Sigma-Aldrich) and 20 pmol of scyllo-inositol
was also prepared. Samples were dried and subjected to strong acid hydrolysis with 50 µL of 6 M
constant boiling HCl at 110 °C for 24 h. The products were dried, redried upon 20 µL methanol addition,
and

derivatized

for

30

min

with

15

µL

freshly

made

trimethylsilyl

(TMS)

reagent

(hexamethyldisilazane:trimethylchlorosilane:pyridine, 15:5:100, v:v:v). The inositol-TMS derivatives
were analyzed on a TRACE GC Ultra gas chromatography system linked to a Polaris Q mass
spectrometer (GC–MS, Thermo Fisher Scientific) using a Supelco SP2380TM column (30 cm x 0.25 mm
ID x 0.25 µm). The initial oven temperature was set to 100 °C for 3 min and then a gradient of 15 °C/min
up to 250 °C was applied. The final temperature of 250 °C was kept for 5 min. The splitless injector was
held at 200 °C, the MS transfer line at 260 °C, and the carrier gas flow at 0.7 mL/min. Extracted-ion
chromatogram for myo-inositol was plotted using the diagnostic fragment ions at m/z 305 and 318. For the
myo-inositol quantification, the chromatogram peaks were integrated and the following formula was
applied: [area sample myo-inositol peak/area scyllo-inositol internal standard peak] x [amount of internal
standard/(area standard myo-inositol peak/ area standard scyllo-inositol peak)].

NF-κB-dependent CD25 expression in Chinese hamster ovary (CHO) reporter cells
Chinese hamster ovary (CHO) cells stably transfected with cDNA for human TLR2 or TLR4 and
constitutively expressing CD14 (Lien et al., 1999) were cultured in Ham’s F-12/DMEM supplemented
with 5% FBS, at 37 °C, 5% CO2. These cells have been stably transfected with a reporter NF-κB-driven
CD25 expression construct. Cells were plated in a 24-well tissue culture plate. In the following day, cells
were stimulated with tGPI-mucins or stGPIs, and incubated for 18 h, 37 oC, at 5% CO2 atmosphere. Cells
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were harvested with 1 mM EDTA-PBS on ice and washed twice with medium. Cells were counted, and
105 cells were incubated on ice with FITC-conjugated mouse monoclonal anti-human CD25 (clone
CD25-3G10, IgG1 isotype, Caltag Labs., Invitrogen) diluted 1:100 in PBS in the dark, for 1 h. After
labeling, cells were washed twice with 1 mM sodium azide in PBS, suspended in 1 mM sodium azide in
0.1% paraformaldehyde, and analyzed by flow cytometry for expression of surface CD25 using a
Beckman Coulter EPICS XL flow cytometer (Beckman Coulter). Samples were gated for live cells based
on forward and side scatter parameters, and 10,000 events per sample were collected and analyzed using
the EXPO32 software.

Expression constructs
Mouse CD14 (Underhill et al., 1999), MD-2 (Akashi et al., 2000, Mizushima et al., 1990) and
hemagglutinin (HA) epitope-tagged TLR1, TLR4, TLR6 (Hajjar et al., 2001) and TLR2 (Underhill et al.,
1999) constructs as well as the β-actin Renilla luciferase (Sweetser et al., 1998) and the reporter
endothelial leukocyte molecule (ELAM)-1-firefly luciferase (Schindler et al., 1994) constructs were
kindly provided by Dr. Richard Darveau (University of Washington, Seattle, WA). The mouse CD36
construct (Stuart et al., 2005) was generously provided by Dr. Kathryn J. Moore (Harvard Medical
School, Boston, MA). All plasmids used in mammalian cell transfections were purified using the
EndoFree Plasmid Purification Maxi Kit (Qiagen) according to manufacturer’s instructions.

HEK293A cell transfection and stimulation of transfected cells
HEK293A cells were seeded on 12-well plates (5 x 105 cells/well) the day before transfection. HEK293A
cells were transiently cotransfected with CD14, CD36, MD-2, and/or mouse TLR1, TLR2, TLR4, or
TLR2 alone, or a combination of TLR1 and TLR2 (TLR1/2), or TLR2 and TLR6 (TLR2/6) constructs
using Lipofectamine 2000 according to the manufacturer’s recommendations. For luciferase reporter
assays, cells were also cotransfected with ELAM-1-firefly luciferase and β-actin Renila luciferase. Total
DNA per well was normalized to 2 µg by adding empty vector. In the following day, the cells were plated
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in 96-well plates (4 x 104 cells/well). After 24 h, the cells were stimulated for 4 h (for luciferase reporter
assay) or 20 h (for IL-8 detection) at 37 oC with the TLR ligands in DMEM containing 10% FBS at
concentrations described in the figures.

Immunofluorescence and flow cytometry
In the preliminary experiments, the transfection efficiency was verified by transfection of pEGPF-N1
plasmid (Clontech) and analysis of enhanced green fluorescent protein (eGFP) expression by flow
cytometry or fluorescent microscopy (not shown). To confirm the expression of TLRs in transfected
HEK293A cells, 24 h after transfection, cells were plated on coverglass and in the following day cells
were washed with PBS and fixed with 4% paraformaldehyde (for surface staining) or fixed and
permeabilized with 0.1% Triton X-100 for 5 min on ice (for intracellular staining). Then, cells were
incubated with 1% bovine serum albumin (BSA) for 30 min followed by anti-HA (Convance) or rat antimouse CD14 (eBiosciences) antibodies (for staining of cells transfected with TLRs or with CD14,
respectively) for 1 h. After washing, samples were incubated with anti-mouse or anti-rat Alexa Fluor 488
or 594 (Molecular Probes) for 30 min. All steps were performed at room temperature. Slides were
mounted using Vectashield mounting media. Images were acquired on a Leica DMI 6000B microscope or
a Pascal 5L5M confocal microscope. For flow cytometry, transfected cells were harvested 48 h after
transfection, centrifuged and fixed with 4% paraformaldehyde. Subsequently, cells were stained as
described above. Ten thousand cells per sample were analyzed on a FACSCalibur flow cytometer (Becton
Dickinson, San Jose, CA).

Luciferase Reporter Assay for NF-κB Activation
Cells were washed once in PBS and lysed in Passive Lysis Buffer (Promega). The luciferase activity was
measured using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's
instructions. The relative luminescence units (RLU) were quantitated using the Luminoskan Ascent
luminometer (Thermo Fisher Scientific). Luciferase activity was expressed as the ratio of NF-κB
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dependent firefly luciferase activity to constitutively expressed Renilla luciferase activity. Results are
shown as the means ± standard deviation of triplicate wells.

IL-8 detection
After the 20 h-stimulation, cell culture supernatants were collected and stored at -80 oC until further
analysis. IL-8 was determined using the OptEIA Human IL-8 ELISA Kit (BD Biosciences) according to
the manufacturer’s instructions, except that the detection was carried out using a chemiluminescent
substrate (Supersignal West Pico, Pierce). The relative luminescence units (RLU) were quantitated using
the Luminoskan luminometer. Recombinant human IL-8 provided in the kit was used as standard.

Statistical analysis
Statistical significance was determined by Student’s t-test using GraphPad software (GraphPad Software,
Inc.). Differences were considered to be statistically significant at p value <0.05.
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2.3.

Results

Purity and quantification of synthetic tGPIs. The stGPIs used in these studies included a 2aminoethylphosphonate at the glucosamine moiety and unsaturated fatty acids (C18:1 and C18:2) in the
lipid moiety, which are T. cruzi-specific structural features (Yashunsky et al., 2006). Prior to biological
assays, the identity and purity of the GPIs were determined by mass spectrometry. The spectra showed
high intensity peaks corresponding to the expected molecular mass of the GPIs (data not shown). To
ensure that equal amounts of the distinct GPIs and tGPI-mucin were used in the comparative studies,
samples were quantified by myo-inositol analysis using GC-MS (data not shown).

stGPIs are biologically active. Previous work demonstrated that tGPI-mucins or the isolated tGPIs were
able to induce NF-κB dependent surface expression of CD25 in CHO/CD14 cells transfected with TLR2,
but not in cells transfected with TLR4, as well as cytokine production in macrophages in a TLR2dependent manner (Campos et al., 2001). To initially assess the biological activity of stGPIs, we used
CHO/CD14/TLR2 and CHO/CD14/TLR4 reporter cells which express CD25 upon TLR2- and TLR4dependent NF-κB activation, respectively (Figure 2.1). A significant CD25 expression was observed
upon TLR2-dependent NF-κB activation in cells stimulated with purified tGPI-mucins (at 30 nM) and
C18:1 and C18:2-stGPIs (at 100 nM), demonstrating that these synthetic GPIs are biologically active but
apparently less potent than native tGPI-mucins. On the other hand, very little or no activation
CHO/CD14/TLR4 reporter cells were observed even with higher amounts (up to 500 nM) of stGPIs.

HEK293A cell transfection model. In order to clearly investigate whether heterodimerization of TLR2
with TLR1 or TLR6 is important in the recognition of stGPIs, we used the widely applied HEK293A cell
transfection model. To delineate the TLRs and coreceptors involved in the recognition of stGPIs, the
TLR-deficient HEK293A cells were transiently transfected with constructs encoding distinct TLRs and
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coreceptors which allow the selective expression of these surface molecules, in a gain-of-function assay
(Figure 2.2.A). We initially verified by RT-PCR that HEK293A cells, a more adherent clone of the
conventional HEK293 cells, do not express mRNAs for TLR1, 2, 4, 7, 8, 9, and 10. However, low levels
of TLR3, 5, and 6 mRNAs were detected (data not shown). The cell surface expression of TLRs in
transfected cells was confirmed by performing immunofluorescence and flow cytometry using anti-HA
antibody to label the HA-tagged TLRs in non-permeabilized cells (data not shown). Additionally, we
evaluated the functionality of expressed receptors by cotransfecting plasmids encoding constitutively
expressed Renilla luciferase and NF-κB-driven firefly luciferase reporter. Upon stimulation with control
TLR ligands, the NF-κB luciferase reporter gene activity was measured (Figure 2.2.B). LPS, a TLR4
ligand, induced NF-κB activation only in cells expressing TLR4 while FSL and P3C, TLR2/6 and
TLR2/1 specific ligands, activated NF-κB in cells expressing TLR2. TLR6 and TLR1 expression in
addition to TLR2, increased the response to FSL and P3C, respectively. As expected, no response was
observed in cells transfected only with plasmids encoding the reporter plasmid, TLR1 or TLR6.
Additionally, IL-1 was used as positive control for NF-κB activation since parental HEK293A cells
respond to this cytokine (data not shown). The control TLR ligands were included in every assay to
ensure proper expression and functionality of TLRs.
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Figure 2.1. C18:1- and C18:2-stGPIs are biologically active and induce TLR2-dependent CD25
expression in CHO/CD14/TLR2 reporter cells.
TLR2-transfected CHO/CD14 reporter cells were stimulated with C18:1- or C18:2-stGPI (100, 10, 1, and
0.1 nM), whereas TLR4-transfected CHO/CD14 reporter cells were stimulated with 500, 250 and 50 nM
C18:1- or C18:2-stGPI. After incubation for 18 h, 37 oC, cells were stained with FITC-labeled anti-CD25
and analyzed by flow cytometry for expression of surface CD25. Non-related IgG1 antibody was used as
negative control for FITC-labeled anti-CD25. Results are shown as the mean ± standard deviation of
triplicate samples.
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CD14, CD36 and/or TLR-encoding plasmids
+ β actin promoter-driven Renilla luciferase
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Transfection
Figure 2.2. Expression of functional TLRs in HEK293A cells.
A. Schematic diagram of immunological/functional assays using transfected HEK293A cells. B. TLRdeficient HEK293A cells were transiently transfected with plasmids encoding ELAM-1-firefly luciferase
and β-actin Renilla luciferase in addition to mouse CD14, CD36, TLR1, TLR2, TLR6, TLR2 and 1,
TLR2 and 6 or TLR4. Control transfection indicates cells transfected with the reporter constructs and
empty vector (no TLR-enconding sequence). Forty-eight hours after transfection, cells were stimulated
with the indicated TLR ligands for 4 h at 37 °C. The luciferase activity was measured using the DualLuciferase Reporter Assay System. Luciferase activity is expressed as the ratio of NF-κB-dependent
firefly luciferase activity to constitutively expressed Renilla luciferase activity (Luc/Ren luc ratio).
Results are shown as the mean ± standard deviation of triplicate wells.
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C18:1- and C18:2-stGPIs induce stronger NF-κ
κB activation in TLR2/6-expressing cells than in
TLR2/1-expressing cells. Although it has been claimed that TLR2/6 heterodimer in addition to CD14 are
involved in the recognition of T. cruzi GPIs (Gazzinelli et al., 2006), no clear experimental evidence has
been demonstrated to date. To determine whether recognition of T. cruzi GPIs is dependent on the
heterodimerization of TLR2 with either TLR1 or TLR6, we assessed the activation of NF-κB in
HEK293A cells expressing TLR2/1 or TLR2/6 (Figure 2.3). In our first experiments, we included CD14
in all transfections since previous work has been performed in macrophages and CHO cells that
constitutively express CD14 (Campos et al., 2001). C18:2-stGPI induced NF-κB activation measured as
the ratio between NF-κB-driven firefly luciferase activity (gene reporter) and constitutively expressed
Renilla luciferase activity (control) (Figure 2.3.A). NF-κB activation was significantly higher in TLR2/6expressing cells when compared to cells transfected with the reporter constructs and empty vector (no
TLR-encoding sequence), than in TLR2/1-expressing cells. Similar results were obtained with C18:1stGPIs (Figure 2.3.B).
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Figure 2.3. C18:1- and C18:2-stGPIs are biologically active and induce stronger NF-κB activation in
TLR2/6-expressing cells than in TLR2/1-expressing cells.
Transfected HEK293A cells were stimulated for 4 h at 37 °C with (A) C18:2- or (B) C18:1-stGPI at the
indicated concentration (1.25, 2.5, 5, or 10 µM), and NF-κB activation was measured as described in
Figure 2.2. In each assay, P3C and FSL were used as positive controls for TLR2/1 and TLR2/6,
respectively (data not shown). Control, cells transfected with the reporter constructs and empty vector (no
TLR-enconding sequence). Results are shown as the mean ± standard deviation of triplicate wells.
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TLR2/6-dependent NF-κ
κB activation by stGPIs and live trypomastigotes seems to be enhanced in
the presence of CD14 and CD36. It has been proposed that CD14 plays a role in the sensing of T. cruzi
GPIs since CHO cells used in initial studies as well as macrophages express CD14. To clarify whether
CD14 is strictly essential in the recognition of T. cruzi GPIs, we stimulated cells expressing TLR2/6 plus
CD14 or TLR2/6 only with C18:2-stGPI (Figure 2.4.A). Clearly, CD14 expression conferred higher NFκB activation as compared to cells expressing TLR2/6 only. In view of recent reports demonstrating that
CD36 cooperates with TLR2/6 in the sensing of several pathogenic microorganisms including P.
falciparum GPI anchor (Patel et al., 2007), we sought to evaluate whether CD36 collaborates with
TLR2/6 in the induction of NF-κB by stGPIs. Upon stimulation with C18:2-stGPI, a slight but significant
increase in the response was observed in cells expressing CD36 in addition to TLR2/6 in comparison to
cells transfected with TLR2/6 only. Unexpectedly, coexpression of CD14 and CD36 with TLR2/6
resulted in even higher responsiveness. No response was observed in cells expressing CD14 or CD36 in
the absence of TLR2/6 expression. Similar results were observed when transfected cells were stimulated
with live trypomastigotes (Figure 2.4.B).
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Figure 2.4. TLR2/6-dependent NF-κB activation by stGPIs and live trypomastigotes seems to be
enhanced in the presence of CD14 and CD36.
Transfected HEK293A cells were stimulated for 4 h at 37 °C with C18:2-stGPI (A) or live
trypomastigotes (B) at a host cell:parasite ratio of 1:20 or 1:40 as described in Figure 2.2. Results are
shown as the mean ± standard deviation of triplicate wells.
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Assessment of TLR-dependent IL-8 production in transfected HEK293A cells and confirmation of
CD14 and CD36 participation in stGPI recognition by TLR2/6. The use of NF-κB activation has been
widely applied as a measure of TLR stimulation (Krishnegowda et al., 2005, Hajjar et al., 2001). Here,
stimulation of transfected cells with the control ligands FSL, P3C and LPS resulted in high induction of
luciferase activity (NF-κB activation) (Figure 2.2.B) which implies that TLR stimulation by these ligands
has a strong NF-κB component. Nevertheless, in our hands, stimulation of transfected cells with stGPIs
consistently resulted in significant but lower luciferase readouts (Figure 2.3). This could indicate that
either stGPIs are weaker TLR activators or the stimulation of TLRs induced by these molecules results in
activation of other signaling pathways besides NF-κB signaling. In the second case, the NF-κB readout
might not be the best indication of TLR stimulation. Therefore, we sought to measure the TLR-dependent
cytokine production which is a downstream event (Figure 2.5.A). We measured levels of IL-1β, IL-10,
and TNF-α secretion upon stimulation of transfected cells with stGPIs; however, only low amounts were
detected (data not shown). On the other hand, we observed high production of IL-8 in transfected cells
stimulated with stGPIs (Figure 2.5.B). Using this approach, we were able to confirm that activation of
TLR2/6 heterodimer by C18:2-stGPIs is clearly enhanced by coexpression of CD14 and CD36.

Correlation between stGPI structure and activity. Previous studies demonstrated that GPIs isolated
from the infective T. cruzi trypomastigote forms are stronger inducers of cytokine production by
macrophages than GPIs isolated from non-infective epimastigote forms (Almeida et al., 2000). It has been
proposed that the structural differences such as differences in the lipid at sn-2 position might play a role in
the activity of these GPIs. Hence, we compared the activity of stGPIs containing C18:2, C18:1 or C16:0
lipids at sn-2 position. stGPIs containing unsaturated fatty acids at sn-2 position, that is C18:2 and C18:1,
induced higher IL-8 secretion in transfected cells than stGPIs containing saturated fatty acid (C16:0)
(Figure 2.5.B). Interestingly, upon stimulation with C16:0-stGPI, no IL-8 production was observed in
cells expressing TLR2/6 only or TLR2/6 plus CD36 as opposed to C18:2- and C18:1-stGPIs. In addition,
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coexpression of CD14 and CD36 enhanced the TLR2/6-dependent responses to C18:2-, C18:1- and
C16:0-stGPIs. However, it is apparent that CD14 expression together with TLR2/6 is essential for C16:0stGPI recognition while the additional expression of CD36 promoted only a marginal increase in the
response.
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Figure 2.5. TLR2/6-dependent IL-8 secretion in transfected HEK293A cells.
A. Measurement of TLR-dependent IL-8 secretion in transfected HEK293A cells. TLR-dependent IL-8
secretion is a downstream event that results from activation of several signaling pathways including NFκB signaling. B. stGPIs-induced TLR2/6-dependent IL-8 secretion in transfected HEK293A cells is
significantly enhanced by coexpression of CD14 and CD36. HEK293A cells were transiently transfected
with plasmids encoding CD14, CD36 and/or TLRs. Forty-eight hours after transfection, cells were
stimulated with the indicated TLR ligands for 24h at 37 °C. TLR-dependent IL-8 secretion was measured
by ELISA in the supernatant of the cells. Results are shown as the mean ± standard deviation of triplicate
wells.
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Trypomastigote GPI-mucins and stGPIs are differentially recognized by TLR2/1 and TLR2/6
heterodimers. GPI-mucins purified from T. cruzi trypomastigostes were shown to induce TLR2dependent proinflammatory cytokine production by inflammatory and bone-marrow murine macrophages
(Campos et al., 2001). To ascertain that the recognition of tGPI-mucins by TLR2 requires the
heterodimerization with TLR6 in a similar manner as stGPIs, we evaluated the activity of tGPI-mucins in
the transfected cells. Upon stimulation with tGPI-mucins, IL-8 production by cells expressing TLR2/6
plus CD14 and CD36 was higher than in cells expressing TLR2/6 only as observed with tGPIs (Figure
2.6). However, our results indicated that tGPI-mucins are more potent than C18:2-stGPI, since the former
at a 20-fold lower concentration (0.1 µM) showed the same IL-8 inducing activity as the latter at 2 µM.
Surprisingly, while the levels of IL-8 secretion induced by stGPI were much lower in cells expressing
TLR2/1 plus CD14 and CD36 in a similar way to cells expressing TLR2/6 only, the response to tGPImucins at 0.1 µM was remarkably higher in cells transfected with TLR2/1 plus CD14 and CD36 as
compared to cells expressing TLR2/6 plus CD14 and CD36. On the other hand, no or very little
activation of TLR4 (co-expressed with CD14 and CD36) was observed upon stimulation with either
C18:2-stGPI or tGPI-mucin.
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Figure 2.6. GPI-mucins purified from T. cruzi trypomastigotes and stGPIs are differentially recognized
by TLR2/1 and TLR2/6 heterodimers, respectively.
HEK293A cells were transiently transfected with plasmids encoding CD14, CD36 and/or TLRs. Fortyeight hours after transfection, cells were stimulated with the indicated TLR ligands for 24h at 37 °C.
TLR-dependent IL-8 secretion was measured by ELISA in the supernatant of the cells. Results are shown
as the mean ± standard deviation of triplicate wells.
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2.4.

Discussion

Several studies have demonstrated that various protozoan parasites activate host macrophages
triggering the production of proinflammatory cytokines and nitric oxide which can contribute to both
disease pathogenesis and host resistance to infection (Gazzinelli et al., 2006, Seder et al., 1999, DebierreGrockiego et al., 2010, Gowda, 2007, Raes et al., 2007, Brunet, 2001, Teixeira et al., 2002). The main
parasite molecules that mediate these proinflammatory responses are GPIs, the predominant surface
constituents of parasites such as T. cruzi, T. brucei, Plasmodium spp., and Leishmania spp. (Ferguson,
1999, Guha-Niyogi et al., 2001). The GPIs of different organisms strikingly vary in their overall structure
and in the ability to activate macrophages (Almeida et al., 2001, Ropert et al., 2002).
T. cruzi GPIs were shown to strongly activate TLR2 resulting in the activation of MyD88dependent signaling pathways including NF-κB and MAPKs and downstream expression of cytokines
and nitric oxide (Campos et al., 2001, Ropert et al., 2001). However, the role of other TLRs and
accessory molecules in the recognition of T. cruzi GPIs has not been elucidated yet. In this study we have
conclusively demonstrated that synthetic T. cruzi tGPIs are sensed by the innate immune system, mainly
through the TLR2/6 heterodimer. This result is consistent with previous findings demonstrating that
TLR2/6 heterodimers recognize a variety of microbial components that share a common hydrophobic
moiety with two lipid tails, similarly to T. cruzi GPIs, such as Staphylococcus aureus LTA and diacylated
mycobacterial lipopeptides (Akira et al., 2004). Additionally, innate immune responses to P. falciparum
GPIs containing two fatty acids were shown to be mediated mainly through TLR2/6 (Krishnegowda et al.,
2005).
Conversely, our results revealed that tGPI-mucins strongly activated cells expressing the TLR2/1
heterodimer which has been implicated in the recognition of triacylated molecules such as GPIs from P.
falciparum and bacterial lipopeptides (e.g, PAM3CSK4). Since it has been established that the biological
activity of tGPI-mucins is essentially attributed to the GPI anchor (Almeida et al., 2000), the differential
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recognition of tGPI-mucins and stGPIs by TLR2/1 and TLR2/6, respectively, was a surprising finding.
Recent studies on the crystal structures of TLR2/1 and TLR2/6 revealed that ligand-induced
heterodimerization of extracellular domains results in formation of a ‘‘m’’ shaped dimeric structure and
brings the two intracellular Toll/interleukin-1 receptor-like domain (TIR) domains into close proximity,
leading to initiation of signaling (Jin et al., 2007, Kang et al., 2009). It was also demonstrated that several
subtle structural features of the ligands contribute to ligand specificity and subsequent activation of the
TLR2 heterodimers. The intriguing finding that tGPI-mucins are mainly recognized by TLR2/1
heterodimer suggests that the highly O-glycosylated polypeptide core linked to the GPI anchor (Almeida
et al., 1994) may affect the solubility and/or conformation of the GPI moiety, thus facilitating its
recognition by distinct TLR2 heterodimers. Voss et al. (2007) demonstrated that the bioactivity of
lipopeptides which are TLR2 agonists is critically dependent on their solubility (Voss et al., 2007).
Alternatively, the tGPI-mucin glycoprotein moiety which contains numerous sialylated O-glycans linked
to the protein (Almeida et al., 1994), while hindering the interactions in the larger hydrophobic interface
of TLR2 and TLR6, it might substantially interact with TLR1 promoting a stable binding and
dimerization of the TLR2 and TLR1. This interaction between the glycoprotein and TLR1 may
compensate for the lack of stabilization of the TLR2/1 heterodimer by a third lipid chain. Moreover, it
remains to be elucidated whether the presence of up to four extra galactose residues along the glycan core
in the case of tGPIs from tGPI-mucins (Almeida et al., 2000) might play an important role in the
biological activity of tGPIs. If so, this might explain as well the difference in proinflammatory activity
between the stGPIs and native tGPI-mucins.
The crystal structure of the TLR2 heterodimers also revealed that the two fatty acids of the
ligands are inserted into the internal hydrophobic pocket of TLR2 (Kang et al., 2009, Jin et al., 2007).
The volume of this pocket allows structural flexibility of the lipids including slight modifications in the
length and chemical structure of the lipids. Characterization of the contribution of the lipid moiety to the
TLR2-dependent pattern recognition showed that lipopeptides containing distinct saturated lipids bound
in ester linkage to the cysteine residue activated NF-κB to different degrees in the order palmitic (C16:0)
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> stearic (C18:0) > lauric (C12:0) > octanoic (C8:0) acid (Chua et al., 2007). In addition, BuwittBeckmann et al. (2005) found that the TLR2-dependent responses to lipopeptides were usually higher
when cells stimulated with lipopeptides containing ester-bound oleic (C18:1) or linoleic (C18:2) acids
than palmitic acid (C16:0) (Buwitt-Beckmann et al., 2005). Regarding T. cruzi GPIs, it has been proposed
that the presence of unsaturated fatty acids in the lipid moiety may be responsible for the higher
proinflammatory activity of the infective trypomastigote-derived GPIs (tGPIs) as compared to the
noninfective epimastigote-derived GPIs (eGPIs) (Almeida et al., 2000, Camargo et al., 1997). By using
the synthetic GPIs containing distinct lipids at the sn-2 position, we clearly demonstrated that the tGPI
lipid composition at sn-2 position does not affect the specificity of TLRs (TLR2/6 vs. TLR1/2) required
for recognition of these molecules. However, the lipid moiety significantly influenced the potency of the
cellular responses induced by tGPIs. Clearly, in our model, stGPIs containing unsaturated fatty acids
(C18:1 and C18:2) are more potent activators of TLR signaling than stGPIs containing saturated fatty
acids (C16:0), although we cannot exclude the possibility that this could be a result of the differences in
the fatty acid length, as observed in the case of lipopeptides (Buwitt-Beckmann et al., 2005).
Furthermore, we speculate that the differences in proinflammatory activity (IL-8 production)
between stGPIs and tGPI-mucins observed here might also be due to an eventual difference in cis-trans
(or Z-E) isomerism of the unsaturated fatty acids found in these molecules. While the synthetic GPIs used
here contain typical oleic (C18:1) or linoleic (C18:2) acid, with double bound(s) in cis (Z) configuration
at C9 (oleic) or C9,12 (linoleic) (Yashunsky et al., 2006), we have not determined whether the native
tGPIs obtained from tGPI-mucins contain the same C18:1 and C18:2 isomers. Alternatively, native tGPIs
could contain trans isomers of oleic and linoleic acids, namely elaidic (trans-9-octadecadenoic acid) and
linolelaidic acid (trans-9,trans-12-octadecadienoic acid), or even a mixture of cis and trans isomers.
Besides the geometric isomerism, we also need to investigate the actual position of the double bond(s) at
the C18:1 and C18:2 fatty acids found in native tGPIs. It is well established that geometric (cis-trans)
isomers of monoenoic or dienoic fatty acids as well as isomers with different double-bond location(s)
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might have completely distinct biological activities on macrophages and other cell types (Mensink, 2005,
Mozaffarian, 2006, Mozaffarian et al., 2009).
Most TLR2 ligands are amphiphilic molecules and due to their hydrophobic component, these
molecules have the tendency to form aggregates. It has been proposed that the innate immune system
utilizes specific accessory molecules for proper recognition of these aggregates (Seong et al., 2004). A
typical example is LPS-binding protein (LBP) which facilitates the transfer of amphiphilic bacterial
lipopolysaccharide (LPS) monomers from LPS aggregates to CD14, which in turn delivers it to the
coreceptor MD-2 to initiate TLR4 signaling (Triantafilou et al., 2005). Recent studies demonstrated the
role of several coreceptors in TLR2 signaling including CD14 (Drage et al., 2009, Nakata et al., 2006,
Henneke et al., 2001, Manukyan et al., 2005) and CD36 (Triantafilou et al., 2006, Drage et al., 2009,
Areschoug et al., 2009, Akashi-Takamura et al., 2008, Hoebe et al., 2005, Stuart et al., 2005).
Nevertheless, thus far the role of accessory molecules in the innate recognition of T. cruzi GPIs has
remained poorly studied. Here, we observed a synergistic interaction between TLR2/6 heterodimer and
the accessory molecules CD14 and CD36 in the induction of NF-κB activation as well as IL-8 secretion
by tGPIs. Although the contribution of CD14 and CD36 separately in the responses to tGPIs was similar,
coexpression of these accessory molecules resulted in additive effect in the TLR2/6-mediated responses.
Interestingly, for C16:0-containing stGPI, which did not show activity in cells solely expressing TLR2/6
at the same concentrations as C18:1- and C18:2-tGPIs, CD36 co-expression with TLR2/6 was unable to
enhance the TLR2/6 activation.
CD14 has been proposed to up-regulate signaling by delivering molecules to TLRs and by
accumulating the ligand at signaling complexes in lipid raft microdomains where CD14 is associated with
src family kinase and heterodimeric G proteins (Lentschat et al., 2005, Solomon et al., 1998). However,
due to its lack of a transmembrane domain, CD14 has not been implicated in induction of signaling
pathways. In this regard, the role of CD36 has been less clear since it was reported that CD36 can initiate
signaling cascades (Medeiros et al., 2004, Moore et al., 2002, Rahaman et al., 2006). Earlier studies
demonstrated that associations between CD36 and TLR2 heterodimers are not preformed and the
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interaction is ligand-induced (Triantafilou et al., 2006, Jimenez-Dalmaroni et al., 2009). Recently, further
insights into the role of CD36 in TLR2 signaling were provided. Jimenez-Dalmaroni et al. (2009) showed
that CD36 directly and selectively binds to negatively charged moieties of TLR2/6 ligands
(polyglycerophosphates and myo-inositol phosphate for LTA and phosphatidylinositol mannosides
(PIMs), respectively). It was proposed that CD36 binds and transfers diacylglycerol ligands to CD14,
which subsequently transfers the ligands to TLR2/TLR6 in a similar way to its role in TLR4 signaling
(Triantafilou et al., 2005). Additionally, their results revealed that the role of CD36 as a co-receptor solely
involves the ectodomain of CD36, and not signaling or endocytosis mediated by the intracellular domains
of CD36 as previously proposed (Nilsen et al., 2008, Stuart et al., 2005, Triantafilou et al., 2006).
Conversely, Stewart et al. (2010) proposed that CD36-dependent Lyn kinase activation modulates TLR
heterodimer formation, signal transduction and phagocytosis (Stewart et al., 2010). The mechanisms by
which CD14 and CD36 cooperate with TLR2/6 in the recognition of T. cruzi GPIs and induction of
signaling pathways remains to be clarified.
TLR2-mediated signaling has been implicated not only in the innate immune responses to T. cruzi
but also in several aspects of the interaction between this parasite and the host such as induction of
dendritic cell response, type 1 immunity, cardiomyocyte hypertrophy as well as survival of infected host
cells (Gazzinelli et al., 2006, Ropert et al., 2008, Golgher et al., 2004). CD36 is also involved in many
biological processes from phagocytosis of bacteria and endocytic uptake of altered self components,
including oxidized phospholipids, apoptotic cells and amyloid proteins to platelet biology, angiogenesis
and in the aetiopathology of atherosclerosis and cardiovascular diseases (Areschoug et al., 2009, Ge et al.,
2005, Febbraio et al., 2007, Silverstein et al., 2009). The link between these diverse functions of both
TLR2 and CD36 and their ability to act as a parasite-recognition molecule for T. cruzi GPIs remains to be
elucidated. Further studies are underway to clarify the overall in vivo role of CD36 during T. cruzi
infection.
Finally, in addition to elucidating the mechanism by which the host innate immune system
initially recognizes the major surface molecules of T. cruzi, our current findings may contribute to a better
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understanding of the modulation of host inflammatory responses by the parasite for development of more
efficient therapeutic interventions for Chagas disease.
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Chapter 3: Exploitation of an Innate Immune Receptor by an Intracellular Pathogen: TollLike Receptor 2-Mediated Trypanosoma cruzi Infection †

3.1.

Introduction

Intracellular pathogens have evolved numerous mechanisms to successfully infect, survive, and
proliferate within the cell, which are essential features for completion of their life cycle in the mammalian
host cell (Sibley et al., 2000, Carmen et al., 2007, Ibarra et al., 2009, Schroeder et al., 2008, Seveau et al.,
2007). The infective trypomastigote forms of the intracellular protozoan parasite Trypanosoma cruzi, the
etiologic agent of Chagas disease (American trypanosomiasis), are capable of invading a wide variety of
phagocytic and non-phagocytic mammalian cell types, although the pathology of the disease is mainly
related to persistence of the parasite in non-phagocytic cells (Andrade et al., 2005, Dias et al., 2008). In
striking contrast to phagocytosis or other actin-driven internalization processes exploited by intracellular
pathogens (Conner et al., 2003, Dramsi et al., 1998), T. cruzi entry into non-phagocytic cells is
significantly enhanced upon disruption of the host cell actin cytoskeleton (Woolsey et al., 2004, Andrade
et al., 2004, Woolsey et al., 2003, Tardieux et al., 1994). The two best characterized trypomastigote host
cell invasion strategies are the lysosome-mediated invasion pathway (Burleigh et al., 2002) and the
plasma-membrane invagination process (Woolsey et al., 2003, Burleigh, 2005).
In the lysosome-mediated pathway, T. cruzi elicits signals that lead to mobilization of calcium
from host cell thapsigargin-sensitive intracellular stores (Burleigh et al., 2002), subsequent transient
reorganization of the cortical actin cytoskeleton, and host cell lysosome recruitment to the site of parasite
entry, resulting in the formation of a parasitophorous vacuole with lysosomal properties (Burleigh et al.,
† Note: This chapter is the basis for the manuscript 7 (see list of publications and manuscripts): Nohara, L.L. and Almeida, I.C.

Exploitation of an innate immune receptor by an intracellular pathogen: Toll-Like Receptor 2-mediated Trypanosoma cruzi
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2002). Interestingly, this calcium-regulated lysosomal exocytosis process was later shown to be a general
mechanism of mammalian cell plasma membrane repair (Andrews, 2002, Reddy et al., 2001). On the
other hand, in the plasma membrane invagination pathway, trypomastigotes enter host cells enveloped in
a cell plasma membrane-derived vacuole devoid of lysosomal markers. This parasitophorous vacuole then
gradually fuses to lysosomes (Woolsey et al., 2003, Burleigh, 2005). Surprisingly, it was demonstrated
that lysosomal fusion is a critical event not only for escape of T. cruzi from the vacuole and
differentiation from trypomastigotes to amastigotes, and thus for completion of the intracellular cycle, but
also for intracellular retention in favor of a productive infection (Andrade et al., 2004). In addition,
although both mechanisms are actin-independent, Woolsey and Burleigh (2004) showed that host cell
actin reassembly is essential for fusion of lysosomes with plasma membrane-derived vacuole and,
consequently, for retention of the parasite inside the host cell. In addition, several other host cell signaling
pathways and surface receptors were shown to be exploited by T. cruzi during the invasion process
(Burleigh et al., 2002, Andrade et al., 2005, Villalta et al., 2009).
Notably, T. cruzi employs a variety of molecules and strategies not only to infect host cells but
also to modulate the host immune responses (Tarleton, 2007). The major antigens on the plasma
membrane of T. cruzi trypomastigotes are glycosylphosphatidylinositol (GPI)-anchored mucins (tGPImucins), which are heavily glycosylated glycoproteins (Acosta-Serrano et al., 2007, Buscaglia et al.,
2006). tGPI-mucins and their isolated GPI anchors (tGPIs) were shown to strongly elicit the synthesis of
proinflammatory cytokines by macrophages through a signaling pathway dependent on upstream
activation of Toll-like receptor 2 (Campos et al., 2001, Ropert et al., 2001).
Toll-like receptors (TLRs) are evolutionarily conserved innate immune receptors expressed in
various immune and nonimmune cells of the mammalian host (Sandor et al., 2005). TLRs are capable of
sensing organisms ranging from protozoa, bacteria, fungi or viruses upon recognition of specific ligands
from the pathogen, the pathogen-associated molecular patterns (PAMPs) (Akira et al., 2004). Hence,
TLRs play a key role in the stimulation of innate immune responses, which is the first line of defense that
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protects the host from invading pathogens, as well as in the subsequent development of adaptive
immunity (Akira et al., 2004, Kawai et al., 2006).
Although it has been demonstrated that T. cruzi tGPIs induced the activation of TLR2, it
remained elusive how these surface molecules are presented to the receptor. Previous studies indicated
that surface antigens can be released in soluble and/or membrane-bound form (Goncalves et al., 1991,
Ouaissi et al., 1992, Pinho et al., 2002). In this view, our group has recently demonstrated that cellderived T. cruzi trypomastigote forms release vesicles containing a diversity of molecules known to play
important roles in host cell adhesion and invasion by the parasite (Torrecilhas et al., unpublished). T.
cruzi vesicles were shown to trigger proinflammatory response in macrophages via TLR2 activation
(Torrecilhas et al., unpublished) in a similar way to tGPIs. Unexpectedly, a remarkable increase in both
the percentage of infected cells, and number of intracellular parasites per cell, were observed in host cells
exposed to vesicles (Torrecilhas et al., unpublished). Moreover, consistent with these observations,
BALB/c mice pre-treatment with vesicles and subsequently infection with T. cruzi demonstrated not only
a significant exacerbation in the inflammation of the heart and hastened mortality, but also significantly
higher parasite load in the heart (Trocoli Torrecilhas et al., 2009). Further, in vitro studies demonstrated
that the enhancement of host cell invasion by trypomastigotes induced by the vesicles was clearly
dependent on TLR2 (Torrecilhas et al., unpublished), which seems quite contradictory since TLRs play
major roles in the host defense against pathogens.
Here, we further evaluated the role of TLR2 in host cell invasion by T. cruzi. We demonstrate that
in addition to trypomastigote vesicles, distinct TLR2-specific ligands significantly increase parasite
infection in phagocytic and non-phagocytic cells. Moreover, silencing of TLR2 by short hairpin (sh) RNA
confirmed the participation of TLR2 in the invasion process. We have also observed that host cell
intracellular calcium levels are essential in the enhanced parasite infectivity and that TLR2 activation
induces host cell actin depolymerization, which may facilitate parasite internalization. Taken together, we
propose that TLR2-activation by T. cruzi molecules facilitate host cell invasion by subverting the
established role of TLR2.
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3.2.

Materials and Methods

Parasite and mammalian cell cultures
NIH3T3 (mouse fibroblast cell line) (ATCC) cells were maintained in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% bovine calf serum (BCS) and antibiotics at 37 °C under 5%
CO2 humidified atmosphere. RAW267.4 (mouse monocyte/macrophage cell line) and LLC-MK2 (green
monkey kidney epithelial cell line) cells from ATCC were maintained in DMEM supplemented with 10%
heat-inactivated fetal bovine serum (FBS) and antibiotics. Tissue culture-derived Trypanosoma cruzi
trypomastigote forms (Y strain) (ATCC) were obtained from the supernatant of infected LLC-MK2 cells
5 to 9 days post-infection (Andrews et al., 1982). Cell cultures were regularly tested for Mycoplasma by
polymerase chain reaction (Uphoff et al., 2005).

Analysis of TLRs mRNA expression by reverse transcription-polymerase chain reaction (RT-PCR)
To determine the level of TLR mRNA expression in NIH3T3 cells, total RNA was isolated using TRIzol
Reagent (Invitrogen) according to the manufacturer’s recommendations and treated with RQ1 RNAsefree DNase (Promega) to degrade contaminant genomic DNA. The integrity of the total RNA was
evaluated by agarose gel electrophoresis. The presence of sharp bands corresponding to 28S and 18S
ribosomal RNAs was considered as an indicative of RNA integrity. Total RNA was quantitated and 0.5-1
µg of RNA was reverse transcribed using the First-Strand cDNA Synthesis Kit and oligo dT primer
(Fermentas) according to the manufacturer’s recommendations. A control reaction was performed in the
absence of reverse transcriptase. Mouse TLR1 to TLR9 specific primers from the TLR RT-Primer Set
(InvivoGen) were used for the amplification of TLRs mRNAs and the following mouse β-actin primers
were used as control:

β-actin forward 5’-ATTGTTACCAACTGGGACGA-3’ and reverse 5’-

AAACGCAGCTCAGTAACAGTC-3’. PCR amplification was performed on a Mastercycler Thermal
Cycler (Eppendorf) for 35 cycles using the following cycling conditions for TLR primers: 95 °C for 2
min, followed by 35 cycles of 95 °C for 30 sec, 55 °C for 30 sec, 72 °C for 2 min, and then a final
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extension of 72 °C for 5 min. For β-actin primers the annealing temperature was 60 °C. Lack of DNA
contamination in the RNA preparations was verified by PCR amplification of a cDNA synthesis control
prepared in the absence of reverse transcriptase. A positive-control double stranded DNA provided in the
kit was used to ensure proper amplification and to visualize the following expected PCR fragments:
309bp (TLR1), 400bp (TLR2), 415bp (TLR3), 997bp (TLR4), 545bp (TLR5), 575bp (TLR6), 610bp
(TLR7), 769bp (TLR8) and 808bp (TLR9). The expected PCR fragment sizes were confirmed by running
the PCR products on a 1.5% agarose gel.

Stimuli
The following stimuli were used in the experiments: Pam3Cys-SKKKK (P3C) and FSL-1 (FSL) (EMC
Microcollections), ultra pure lipopolysaccharide (LPS) from E. coli 0111:B4 strain (InvivoGen), zymosan
A from S. cerevisiae (Sigma-Aldrich), S. aureus lysate and T. cruzi trypomastigote shed vesicles
(indicated as parasite equivalents). Staphylococcus aureus lysate was obtained as follow: S. aureus
(ATCC) cells were grown overnight in nutrient broth. The cell suspension was centrifuged and
resuspended in phosphate buffered saline (PBS). Bacterial density was resolved by limiting dilution and
determining the colony-forming units (CFUs). Bacteria (1 x 109 cells/mL) were killed by sequential
cycles of freeze-thaw and sonication, and then stored at -20 °C until use. T. cruzi trypomastigote shed
vesicles were obtained from the supernatant of trypomastigotes, 5 to 9 days after the infection of
LLCCMK2 cells. Parasites (1 x 108 parasites/mL) were incubated for 3 h at 37 °C, under 5% CO2
atmosphere, in DMEM with 5% FBS. The FBS was previously ultracentrifuged at 100,000 g for 2 h, at 10
°C to remove bovine exosomes. Trypomastigotes were then removed by centrifugation (10 min, 3000 g, 4
o

C), and the supernatant containing the total shed was filtered through a 0.45-µm sterile cartridge

(Goncalves et al., 1991, Trocoli Torrecilhas et al., 2009). Under these conditions, there was no significant
increase in the number of dead parasites up to 3 h of incubation, as assessed by flow cytometry following
the labeling of the parasites with propidium iodide (data not shown). The supernatant was loaded onto a
Sepharose CL-4B column (1 x 40 cm, GE Healthcare) pre-equilibrated with 100 mM ammonium acetate,
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pH 6.5. The column was eluted with the same buffer, at 0.2 mL/min flow rate. One-mL fractions were
collected and then screened by chemiluminescent enzyme-linked immunosorbent assay (CL-ELISA)
using anti-α-galactosyl antibodies from patients with chronic Chagas disease (Ch anti-αGal) as described
(Almeida et al., 1994). αGal-positive fractions were pooled and immediately lyophilized. Vesicle
concentration was expressed as equivalents of trypomastigotes. The stimuli were diluted in complete
media and used at the concentrations indicated in each experiment.

Infection assays by manual counting and thapsigargin-treatment of host cells
NIH3T3, RAW264.7, or LLC-MK2 cells were grown for 24 h in a 24-well plate containing 12-mm round
coverslips at 37 °C in a 5% CO2 humidified atmosphere. Then, cells were exposed to trypomastigotes at
2:1 parasite:host cell ratio in the presence or absence of stimuli (as indicated in each figure) for 2 h at 37
°C. Where indicated, NIH3T3 cells were treated with 1 µM thapsigargin (Invitrogen) or DMSO (vehicle
control) for 30 min at 37 °C immediately before infection. After infection, cells were extensively washed
and reincubated in complete medium for 16 h at 37 °C. Cells were washed with PBS and fixed with 4%
paraformaldehyde for 15 min. Parasite and host cell DNA were stained with 4’,6-diamidino-2phenylindole (DAPI) (Invitrogen) at 1 µg/mL for 5 min, washed with PBS and mounted in Vectashield
mounting media. Slides were analyzed using a fluorescent microscope (Zeiss Axioskop or Leica DMI
6000B) or a confocal microscope (Zeiss Pascal confocal scanning microscope). At least 300 cells in each
triplicate were counted to determine the number of infected cells. Results were expressed as fold change
in the percentage of infected cells compared to non-stimulated control and indicate the mean ± standard
deviation of triplicate slides.

Intracellular calcium imaging
NIH3T3 cells were plated 24 h prior to the experiment on 96-well BD imaging plates which are suitable
for use in the BD Pathway 855 High-Content Cell Analyzer (BD Biosciences). Cells were loaded for 30
min at 37 °C in a 5% CO2 humidified atmosphere with 10 µM Fura2-AM (Invitrogen) in the presence of
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0.02% pluronic acid, and diluted in Hank's Buffered Salt Solution (HBSS) without phenol red. After the
loading time, cells were washed with HBSS and further incubated at 37 °C for 30 min in HBSS to allow
intracellular de-esterification of Fura2-AM. Fura-2 fluorescence imaging was performed at 37 °C in a 5%
CO2 using the BD Pathway 855 High-Content Cell Analyzer and the AttoVision software. An automated
liquid handling system was used for the addition of the following stimuli diluted in HBSS: FSL at
concentrations ranging from 0.1 to 10 nM, P3C from 0.1 µM to 10 µM, ionomycin (Sigma) at a final
concentration of 10 µM as a positive control and HBSS only or HBSS plus DMSO (at a final
concentration equivalent to the DMSO amount in the ionomycin stimuli). Before data acquisition, the
focus as well as the fluorescence intensity at 510 nm (emission wavelength) when Fura-2 is excited at 340
nm and 380 nm were set. Cell body segmentation was applied during the data acquisition based on
loaded cell fluorescence at 380 nm, since in the presence of low calcium concentrations Fura-2 fluoresces
brightly when excited at 380 nm. Fluorescence intensity at 340 nm and 380 nm excitation wavelengths of
multiple single cells were measured every 6 sec for 180 sec and then the 340/380 nm ratio was plotted.

F-actin staining
NIH3T3 cells were treated with 10 µM P3C or 0.1 nM FSL for 30 min at 37 °C. Then, cells were fixed
with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 for 5 min on ice and blocked with 1%
bovine serum albumin (BSA). Subsequently, cells were stained with biotin XX-phalloidin (Molecular
Probes) for 20 min at room temperature. After washing, streptavidin- Alexa Fluor 488 (Molecular Probes)
diluted in 100 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.3% Triton X-100 and 1%BSA was added for 30
min. Then, cells were stained with DAPI. Slides were mounted in Vectashield mounting media. Images
were acquired on a Zeiss Pascal 5L5M confocal microscope.

Silencing of TLR2 expression in NIH3T3 cells by RNA interference
Expression constructs. The psi-h7SKGFPzeo-derived silencing vector encoding a hairpin targeting mouse
TLR2 (psiRNA-mTLR2) and the control vector containing a sequence targeting LacZ (psiRNA-LacZ)
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were purchased from InvivoGen. E. coli LyoComp GT116 cells (InvivoGen) were transformed following
the manufacturer’s instructions. Transformants were selected with zeocin (InvivoGen). Plasmids for
subsequent mammalian cell transfection were purified using the EndoFree Plasmid Purification Maxi Kit
(Qiagen). Stable transfection. NIH3T3 cells were transfected with the shRNA vector by nucleofection
using the Cell Line Nucleofector Kit R and program U-30 from Lonza according to the manufacturer's
recommendations. As the vector contains a GFP::zeo fusion gene (GFP-reporter gene combined with the
zeocin resistance gene), stable transfectants were selected in medium containing zeocin (InvivoGen). The
successful selection of the transfectants was also confirmed by analyzing the percentage of cells
expressing GFP using flow cytometry (not shown).

Real time-RT-PCR
To evaluate the TLR2 mRNA expression levels by real time-RT-PCR, total RNA was extracted from
transfected cells using the RT2 qPCR-grade RNA isolation kit (SABiosciences). The RT2 First Strand kit
(SABiosciences) was used for cDNA synthesis. Primers specific for mouse TLR2 and GAPDH were
purchased from SABiosciences. Real time-RT-PCR was carried out using the RT2 SYBR Green qPCR
Master Mix and a BioRad iCycler following the manufacturer’s instructions. Control reactions were run
in the absence of template or reverse transcription. After amplification, the threshold cycle (Ct) for TLR2
and GAPDH were determined. Fold change in expression of mouse TLR2 mRNA was calculated by
normalizing TLR2 mRNA expression to GAPDH and applying the comparative Ct method as described
(Livak et al., 2001). Results indicate the mean ± standard deviation of triplicate samples.

NIH3T3 cell transfection and stimulation of transfected cells
Expression constructs. The β-actin Renilla luciferase (Sweetser et al., 1998) and the reporter endothelial
leukocyte molecule (ELAM)-1-firefly luciferase (Schindler et al., 1994) constructs were kindly provided
by Dr. Richard Darveau (University of Washington, Seattle, WA). pEGFP-N1 plasmid was obtained from
Dr. Armando Varela (University of Texas at El Paso, El Paso, TX). All plasmids used in mammalian cell
59

transfections were purified using the EndoFree Plasmid Purification Maxi Kit (Qiagen) according to
manufacturer’s instructions. Cell transfection and stimulation. NIH3T3 cells stably expressing TLR2specific shRNA or control cells were plated on 12-well plates at 2.2 x 105 cells/well in DMEM medium
with 10% BCS. In the following day, the medium was removed and 1 mL of medium without BCS was
added. Then, cells were transfected with ELAM-1-firefly luciferase and β-actin Renilla luciferase
constructs using Lipofectamine 2000 according to the manufacturer’s recommendations. After 4 h, 1 mL
of DMEM with 20% BCS was added until the next day, when cells were plated in 96-well plates at 4 x
104 cells/well. In the preliminary experiments, the transfection efficiency was verified by transfection of
pEGPF-N1 plasmid and analysis of eGFP expression by flow cytometry or fluorescent microscopy (not
shown). Forty-eight hours after transfection, cells were stimulated with FSL or P3C, at the concentrations
indicated in the experiment, for 5 h at 37 °C.

Luciferase Reporter Assay for NF-κB Activation
Cells were washed once in PBS and lysed in Passive Lysis Buffer (Promega). The luciferase activity was
measured using the Dual-Luciferase Reporter Assay System (Promega). The relative light-units (RLU)
were quantitated using a Luminoskan luminometer (Thermo Fisher Scientific). Luciferase activity was
expressed as the ratio of NF-κB dependent firefly luciferase activity to constitutively expressed Renilla
luciferase activity. Results are shown as the means ± standard deviation of triplicate wells.

Infection assays of NIH3T3 cells knockdown for TLR2 in 96-well plate format
NIH3T3 cells stably expressing TLR2-specific shRNA or control cells were plated in BD Falcon 96-well
bioimaging plates at a density of 4 x 103 cells per well and incubated overnight at 37 °C in a 5% CO2
humidified atmosphere. Before infection, cells were washed once with complete medium to remove nonadhered cells. Infection of NIH3T3 cells with trypomastigotes was carried out for 2 h at 37 °C in a 5%
CO2 humidified atmosphere. After incubation, cells were washed four times with PBS to remove
extracellular trypomastigotes and reincubated with complete medium for approximately 16 h. Cells were
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washed with PBS and fixed with 4% paraformaldehyde for 15 min. Parasite and host cell DNA were
stained with DAPI at 1 µg/mL for 5 min, washed with PBS and lastly, PBS was added to each well. Plates
were stored at 4 °C until analysis.

High-content imaging for automated counting of T. cruzi infection rate
Image acquisition, processing and analysis of 96-well plate format infections were carried out using the
BD Pathway 855 High-Content Cell Analyzer (BD Biosciences) as described in Chapter 4.

Statistical analysis
Statistical significance was determined by Student’s t-test using GraphPad software (GraphPad Software,
Inc.). Differences were considered to be statistically significant at a p value <0.05.
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3.3.

Results

T. cruzi vesicles and known TLR2 ligands, but not TLR4 ligand, enhance infection in nonphagocytic cells. Previous results from our laboratory have demonstrated that vesicles released by T.
cruzi trypomastigotes are able to induce a potent proinflammatory response and, more strikingly, to
increase the parasite infectivity in a TLR2-mediated process (Torrecilhas et al., unpublished). However,
the effects of other known TLR2 ligands on T. cruzi invasion remained unclear. Furthermore, the outcome
of TLR2 activation in the infection of distinct cell types has not been explored yet. To evaluate whether
known TLR ligands can enhance host cell invasion by trypomastigotes in different cells types, nonphagocytic cells (NIH3T3 fibroblasts and LLC-MK2 epithelial cells) and phagocytic cells (RAW267.4
macrophages) were exposed to trypomastigotes in the presence of the distinct TLR ligands and the
percentage of infected cells was determined. Initially, we purified T. cruzi trypomastigote vesicles and
infected LLC-MK2 epithelial cells in the presence of vesicles. Parasite and mammalian cell DNA were
stained with DAPI and the number of infected cells as well as the number of parasites per cell was
counted using a fluorescent microscope. The results clearly demonstrate that vesicles promoted a
significant increase in the percentage of infected cells (Figure 3.1.A), whereas the number of parasites
per cell remained similar (data not shown). Then, LLC-MK2 cells were exposed to trypomastigotes and
known TLR4 and TLR2 ligands (Figure 3.1.B). Both zymosan and S. aureus lysate (TLR2 ligands)
significantly enhanced infection. Remarkably, lipopolysaccharide (LPS), a TLR4 ligand did not have an
effect at 100 ng/mL which is a concentration extensively demonstrated to present biological activity in a
variety of systems (Campos et al., 2001, Dias et al., 2008, Hajjar et al., 2001, Stuart et al., 2005).
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Figure 3.1. T. cruzi vesicles and known TLR2 ligands, but not TLR4 ligand, induce increased infection in
non-phagocytic cells.
LLC-MK2 epithelial cells were infected with trypomastigotes in the presence of vesicles (A) or TLR
ligands (B) for 2 h at 37 °C. Control experiments were performed in the absence of stimulus (none). After
incubation, cells were washed and reincubated in complete medium for 16 h at 37 °C. Then, cells were
fixed and parasite and mammalian cell DNA were stained with DAPI. Slides were analyzed using a
fluorescent inverted microscope. At least 300 cells in each triplicate were counted to determine the
number of infected cells. The concentration of each stimulus is indicated in the graph. The amount of T.
cruzi vesicles is indicated as parasite equivalents. The result is expressed as fold increase in the
percentage of infected cells compared to nonstimulated control and indicates the mean ± standard
deviation of triplicate slides. Asterisks indicate a significant difference in comparison to nonstimulated
control (Student’s t-test: * p<0.05 and ** p<0.01).
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TLR2/6- and TLR2/1-specific ligands promote enhanced infection in both phagocytic and nonphagocytic cells. Since zymosan and S. aureus lysate are heterogeneous preparations that may trigger the
activation of receptors other than TLR2, we sought to examine the effects of specific TLR2/1 and TLR2/6
ligands. In RAW264.7 macrophages, we observed a 4-fold increase in infection when cells were
stimulated with Pam3Cys-SKKKK (P3C), a triacylated lipopeptide which activates TLR2/1 heterodimer
(Figure 3.2.A). Surprisingly, the infection remained comparable to controls when cells were stimulated
with vesicles or FSL-1 (FSL), a diacylated lipopeptide which preferentially activates TLR2/6
heterodimer. We speculate that although it has been reported that RAW264.7 macrophages express TLR1,
TLR2, and TLR6 mRNAs (Applequist et al., 2002), alterations in cellular localization, protein expression
levels or post-translational modifications may be playing a role in the reduced responsiveness to the
stimuli. Additionally, zymosan is known to trigger phagocytosis in macrophages through activation of
dectin-1 which cooperates with TLR2/6 heterodimer (Gantner et al., 2003). Thus, we expected that
zymosan would stimulate endocytic processes facilitating the parasite internalization mainly in
macrophages. Nevertheless, infection of RAW264.7 macrophages in the presence of zymosan induced
less pronounced effects (Figure 3.2.A) when compared to LLC-MK2 epithelial cells (Figure 3.1.B).
Thus, the results suggest that RAW264.7 cells are less responsive to TLR2/6 ligands. In LLC-MK2 cells,
FSL lead to a dose-response effect in the infection (Figure 3.2.B). We further observed that P3C, FLS
and T. cruzi vesicles induced significantly increased infection in NIH3T3 fibroblasts (Figure 3.2.C).
Taken together, these results indicate that although the responsiveness to specific stimuli is cell typedependent, distinct TLR2 ligands can enhance T. cruzi infectivity in both non-phagocytic (fibroblasts and
epithelial cells) and phagocytic cells (macrophages).
Since we are mainly interested on the link between TLR2 activation and invasion of nonphagocytic cells, and NIH3T3 fibroblasts were responsive to the tested stimuli, this cell line was selected
for subsequent studies. Furthermore, fibroblasts are the most abundant cell type in the connective tissue
and recent studies showed that these cells are essential players in the switch from acute inflammation to
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adaptive immunity as well as in tissue repair and establishment of chronic inflammation (Buckley et al.,
2001, Flavell et al., 2008).

NIH3T3 fibroblasts express functional TLR2. TLRs are primarily expressed on immune cells
(Applequist et al., 2002, Sandor et al., 2005); nevertheless, recently it has been reported that nonimmune
cells such as endothelial, fibroblast and epithelial cells also express some TLRs (Sandor et al., 2005).
However, the protein detection has been a major issue due to low levels of expression. We detected the
presence of mRNAs for TLR1, TLR2, TLR3, TLR4, and TLR6 in NIH3T3 fibroblasts by RT-PCR
(Figure 3.3.A). Furthermore, to confirm that TLR signaling is activated when cells are stimulated with
TLR agonists, NIH3T3 cells were transfected with plasmids encoding constitutively expressed Renilla
luciferase and NF-κB-driven firefly luciferase (reporter plasmid). TLR2 stimulation by FSL and P3C
resulted in NF-κB activation and thus, higher luciferase/Renilla luciferase ratio, indicating that TLRmediated signaling was activated in these cells (Figure 3.3.B).
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Figure 3.3. NIH3T3 fibroblasts express functional TLR2.
A. NIH3T3 fibroblasts express mouse (m) TLR1, TLR2, TLR3, TLR4, and TLR6 mRNAs. The level of
TLRs mRNA expression in NIH3T3 cells was verified by reverse transcriptase-PCR (RT-PCR). Lack of
DNA contamination in the RNA preparations was verified by PCR amplification of a cDNA synthesis
control prepared in the absence of reverse transcriptase (no RT). RT-PCR in the absence of cDNA was
also performed (-). A positive-control double stranded DNA (+) provided in the InvivoGen kit was used
to ensure proper amplification and to visualize the expected PCR fragment sizes. B. FSL and P3C
stimulation leads to activation of TLR signaling (NF-κB activation) in NIH3T3 cells. NIH3T3 cells were
transfected with plasmids encoding β-actin Renila luciferase and ELAM-1-firefly luciferase (NF-κB
luciferase reporter plasmid). Twenty four hours after transfection, cells were not stimulated (none) or
stimulated with FSL (0.1 and 10 nM) or P3C (0.1 and 10 µM) for 4 h at 37 °C. Then, luciferase levels
were measured. The results represent the fold increase in the ratios of NF-κB dependent firefly luciferase
activity (Luc) and constitutively expressed Renilla luciferase activity (Ren luc) compared to the ratio in
non-stimulated transfected cells. Results are shown as the mean ± standard deviation of triplicate wells.
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Silencing of TLR2 results in reduced T. cruzi infection. To further confirm the role of TLR2 in T. cruzi
invasion, we used RNA interference to knockdown TLR2 expression in NIH3T3 cells. Cells stably
expressing a silencing vector encoding a hairpin targeting mouse TLR2 (TLR2 shRNA) and GFP fused to
zeocin-resistance protein were selected in the presence of zeocin. The successful selection was confirmed
by analyzing the percentage of cells expressing GFP using flow cytometry (data not shown). Then, we
assessed the relative mRNA expression levels of TLR2 by real time-RT-PCR (Figure 3.4.A). TLR2
mRNA expression levels in cells expressing TLR2 shRNA was reduced when compared to control cells
(expressing a sequence targeting LacZ). To functionally evaluate the effects of the knockdown on TLR2
signaling, cells were transiently transfected with ELAM-1-firefly luciferase and β-actin Renilla luciferase
constructs for NF-κB reporter assay. We observed that TLR2-mediated NF-κB activation upon
stimulation with FSL was substantially decreased in TLR2 shRNA-cells (Figure 3.4.B). Importantly, T.
cruzi infection was markedly reduced in NIH3T3 cells knockdown for TLR2 as compared to control cells
(Figure 3.5), thus confirming the role of TLR2 in the mechanism of invasion by this parasite.
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Figure 3.4. Knockdown of TLR2 in NIH3T3 cells.
NIH3T3 cells were nucleofected with psi-h7SKGFPzeo-derived silencing vector encoding a hairpin
targeting mouse TLR2 (TLR2 shRNA) or the control vector with a sequence targeting LacZ (control
shRNA). Stable transfectants were selected in medium containing zeocin. A. TLR2 mRNA expression
levels in cells expressing TLR2 shRNA was reduced when compared to control cells. mRNA Expression
level of TLR2 was assessed by real time-RT-PCR and normalized to GAPDH. Fold change in TLR2
mRNA expression was calculated as indicated in Materials and Methods. B. TLR2-mediated NF-κB
activation upon stimulation with 0.1 nM FSL was substantially decreased in cells knockdown for TLR2
that were transiently transfected with ELAM-1-firefly luciferase and β-actin Renilla luciferase constructs.
Luciferase activity was expressed as the ratio of NF-κB dependent firefly luciferase activity (Luc) to
constitutively expressed Renilla luciferase activity (Ren luc). Results are shown as the means ± standard
deviation of triplicate wells. Asterisks indicate a significant difference in comparison to control (Student’s
t-test: * p<0.05).
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Figure 3.5. T. cruzi infection was markedly reduced in NIH3T3 cells knockdown for TLR2.
NIH3T3 cells knockdown for TLR2 or control cells were plated in BD Falcon 96-well bioimaging plates
and incubated overnight at 37 °C. Infection of cells with trypomastigotes was carried out for 2 h at 37 °C.
After incubation, cells were washed four times with PBS and reincubated with complete medium for
approximately 16 h. Cells were washed with PBS, fixed and stained with DAPI. Infection was analyzed
using high-content imaging and automated counting as described in Chapter 4. Image acquisition,
processing and analysis were carried out using the BD Pathway 855 High-Content Cell Analyzer. Results
are shown as the means ± standard deviation of triplicates. Asterisks indicate a significant difference in
comparison to control (Student’s t-test: ** p<0.01).
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Host cell intracellular calcium is essential for TLR2-mediated invasion. The best characterized T.
cruzi invasion process involves the release of host cell intracellular calcium induced by the
trypomastigotes, with subsequent recruitment of lysosomes to the site of parasite attachment (Burleigh et
al., 2002). Moreover, it has been demonstrated that TLR2 activation promotes mobilization of
intracellular calcium in epithelial cells (Chun et al., 2006). To investigate whether TLR2 ligands were
able to induce intracellular calcium release, calcium imaging of NIH3T3 cells loaded with Fura2-AM, a
cell permeable fluorescent calcium indicator, was performed using the BD Bioimaging system. Fura2-AM
is a ratiometric dye that fluoresces when excited at both 340 and 380 nm. At low calcium concentration,
the Fura-2 fluorescence at 340 nm is dim while at 380nm is bright, and the opposite is observed at high
calcium concentrations. Loaded cells were then stimulated with FSL or P3C at concentrations ranging
from 0.1 to 10 nM or 0.1 to 10 µM, respectively, which have shown to enhance infection. Although
ionomycin (positive control) led to increase in the 340/380 nm ratio confirming that cells were responsive
under the experimental conditions, the same effect was not observed when cells were stimulated with the
TLR ligands indicating that FSL and P3C did not induce intracellular calcium mobilization (Figure 3.6,
representative graphs). Corroborating these findings, lysosomal exocytosis, i.e. surface expression of the
luminal lysosomal glycoprotein LAMP-1(Rodriguez et al., 1997), was not observed after stimulation with
TLR2 ligands (data not shown).
To further investigate the role of intracellular calcium mobilization in the process of TLR2mediated parasite invasion, NIH3T3 cells were pretreated with thapsigargin, which induces depletion of
intracellular calcium stores, and then infected with trypomastigotes in the presence or absence of TLR
ligands. The results suggest that host cell intracellular calcium depletion inhibits the enhancement of
invasion mainly by FSL and T. cruzi vesicles and less pronouncedly by P3C (Figure 3.7).
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Figure 3.6. TLR2 ligands do not induce intracellular calcium mobilization.
Fluorescence imaging of NIH3T3 cells loaded with Fura2-AM, an intracellular calcium indicator, was
performed at 37 °C, 5% CO2 using the BD Pathway 855 High-Content Cell Analyzer and the AttoVision
software. An automated liquid handling system was used for the addition of the stimuli diluted in HBSS.
Ionomycin was used as a positive control to confirm that cells were responsive under the experimental
conditions. Cell body segmentation was applied during the data acquisition based on loaded cell
fluorescence at 380 nm. Fluorescence intensity at 340 nm and 380 nm excitation wavelengths of multiple
single cells were measured every 6 sec for 180 sec and then the 340/380 nm ratio was plotted.
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Figure 3.7. Host cell intracellular calcium depletion reduces TLR2-mediated T. cruzi invasion.
NIH3T3 cells were treated with 1 µM thapsigargin (black bars) or DMSO (non-treated, grey bars) for 30
min at 37 °C, immediately before infection. After incubation, the drug-containing medium was replaced
with fresh medium and infection was carried out in the presence or absence of stimulus. The result is
expressed as fold increase in the percentage of infected cells compared to non-stimulated control and
indicates the mean ± standard deviation of triplicate slides. Asterisks indicate a significant difference in
comparison to the respective non-treated cells (Student’s t-test: * p<0.05).
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TLR2 activation induces changes in actin polymerization. Recent studies demonstrated that TLR2
activation induces actin rearrangement and endocytosis in phagocytic cells (Blander et al., 2004, West et
al., 2004). Furthermore, alterations in host cell cytoskeleton have been demonstrated to greatly affect
trypomastigote cell entry (Tyler et al., 2005, Woolsey et al., 2004). It was shown that cytochalasin D
treatment of mammalian cells which promotes actin depolymerization facilitates the invasion process and
subsequent cytoskeleton reassembly is also an essential feature for intracellular retention of the highly
motile trypomastigotes (Woolsey et al., 2004). Therefore, we reasoned that TLR2 activation could
facilitate the parasite entry through changes in actin cytoskeleton. We examined this possibility by
treating the cells with FSL and P3C following immunostaining of filamentous actin. Interestingly,
NIH3T3 cells treated with FSL or P3C showed markedly reduced fluorescence when compared to nontreated cells suggesting that TLR2 ligands induce actin depolymerization (Figure 3.8). In P3C treated
cells we also observed a differential distribution of filamentous actin with noticeably lower fluorescence
around the nucleus (Figure 3.8).
Taken together, our data indicate that although host cell intracellular calcium depletion reduces
TLR2-mediated invasion, TLR2 ligands do not lead to increase in intracellular calcium levels neither
lysosomal exocytosis. Therefore, TLR2 activation does not promote parasite entry through the
lysosome/calcium-mediated pathway but it induces actin depolymerization that may facilitate T. cruzi
internalization by the plasma membrane invagination pathway.
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Figure 3.8. TLR2 ligands induce actin depolymerization.
A. Filamentous actin staining (phalloidin-Alexa 488, green) and DNA staining (DAPI, blue) of NIH3T3
cells. In the right column, the high fluorescence intensity is represented in red and the low intensity in
blue. NIH3T3 cells were untreated (none) or treated with 10 µM P3C or 0.1 nM FSL for 30 min at 37 °C,
5% CO2. Then, cells were washed, fixed, permeabilized with 0.1% Triton X-100 for 5 min on ice and
blocked with 1% BSA. Subsequently, cells were stained with biotin XX-phalloidin (Molecular Probes),
which binds to filamentous actin, for 20 min at room temperature. After washing, streptavidin-Alexa
Fluor 488 was added for 30 min. Slides were mounted in Vectashield mounting media containing DAPI.
Images were acquired on a Pascal 5L5M Confocal microscope. B. Cells were segmented and the
fluorescence intensity per pixels was plotted in the graph.
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3.4.

Discussion

Mammalian cell invasion by T. cruzi is critical to its survival in the host. Recent studies
demonstrated that to successfully invade a variety of mammalian cells and modulate the host cellular
responses, T. cruzi exploits a diversity of host cell surface receptors and signaling pathways (Villalta et
al., 2009, Burleigh et al., 2002). Notably, it has been shown that activation of transforming growth factorβ (Hall et al., 2000), bradykinin B2 (Scharfstein et al., 2000), and nerve growth factor TrKA (de MeloJorge et al., 2007) receptors leads to increased invasion by this parasite. Here, we described an
unanticipated role of an innate immune receptor in the host cell invasion by T. cruzi.
Previous results from our group demonstrated that vesicles released by the infective T. cruzi
trypomastigote forms not only trigger proinflammatory responses in macrophages via TLR2 activation
but also, unexpectedly, promote a remarkable increase in the number of infected cells (Torrecilhas et al.,
unpublished). We provided evidence that TLR2-mediated invasion is not an event restricted to activation
of TLR2 by T. cruzi vesicles. TLR2 ligands such as zymosan and S. aureus lysate significantly enhanced
infection while LPS, a TLR4 ligand, had no effect. Confirming these findings, although specific TLR2/1
and TLR2/6 ligands (FSL and P3C, respectively) demonstrated a cell type-dependent responsiveness in
non-phagocytic and phagocytic cells, a general trend of increasing TLR2-dependent infection was
observed. In line with these results, infection was significantly reduced in cells knockdown for TLR2.
Taken together, our results demonstrate that, contrary to its well established role as one of the primary
sensor of the innate immune defense against pathogens, TLR2 activation results in higher T. cruzi
infection rate.
Correspondingly, subversion of TLR2 activation by S. aureus has been described as a bacterial
strategy for intracellular survival in macrophages (Watanabe et al., 2007). Furthermore, TLR4 and TLR2
activation has been suggested to influence the susceptibility to T. cruzi infection in endothelial cells (Dias
et al., 2008) as well as proliferation of intracellular amastigote forms in macrophages (Maganto-Garcia et
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al., 2008). However, these cellular responses resulted most likely from long-term effects of the signaling
pathway activation. On the other hand, in our model, host cells were exposed to TLR2 ligands and
trypomastigotes for short periods (up to 2 hours) prior to analysis. Therefore, fast cellular responses
following TLR2 activation are responsible for the increase in T. cruzi infection. In this view, the major
focus since the discovery of mammalian TLRs and its essential role in host defense has been the TLRmediated responses that are dependent on changes at the transcriptional level such as induction of
inflammatory cytokines, type I interferon (IFN), and chemokines (Barton et al., 2003) as well as
upregulation of costimulatory molecules on the surface of antigen presenting cells (Akira et al., 2001,
Iwasaki et al., 2004). Only recently, it is becoming clear that activation of TLRs can also trigger several
rapid cellular responses (Blander et al., 2004, Mae et al., 2007, Wang et al., 2006, Kong et al., 2008,
West et al., 2004, Watts et al., 2007, Chun et al., 2006).
Chun et al. (2006) demonstrated that TLR2 ligands induce intracellular calcium mobilization in
epithelial cells (Chun et al., 2006). This event could potentially enhance T. cruzi invasion through the
lysosome-mediated invasion pathway (Burleigh et al., 2002). However, our results showed that despite
the fact that release of calcium from intracellular stores is essential for TLR2-mediated invasion, neither
calcium mobilization nor lysosomal exocytosis was induced by TLR2 activation. Additionally, in line
with novel findings showing the role of TLRs in phagocytic cell cytoskeleton rearrangement (West et al.,
2004, Kong et al., 2008, Zaru et al., 2008, Zaru et al., 2007), we demonstrated that TLR2 activation
results in actin depolymerization in non-phagocytic cells. Therefore, while the precise mechanism by
which TLR2 activation facilitates parasite internalization still remains unclear, we propose that TLR2dependent host cell actin depolymerization may increase plasma membrane flexibility and facilitate the
initial stages of parasite entry into the host cell. This proposition is supported by studies demonstrating
that transient depolymerization of the cortical actin cytoskeleton in non-phagocytic cells promotes
parasite internalization specifically by the plasma membrane invagination pathway (Woolsey et al., 2004,
Andrade et al., 2004, Woolsey et al., 2003).
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Recent reports provided new insights into the signaling pathways connecting TLR activation with
cytoskeleton changes and enhancement in endocytic processes. It was demonstrated that these effects are
dependent on activation of mitogen-activated protein kinase (MAPK) pathways such as p38 and ERK
kinases (Zaru et al., 2008, Zaru et al., 2007, West et al., 2004). Moreover, several studies support the idea
that activation of TLR2 signaling induces phagocytosis of bacteria by macrophages (Mae et al., 2007)
and TLR2 ligand internalization mediated by lipid raft- (Triantafilou et al., 2006) and dynamin-dependent
endocytic processes (Nilsen et al., 2008). Therefore, it is tempting to speculate that TLR2 activation by
the parasite TLR2 ligands may play a role in previously described T. cruzi invasion processes involving
ERK (Mukherjee et al., 2004), lipid rafts (Barrias et al., 2007), and dynamin (Barrias et al., 2010).
However, the link between TLR2 activation and induction of these events remains to be determined.
Concurrently, the upstream mechanisms that facilitate the recognition of TLR2 ligands and
promote ligand or pathogen internalization have begun to unravel. Shamsul et al. (2010) demonstrated
that the TLR2 ligand, FSL-1, internalization is dependent on CD14 and CD36 accessory molecules
(Shamsul et al., 2010) while other studies confirmed the involvement of CD36 in efficient internalization
of bacteria and fungi (Means et al., 2009, Stuart et al., 2005, Baranova et al., 2008). Therefore, based on
these reports and on our recent findings demonstrating that T. cruzi tGPIs recognition by TLR2 involves
CD14 and CD36 (Nohara et al., unpublished data), we speculate that these accessory molecules may
participate in the upstream events related to enhanced TLR2-dependent invasion. To evaluate the final
contribution of CD36 during T. cruzi infection, we are currently investigating the in vivo role of CD36.
In addition to the T. cruzi-shed vesicles and tGPI anchors, T. cruzi-released protein Tc52 has also
been shown to stimulate macrophage proinflammatory cytokine production via TLR2. Interestingly, this
molecule plays an essential role in intracellular survival and parasite infectivity in vivo (Allaoui et al.,
1999). Nevertheless, it remains unclear whether TLR2 activation is associated with these effects.
Furthermore, TLR2-mediated signaling has already been implicated in several other aspects of the
interaction between T. cruzi and the host such as induction of dendritic cell response (Ouaissi et al.,
2002) and cardiomyocyte hypertrophy (Petersen et al., 2003). Therefore, it is evident that TLR2 play
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several roles during infection. Consequently, the T. cruzi-induced activation of multiple TLR2-mediated
pathways is likely to result in highly complex cellular responses which may have a particular outcome
depending on the cell type.
Intriguingly, recent studies demonstrated that although T. cruzi tGPI-mucin was unable to
stimulate cytokine production and nitric oxide by macrophages from TLR2-double knockout (TLR2-/-)
mice as expected, the in vivo effects in T. cruzi infected TLR2-/- mice were much less obvious (Ropert et
al., 2004, Bafica et al., 2006, Campos et al., 2004). In these studies, the parasitemia was unaltered or
slightly reduced in TLR2-/- mice as compared to wild-type control, whereas proinflammatory cytokine
levels were to some extent reduced. Based on these findings, the in vivo relevance of TLR2 during T.
cruzi infection could be met with doubt. On the other hand, we speculate that the lack of the receptor in
TLR2-/- infected mice could lead to a balance between both reduced cell infection and proinflammatory
responses. Also, the absence of TLR2 in TLR2-/- mice could be compensated by the expression of other
TLRs such as TLR1 and TL6 (Nohara et al., unpublished) and TLR9 (Bafica et al., 2006), which are also
strongly activated by the live T. cruzi cells or molecules from the parasite (i.e., tGPI-mucins, free GPIs or
glycoinositolphospholipids-GIPLs, and DNA). Clearly, further studies are necessary to fully clarify the in
vivo contribution of TLR2 and other TLRs and coreceptors in tissue parasitism as well as immune
response.
In conclusion, our results revealed an unexpected role of the TLR2 innate immune receptor in the
host cell invasion by T. cruzi. Remarkably, we demonstrated that this obligate intracellular parasite
exploits TLR2-mediated signaling pathway to enter the host cell. We propose that activation of TLR2 by
T. cruzi molecules may have multiple functions and outcomes during the infection, including a
paradoxical role in stimulating microbicidal responses and increasing the parasite infectivity. This
apparently contradictory effect holds great potential to reveal novel mechanisms of host cell signaling
subversion, which may also be exploited by other intracellular pathogens.
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Chapter 4: Development of a High-Content Imaging-Based Automated Analysis for
Quantification of Host Cell Trypanosoma cruzi Infection and Intracellular Proliferation

4.1. High-content imaging: A new approach for automated determination of host cell
infection rate by the intracellular parasite T. cruzi ‡

4.1.1. Introduction

The year 2009 marked the 100th anniversary of the discovery of Chagas disease and its causative
agent, Trypanosoma cruzi, by the Brazilian physician Carlos R.J. Chagas while he was working at the
Oswaldo Cruz Institute in Rio de Janeiro (Chagas, 1909). The impact of Chagas disease, once thought to
be limited to Latin America, where an estimated 8 to 11 million people are chronically infected, has
moved to the United States and Europe, mainly due to migration from endemic areas of Mexico, Central
America, and South America (Schmunis, 2007). The estimated number of infected persons living in the
United States is 300,000 or more, based on estimated disease rates by country of origin (Bern et al.,
2009). Furthermore, the parasite can be found in local bugs and mammals in the southern regions of the
United States (Bradley et al., 2000, Pung et al., 1995, Reisenman et al., 2010), and there have been a few
reported cases of autochthonous, transplant- and blood donation-related transmissions in humans
(Herwaldt et al., 2000, Bern et al., 2008, Bowling et al., 2009).
Many aspects of Chagas disease pathogenesis are still not well understood. The current drug
treatment regimens for the established chronic phase of the infection are partially effective and highly

‡ Note: This chapter is the basis for the manuscript 5 (see list of publications and manuscripts): Nohara, L.L., Lema, C., Bader,

J., Aguilera, R. and Almeida, I.C. High-content imaging: A new approach for automated determination of host cell infection rate
by the intracellular parasite Trypanosoma cruzi. Submitted to Parasitology International.
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toxic (Lauria-Pires et al., 2000, Croft et al., 2005, Tarleton et al., 2007), and acute disease reactivation
can occur due to immunosuppression (Rodriques Coura et al., 2002). In addition, development of
chemotherapy resistance has been reported (Buckner et al., 1998). Therefore, there is an urgent need to
develop effective chemotherapeutics and/or vaccine against Chagas disease, which is the most significant
parasitic infection of the Americas (Tarleton et al., 2007).
T. cruzi is an intracellular protozoan parasite and its ability to infect and replicate within a cell is
an essential feature for completion of its life cycle in the mammalian host cell. Upon host cell infection,
the infective T. cruzi trypomastigote forms differentiate into replicative amastigote forms and begin to
divide. Then, amastigotes differentiate back into trypomastigotes, the host cell ruptures releasing the
parasites into the extracellular milieu where they can infect adjacent cells, go to the bloodstream to infect
other tissues, or be ingested by a reduviid insect vector (Tyler et al., 2001).
Current new technologies offer numerous advantages when applied to conventional procedures
routinely used in T. cruzi research. A concrete example is direct counting of infected host cells by the use
of light microscopy or fluorescence microscopy, which is well established for in vitro studies of T. cruzi
infection. Briefly, host cells are infected, fixed and stained and the number of parasites per 100 cells
and/or the percent of infected cells are determined by direct counting under the microscope (Figure 4.1.1
A-C). Manual counting, however, has several limitations: it is extremely time consuming, subjective, not
reproducible and therefore not suitable for simultaneous evaluation of large number of samples.
In the present work, we introduce a novel high-content imaging method for automated
quantification of host cell infection rate by the intracellular parasite T. cruzi. This technology combines
fluorescent microscopy and measurement of multiple cellular parameters at a single-cell level, allowing
therefore fast, accurate and automated assays that are especially attractive not only for high-throughput
screening of potential therapeutic drugs but also for studying parasite molecular pathways. Here, the
number of parasites per 100 cells and percentage of infected cells were determined both by conventional
manual counting (manual method) and automated high-content imaging analysis (automated method), and
the data was statistically compared.
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Figure 4.1.1. Conventional manual counting procedure to determine T.cruzi infection rate.
A. For in vitro infection assays, mammalian cells plated on coverslips are incubated for 2 h at 37 °C with
infective T. cruzi trypomastigotes. After infection, cells are washed to remove extracellular
trypomastigotes and reincubated with complete medium for approximately 16 h. Subsequently, cells are
fixed, parasite and host cell DNA are stained with DAPI, and individual slides are mounted. Typically, at
least 300 cells in each triplicate are counted to determine the number of parasites per cells and/or the
percentage of infected cells by direct counting under a fluorescence microscope. B. Images of T. cruzi
infected host cells stained with DAPI (blue). For intracellular parasite staining (left panel, trypomastigotes
and right panel, amastigotes), fixed and permeabilized cells were incubated with diluted serum from
patients with chronic Chagas disease followed by anti-human Alexa Fluor 488 (green). C. Representative
image field of DAPI stained infected host cells (grey). Inset indicates higher magnification of the area
delimited by a white square within the main image. Arrows indicate parasite DNA and asterisk indicate
host cell nucleus.
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4.1.2. Materials and Methods

Parasites
Tissue culture-derived T. cruzi trypomastigote forms were obtained from the supernatant of infected LLCMK2 cells (Rhesus monkey kidney epithelial cells, ATCC, Manassas, VA), 5 to 9 days post-infection as
previously described (Andrews et al., 1982).

Green fluorescent protein (GFP)-expressing host cells
Murine NIH3T3 fibroblasts (ATCC) expressing green fluorescent protein (GFP) were cultured in
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% bovine calf serum (BCS) at 37
°C in a 5% CO2 humidified atmosphere and regularly tested for Mycoplasma by polymerase chain
reaction (PCR).

Infection assays
GFP-expressing NIH3T3 cells were plated in BD Falcon 96-well bioimaging plates (BD Biosciences,
Rockville, MD) at a density of 4 x 103 cells per well and incubated overnight at 37 °C in a 5% CO2
humidified atmosphere. Before infection, cells were washed once with complete medium to remove nonadhered cells. Infection of NIH3T3 cells with trypomastigotes was carried out for 2 h at 37 °C in a 5%
CO2 humidified atmosphere. After incubation, cells were washed four times with phosphate-buffered
saline (PBS), pH 7.4, to remove extracellular trypomastigotes, and reincubated with complete medium for
approximately 16 h to allow the differentiation of internalized parasites into amastigote forms, which are
more easily quantified than intracellular trypomastigotes. Cells were washed with PBS and fixed with 4%
paraformaldehyde for 15 min at room temperature. Parasite and host cell DNA were subsequently stained
with 4’,6-diamidino-2-phenylindole (DAPI) at 1 µg/mL for 5 min and washed with PBS.
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Image acquisition, processing and analysis
Image acquisition and analysis of microplates were carried out using the BD Pathway 855 high-resolution
fluorescence bioimager system (BD Biosciences). Filter sets appropriate for the excitation and emission
spectra of GFP and DAPI were selected. Images from nine contiguous image fields (3 x 3 montage) were
acquired per well with a 20x (0.75 numerical aperture, NA) objective. For optimal segmentation and
counting of parasites associated with host cells, the BD AttoVision™ v1.6.2 Sub Object analysis was
applied. This software tool provides comprehensive measurement of parameters for counting spots
(intracellular parasites) within a boundary object (host cell), enabling their accurate quantification. GFP
was used to define the boundary object (host cell body); whereas DAPI was used to define the counting
spots (intracellular parasites). Host cell nuclei, being much larger than the parasites, were systematically
excluded from the analysis, based on their size. Numerical data was imported into the Microsoft Excelbased BD™ Image Data Explorer (BD Biosciences, Rockville, MD) to determine the parameters
associated to infection of host cell by the intracellular parasite T. cruzi.

Statistical analysis
Statistical analysis (Statistical Analysis System, SAS v.9.2 software, SAS Institute, Inc., Cary, NC) was
applied to compare the data generated by manual and automated counting methods. A set of 21 treatment
groups from an on-going study were used to compare manual and automated assessment of the following
two parameters: (i) number of intracellular parasites per 100 cells and (ii) the percentage of infected cells.
For each treatment group, 3 to 4 replicates were available, rendering a total of 77 data points for analysis.
Manual and automated methods were compared using the paired-sample t-test for testing whether the
mean of the absolute difference or the mean of the percent absolute difference (with manual counting as
base) both differed from 0 for each parameter evaluated. Also, a simple linear regression model was fitted
to the data, the slope of the line tested against 1 and the y-intercept tested against 0 using t-tests. Finally,
the General Linear Mixed Model analysis for repeated measures was applied to compare the mean values
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obtained by the manual and automated methods for both parameters across the 21 treatment groups. All
tests were conducted at the 0.05 level of significance (p-value).
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4.1.3. Results and Discussion

As with any high-content assay, numerous parameters including adaptation to multiwell
microplates, image acquisition, and image analysis were optimized during the development of the assay.
A general scheme of the image acquisition, processing and analysis of multiparametric data is shown in
Figure 4.1.2. To obtain sufficient population numbers for robust data, we determined the optimal cell
density per well, and images from 9 contiguous image fields (3 x 3 montage) were acquired. We then
combined several image pre-processing and segmentation tools in order to optimize the image analysis
protocol, which enabled specific and reproducible host cell and parasite segmentation as verified by
visual inspection of the images (Figure 4.1.3). Briefly, segmentation consists of the application of
intensity thresholds to define cellular regions (also called regions of interest or ROIs) where
measurements will be made. Figure 4.1.3 shows representative segmented images of the host cell body
(boundary object), host cell nuclei, and intracellular parasites (sub-object counting spots). Host cells were
properly segmented based on whole-cell GFP expression and DAPI-stained individual nuclei. Although
parasites were also stained with DAPI, they were specifically selected by setting a small size threshold
that excluded cellular nuclei from all counts. The generation of multiparametric data based on single cell
information allowed us to determine several parameters linked to host cell infection by T. cruzi in a highly
accurate and rapid manner. The number of parasites per hundred cells was obtained through the results of
the sub-object analysis, while the percentage of infected cells was determined by applying a data
constraint to assess the number of cells (objects) containing at least one parasite (sub-object).
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BD Pathway 855 High-Content Cell Analyzer
Set up : image acquisition, macro, dyes, autofocus, montage
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(AttoVision software)
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Select data, set up reference image, segmentation
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Cell body
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(object)

Host cell nuclei
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Parasite nuclei
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(BD Image Data Explorer software)
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% infected cells
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Figure 4.1.2. General scheme of high-content imaging applied for automated analysis of infection rate by
T. cruzi.
The BD Pathway 855 high-resolution fluorescence bioimager system was applied for image acquisition,
data processing and analysis of T. cruzi infected, GFP-expressing NIH3T3 cells, in a 96-well plate format.
Images of GFP fluorescence (host cell) and DAPI (host cell and parasite DNA) from nine contiguous
image fields (3x3 montage) were acquired per well with a 20x objective. For optimal segmentation and
accurate quantification, the BD AttoVision™ v1.6.2 Sub Object analysis was applied and several image
processing and segmentation tools were combined in order to optimize the image analysis protocol. GFP
was used to define the host cell body (boundary object), whereas DAPI was used to define the
intracellular parasites (sub-object) and the host cell nuclei. Numerical data was imported into the
Microsoft Excel-based BD™ Image Data Explorer to analyze the multiparametric data associated to
infection of host cell by T. cruzi.

88

A. Image acquisition

B. Data processing

GFP

Cell body
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Host cell nuclei

C. Segmentation mask

Parasite

Figure 4.1.3. Representative cropped images of GFP-expressing NIH3T3 cells infected with T. cruzi.
A. Image acquisition. Images (20x, 0.75 NA) of T. cruzi infected, GFP-expressing NIH3T3 cells
(pseudocolored in green) and DAPI stained host cell and parasite DNA (pseudocolored in red). B. Data
processing. Fluorescence intensity thresholds were applied to define cellular regions (regions of interest
or ROIs). Segmented images of host cell body (based on GFP expression), host cell nuclei (based on
DAPI staining) and parasites (based on DAPI staining and size threshold of the parasite DNA). Small
numbers denote host cell ROIs. Insets indicate higher magnification of areas delimited by white squares
within the main images. Yellow arrows denote parasite DNA. C. Segmentation mask. Segmentation mask
of the same image generated after sub-object analysis depicting host cells bodies (red), host cells nuclei
(blue), and parasites (yellow).
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Overall, the values generated by the manual method were slightly higher than those obtained by
the automated quantification. A summary of the statistics for the absolute difference and the percent
absolute difference between the manual and automated methods is given in Table 4.1.1. Both the mean of
the absolute difference and the mean of the percent absolute difference were significantly different from 0
(p < 0.05), by the paired sample t-tests (not shown). However, for both parameters, the mean of the
absolute difference was very small (2.5 and 1.7 for number of parasites per 100 cells and percent of
infected cells, respectively). Likewise, the mean of the percent absolute difference was less than 20%
(15.4 and 13.6 for number of parasites per 100 cells and percent of infected cells, respectively). The
scatter plots of manual versus automated values of number of parasites per 100 cells and percent of
infected cells are given in Figure 4.1.4, panels A and B, respectively. For both parameters, the scatter
about the fitted regression line was quite small, so there was a strong linear relationship between the two
methods. In fact, the estimated correlation coefficients for number of parasites per 100 cells and percent
of infected cells were 0.97 and 0.96, respectively. However, the slope of the line was significantly
different from 1 (p < 0.05) although the y-intercept was not significantly different from 0 (p > 0.1) (not
shown). Again, these results reflect the slightly increased values generated by the manual method as
compared to the automated procedure. When the number of parasites per 100 cells was evaluated, the
derived data showed that the manual values were consistently higher than the automated values, by about
0.2230, the y-intercept of the estimated regression line. Likewise, when the percentage of infected cells
was evaluated, the data showed the same tendency, i.e., the manual values were consistently higher than
the automated values, by about 0.6229, the y-intercept of the estimated regression line. The estimated
slopes for the number of parasites per 100 cells and the percent of infected cells were 1.1691 and 1.1000,
respectively.
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Table 4.1.1. Summary of statistics for the absolute difference and the percent absolute difference between
the manual and automated intracellular T. cruzi counting methods.

Parameter
Number of parasites per 100 cells

Percentage of infected cells

Variable

N

Mean

Absolute difference

77

2.5

1.5

Percent difference

77

15.4

6.3

Absolute difference

77

1.7

1.0

Percent difference

77

13.6

6.3
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Std. Dev.

A

B
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20

Manual

Manual

30

10

10

Manual = 1.1004 *Automated + 0.6229

Manual = 1.1691 *Automated + 0.2230

0

0
0

10

20

0

30

10

20

30

Automated

Automated

Figure 4.1.4. Scatter plots of manual versus automated intracellular T. cruzi counting methods.
A. Scatter plot comparing manual versus automated method for number of parasites per 100 cells with
the fitted regression line and the 95% confidence bounds for individual values. B. Scatter plot comparing
manual versus automated method for percentage of infected cells with the fitted regression line and the
95% confidence bounds for individual values. In both plots, the scatter about the fitted regression line is
quite small and the slope of the line is positive (small manual values correspond to small automated
values; large manual values correspond to large automated values), thus indicating a positive correlation
between manual and automated methods.
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The results of the General Linear Mixed Model analysis for repeated measures indicate
differences in the means of the two methods across the treatment groups (Figure 4.1.5). As expected, we
also observed the same trend of higher means for manual method compared to automated method across
all of the 21 treatment groups.
Apparently, there are two main factors responsible for the slight discrepancy between the manual
and automated methods. First, the weak fluorescence intensity (GFP and /or DAPI) may determine suboptimal segmentation not only for parasites but also for host cells. Second, parasites localized
immediately next to the host cell nuclei are frequently not identified as individual entities but part of the
host nuclei and, therefore, undercounted. Despite the observed difference, data showed a linear
relationship between the two methods and the increase in the values derived from the manual method was
consistent across all the data points analyzed.
In contrast to manual counting, automated high-content imaging is highly objective and
reproducible since it is based on automated digital microscopy coupled with computer-based data
analysis. The images clearly show the feasibility of documenting and quantitatively analyzing not only
the degree of T. cruzi infection but also the level of parasite intracellular proliferation using this method.
Additionally, when the methodology is applied for the study of compounds effects on the parasite
infectivity or proliferation, the response of mammalian cells to the treatment (cytotoxicity) can be
determined by monitoring the total cell number. Therefore, multiple parameters on a cell-by-cell basis can
be evaluated simultaneously in a single experiment and all captured images are stored automatically and
can be reanalyzed later in time in order to extract meaningful quantitative data. In addition, its intuitive
information content, the ability to visually confirm the data within the captured images, as well as its easy
adaptability to 384 well-plates or higher throughput formats makes the assay particularly attractive for
screening applications. Successful use of high-content imaging for quantitative assessment of bacteria
intracellular replication has been described (Kuijl et al., 2007). However, this is the first report on highcontent imaging applied on assessment of host cell infection rates by an intracellular parasite. The assay
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might be especially useful for a wide range of applications in Chagas disease research, from smallmolecule drug and inhibitor discovery to pathway elucidation.
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Figure 4.1.5. Comparison of data point means between manual and automated intracellular T. cruzi
counting methods.
A. Mean number of parasites per 100 cells, by treatment and method. B. Mean percentage of infected
cells, by treatment and method. Open circles and asterisks indicate the mean values obtained by manual
and automated methods, respectively.
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4.2. Application: Evaluation of N-myristoyltransferase inhibitors as anti-T.cruzi agents

4.2.1. Introduction

Chagas disease (or American trypanosomiasis), caused by the protozoan parasite Trypanosoma
cruzi, is considered a neglected infectious disease with an estimate of 11 million of cases in Latin
America, and about 50,000 deaths annually (Dias et al., 2002, Stuart et al., 2008, Tarleton et al., 2007).
Chagas disease is becoming a global public health concern in the United States (US) and Europe due to
the high number of infected people migrating from endemic areas (Bern et al., 2007, Schmunis et al.,
2009). It is estimated that approximately 300,000 individuals with T. cruzi infection live in the US (Bern
et al., 2009). Additionally, autochthonous vector-borne cases of infection have already been reported and
the southern states have enzootic transmission of the parasite (Tarleton et al., 2007, Bern et al., 2009).
Currently, there are only two drugs, namely Benznidazole and Nifurtimox, commercially
available for the treatment of Chagas disease, and both are highly toxic and only partially effective
(Urbina, 2009). Moreover, an increasing number of drug-resistant T. cruzi strains have been reported
(Wilkinson et al., 2008) and there is no available vaccine for the prevention or treatment of Chagas
disease (Dumonteil, 2007, Garg et al., 2005). Therefore, there is an urgent need to develop new
chemotherapies against T. cruzi.
N-myristoyltransferase (NMT) has recently been proposed to be a potential drug target in
kinetoplastid parasites (Bowyer et al., 2008, Gelb et al., 2003). NMT is a cytosolic enzyme, ubiquitous in
eukaryotes, that catalyzes the covalent co- and post-translational transfer of myristate to the N-terminal
glycine residue of a number of proteins (Farazi et al., 2001). This modification increases the
hydrophobicity of the protein enhancing associations with both cellular membranes and other proteins
(Farazi et al., 2001). It also plays a role in conformational changes that result in reversible membrane
binding through a myristoyl switch mechanism (McLaughlin et al., 1995). N-myristoylation is essential
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for the biological function of numerous proteins including signaling pathway components such as
heterotrimeric G proteins and tyrosine protein kinases (Farazi et al., 2001). Due to its many functions,
NMT has been explored as therapeutic target for the development of antiviral, antifungal and anticancer
compounds (Sheng et al., 2009).
Recently, the NMTs from the protozoan parasites L. major, T. brucei and P. falciparum have
been characterized and it was shown that they share high similarity with other characterized NMTs in
their primary sequence including conservation of key amino acids essential for catalysis (Panethymitaki et
al., 2006, Sheng et al., 2009). It has also been demonstrated that NMT is essential for viability in both L.
major and T. brucei (Price et al., 2003). However, up to now, only a small number of inhibitors of
protozoan parasite NMTs have been reported (Panethymitaki et al., 2006, Bowyer et al., 2007).
In T. cruzi, although few N-myristoylated proteins have been experimentally validated thus far,
including phosphatidylinositol-phospholipase C involved in the parasite differentiation process (Furuya et
al., 2000) and flagellar calcium-binding protein (Godsel et al., 1999), bioinformatic analyses predicted
with high confidence that more than 120 proteins in this parasite are NMT substrates (Bowyer et al.,
2008, Mills et al., 2007). Therefore, inhibition of T. cruzi NMT is expected to have pleiotropic effects on
the physiology of the parasite. Nevertheless, compounds with potential to act as NMT inhibitors have not
been tested against T. cruzi yet.
More recently, Frearson et al. (2010) identified potent inhibitors of T. brucei NMT through an
initial screening of a 62,000 diversity-based compound library followed by further optimization of
compounds based on a pyrazole sulfonamide scaffold. These compounds presented strong T. brucei
inhibition characteristics both in vitro and in vivo (Frearson et al., 2010). Although the compounds were
highly efficient against the extracellular parasite T. brucei, their effect on the intracellular parasites such
as T. cruzi remained to be determined. In the present investigation, we evaluated the effect of these novel
NMT inhibitors against T. cruzi as a model to assess the applicability of the newly developed highcontent imaging and automated analysis as well as to carry out a preliminary in vitro study to assess the
ability of these compounds to inhibit the parasite intracellular proliferation.
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4.2.2. Materials and Methods

Compounds
Selected compounds that were previously shown to have remarkable efficacy against T. brucei NMT
(Frearson et al., 2010) were kindly provided by Dr Paul Wyatt and Dr Stephen Brand (University of
Dundee, UK).

Parasite and mammalian cell cultures
Cell culture procedures as well as the generation of green fluorescent protein (GFP)-expressing NIH3T3
cells were carried out as previously described in section 4.1.2.

Proliferation assay
GFP-expressing NIH3T3 cells were plated in BD Falcon 96-well bioimaging plates at a density of 2 x 103
cells per well and incubated overnight at 37 °C in a 5% CO2 humidified atmosphere. T. cruzi
trypomastigotes were added at a parasite:host cell ratio of 10:1. Infections were carried out for 2 h at 37
°C in a 5% CO2 humidified atmosphere. After the incubation, cells were washed four times with media to
remove extracellular trypomastigotes. The compounds (as well as the DMSO vehicle control) were
diluted in complete media at concentrations ranging from 50 µM to 1 nM. The medium in the wells was
replaced by medium containing the compounds and the cells were reincubated for approximately 72 h to
allow the differentiation of internalized parasites into amastigote forms and the intracellular proliferation
of the parasite. Then, cells were washed with phosphate-buffered saline (PBS) and fixed with 4%
paraformaldehyde for 15 min. The parasite and mammalian cell DNA were stained with 4’,6-diamidino2-phenylindole (DAPI) at 1 µg/mL for 5 min and washed with PBS.
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Image acquisition, processing and data analysis
Image acquisition and processing were performed as described in section 4.1.2. Quantification of number
of parasites per host cell, total number of host cells, total number of parasites, percentage of infected host
cells, percentage of cells with equal or more than 1, 3 or 5 parasites per well were performed from
captured images in adequate probe channels for both fluorophores using the BD AttoVision™ v1.6.2 and
BD™ Image Data Explorer softwares (BD Biosciences, Rockville, MD).

Determination of IC50
IC50s were determined with GraphPad software (GraphPad Software, Inc.) using a sigmoidal doseresponse variable slope model with response values based on total number of parasites (normalized to
span the range from 0 to 100%) plotted against the logarithm of compound concentration.
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4.2.3. Results and Discussion

Previous studies demonstrated the remarkable efficacy of the studied compounds against T.
brucei (Frearson et al., 2010). Based on these studies, selected compounds were tested to determine their
effects on the intracellular proliferation of T. cruzi by applying the newly developed automated counting
of intracellular parasites. The experimental procedure used to evaluate the anti-proliferative effects of the
compounds is described in Figure 4.2.1. In order to obtain data on the number of parasites within the cell
boundaries at a single cell level, GFP-expressing NIH3T3 cells were used in this study for the delineation
of the host cell boundaries based on GFP fluorescence. Cells were seeded on 96-well plates and in the
following day, cells were infected with T. cruzi trypomastigotes. Upon host cell infection, the infective
trypomastigote forms differentiate into replicative amastigote forms and begin to divide. At
approximately 96 h post-infection, amastigotes differentiate back into trypomastigotes, the host cell
ruptures releasing the parasites into the extracellular milieu. Since we were interested in the antiproliferative effects of the compounds on T. cruzi, infected cells were incubated for 72 h in the presence
of diluted compounds prior to fixation. At this time point, significant intracellular replication and very
little or no disruption of infected cells with release of trypomastigotes was observed (Figure 4.2.2.A,
vehicle control), which is critical to clearly investigate the effect of the compounds on proliferation.
After fixation, host cell and parasite DNA were stained with DAPI to rapidly determine the total
number of host cells and parasites. To achieve increased cell counts for a more accurate analysis, multiple
adjacent image fields per sample were acquired to obtain a montage image. Images were acquired for
both DAPI (host cell and parasite DNA) and GFP (host cell body) fluorescence. The images were
segmented based on fluorescence and size thresholds and the segmentation mask was generated as
previously described (section 4.1).
We then explored the multiparametric data obtained on a cell-by-cell basis to precisely and
promptly determine several parameters associated to infection of host cell by T. cruzi including the effects
of compounds on mammalian cells and intracellular parasite proliferation. First, the total number of cells
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(objects segmented based on DAPI staining of the host cell) was analyzed to monitor the cytotoxicity of
the compounds (Figure 4.2.2.B). Compounds DDD100153 and DDD100097 demonstrated low
cytotoxicity at 0.1 µM, whereas compound DDD87769 showed low cytotoxicity even at 50 µM when
compared to the vehicle control (DMSO). Next, through the results of the sub-object analysis, we
evaluated the total number of parasites (sub-objects, Figure 4.2.2.C). A significant reduction in the
number of parasites (about 70%) was observed in wells treated with compounds DDD100153,
DDD100097 and DDD87769 at non-cytotoxic concentrations (0.1, 0.1, and 10 µM, respectively). The
results were also evident in the acquired images (Figure 4.2.2.A).
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Plate NIH3T3 mouse fibroblasts
Overnight incubation

Infection of attached cells
(add T. cruzi trypomastigotes)
2h incubation
Wash

Add compounds diluted in media
~72h incubation

Fixation and staining
High content imaging and data analysis

Figure 4.2.1. Experimental procedure to evaluate the effects of compounds of interest on intracellular T.
cruzi proliferation.
GFP-expressing NIH3T3 cells were plated in 96-well bioimaging plates and incubated overnight at 37 °C.
Infection with trypomastigotes was carried out for 2 h at 37 °C. After incubation, cells were washed and
reincubated with compounds diluted in complete medium or vehicle control (DMSO) for approximately
72 h. During this period, trypomastigotes differentiate into replicative amastigote forms followed by
intracellular proliferation. Cells were washed, fixed and stained with DAPI. Then, high-content imaging
and data analysis was carried out as previously described in section 4.1.2.
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Figure 4.2.2. Automated counting of the total number of cells and parasites as initial indicators of the
cytotoxicity and anti-T. cruzi effect of the tested compounds.
A. Representative images (DAPI fluorescence of host cell and parasite DNA) of wells treated with
compounds or vehicle control (DMSO). Arrows indicate host cells in which the parasite proliferated. The
total number of cells in each well (B) was counted to evaluate the cytotoxicity of the compounds while
the total number of parasites (C) indicates the effects of the compounds on T. cruzi intracellular
proliferation.

104

To determine the percentage of infected cells, we performed a constriction by obtaining the
number of cells containing at least one parasite (Figure 4.2.3.A). Since compounds were added after the
infection period, changes in the percentage of infected cells are only expected to be observed if
compounds are trypanocidal, such as the compound DDD87769 at 10 µM. In wells treated with
compounds DDD100153 and DDD100097, the percentage of infected cells did not differ significantly
and/or consistently when compared to control indicating that these compounds did not have the ability to
kill the parasite. Then, to investigate the number of cells in which the parasites have proliferated, the
number of cells containing at least 3 (Figure 4.2.3.B) or at least 5 parasites (Figure 4.2.3.C) were plotted.
Compounds DDD100153, DDD100097, and DDD87769 at non-cytotoxic concentrations markedly
inhibited T. cruzi intracellular proliferation (Figure 4.2.3.B and C).
The IC50 values against T. cruzi and NIH3T3 cells as well as the selectivity of five of the tested
compounds (DDD87769, DDD100153, DDD100097, DDD99837, and DDD100144) are shown in Table
4.2.1. The compound with highest inhibitory effect was DDD100097 with an IC50 value of 9 nM and 58fold selectivity over NIH3T3 cells (Table 4.2.1). On the other hand, although compound DDD87769 had
an IC50 value of 1.3 µM, it showed the highest level of selectivity (85% at 50 µM, Table 4.2.1). We have
also evaluated other compounds including the compound DDD85646 with high efficacy against T. brucei
both in vitro and in vivo (Frearson et al., 2010). However, interestingly, this compound did not show any
inhibitory effect in our model (data not shown). Overall, it is likely that the effects of the tested
compounds on T. cruzi are a result of several downstream events since inhibition of NMT is expected to
affect the function of numerous proteins what could also explain the strong inhibitory effects of these
compounds on parasite proliferation.
These results not only demonstrate the potential of the tested compounds as anti-T. cruzi agents,
but also confirm the usefulness and uniqueness of high-content imaging in the determination of several
parameters to assess the efficacy of compounds against pathogens. Clearly, the generation of
multiparametric data on a cell-by-cell basis provided the unique ability to determine, in a single
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experiment, the number of cells and parasites, and the percentage of host cells containing specific number
of parasites to quickly assess the cytotoxic effects of the tested compounds as well as the changes
infection rates and the intracellular proliferation of T. cruzi. Importantly, the assessment was performed in
a drastically short period when compared to manual counting. It is also clear that the level of quantitative
information obtained in a single experiment through the analysis of the multiparametric data is only
possible through the use of this novel automated methodology.
In conclusion, our results emphasize the immense potential of high-content imaging for highthroughput drug screening and to study other intracellular pathogens and cellular processes that require
accurate information based on single cell analysis. Moreover, the tested compounds demonstrated
significant anti-proliferative effects and hold great potential to be explored as anti-T. cruzi agents.
Additional studies will be carried out to further evaluate the in vitro inhibitory effects of several
compounds as well as the in vivo effects of selected compounds in a murine model of Chagas disease.
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Figure 4.2.3. Uniqueness of the automated analysis of multiparametric data to quantify T. cruzi infection
rates and intracellular proliferation.
The multiparametric data obtained on a cell-by-cell basis was analyzed to precisely and promptly
determine several parameters associated to infection of host cell by T. cruzi including the (A) percentage
of cells with at least one parasite (percentage of infected cells) and the percentage of cells with (B) at least
3 or (C) at least 5 parasites (percentage of cells in which the parasite proliferated).
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Table 4.2.1. IC50 values of tested compounds against T. cruzi and NIH3T3 cells.

Compound

T. cruzi
(µ
µM)

NIH3T3 cells
(µ
µM)

Selectivity
(T. cruzi/NIH3T3 cells)

DDD87769

1.29

85% at 50

N/A

DDD100153

0.02

2.53

126

DDD100097

0.009

0.56

58

DDD99837

0.12

4.7

40

DDD100144

0.014

0.64

44
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Chapter 5: Final Conclusions and Future Directions

5.1.

Overview and Final conclusions

The focus of the first part of this dissertation was to gain insight into the molecular aspects of the
host cell-T. cruzi interaction and particularly, the upstream molecules involved in TLR2 recognition of
tGPIs by innate immune system and the role of TLR2 signaling in the invasion process. Firstly, the results
revealed that chemically synthesized tGPIs containing sn-1-O-(C16:0)-alkyl-2-O-(C18:1, C18:2, or
C16:0)-acylglycerol lipid were biologically active. These stGPIs were preferentially recognized by the
TLR2 and TLR6 heterodimer, while co-expression of CD14 accessory molecule induced a significant
enhancement in cellular responses assessed as NF-κB activation and IL-8 production by cells transfected
with constructs encoding distinct TLRs and coreceptors. In addition to CD14, CD36 was able to enhance
the TLR2/6-mediated proinflammatory reponses induced by tGPIs. Although the TLRs and coreceptor
requirements of stGPIs with different lipid moieties were similar, stGPIs containing unsaturated (C18:1 or
C18:2) fatty acid induced a much stronger response as compared to the saturated (C16:0) fatty acidcontaining stGPI. Interestingly, trypomastigote tGPI-mucins and stGPIs were differentially recognized by
TLR2/1 and TLR2/6 heterodimers. In summary, in addition to reveal new insights into the GPI structureactivity relationship, our results provided the first clear evidence regarding the participation of TLR2 and
TLR6 heterodimer as well as CD14 and CD36 in recognition of T. cruzi GPIs.
Secondly, contrary to the well established role of TLR2 as one of the primary sensor of the innate
immune defense against pathogens, activation of TLR2 signaling by TLR2-specific ligands significantly
enhanced parasite infection in both phagocytic and non-phagocytic cells. In our model, although the
TLR2 ligands FSL and P3C did not induce intracellular calcium mobilization, an event known to be
important during the invasion process, depletion of host cell intracellular calcium reduced the levels of
TLR2-mediated invasion. Furthermore, TLR2 activation induced host cell actin depolymerization, which
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is proposed to facilitate parasite internalization. Silencing of TLR2 resulted in significantly decreased
infection confirming the role of TLR2 in the mechanism of invasion. In conclusion, our results revealed
an unexpected role of TLR2 by demonstrating that this obligate intracellular parasite exploits TLR2mediated signaling pathway to enter the host cell.
Taken together, these results suggest that host cell TLR2 may have a dual paradoxical function
during T. cruzi infection by eliciting immune responses and increasing the parasite infectivity. Both,
control of the parasite proliferation by the immune system to avoid severe tissue pathology and lethality
of the host as well as employment of efficient strategies to evade immune system and infect host cells are
essential features to favor the parasite’s persistence in host tissue and encounter with the transmission
vector ensuring the maintenance of its life cycle. Therefore, it can be speculated that TLR2 activation
during T. cruzi infection may contribute to ultimately favor the perpetuation of the infection in the host by
maintaining a fine equilibrium between host immune responses and infection.
On the other hand, TLR2-mediated signaling has been implicated in several other aspects of the
interaction between T. cruzi and the host such as induction of dendritic cell response (Ouaissi et al., 2002)
and cardiomyocyte hypertrophy (Petersen and Burleigh, 2003). Thus, it is evident that TLR2 stimulation
plays several roles during T. cruzi infection. Consequently, the T. cruzi-induced activation of multiple
TLR2-mediated pathways is likely to result in multiple cellular responses which may have a particular
outcome depending on the cell type. Clearly, further studies are necessary to fully clarify the contribution
of TLR2 and other TLRs, and coreceptors during T. cruzi infection.
Our studies begin to reveal novel mechanisms of host cell signaling subversion, which may also
be exploited by other intracellular pathogens. Several studies also provide evidence of manipulation of
host cell signaling pathways by T. cruzi. Earlier studies on the mechanisms of T. cruzi invasion
demonstrated that the infective trypomastigotes have evolved the unique capacity to invade nonphagocytic cells by subverting a calcium-regulated lysosomal exocytosis pathway involved in the
mechanism of mammalian cells plasma membrane repair (Andrews, 2002, Reddy et al., 2001). In
addition to unravel this repair mechanism, studies initiated on T. cruzi revealed that calcium-induced
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lysosomal exocytosis can limit the intracellular growth of pathogenic bacteria (Roy et al., 2004). Another
example of host cell signaling subversion is the activation of the host cell receptor tyrosine kinase TrkA
by a T. cruzi-derived molecule. Interestingly, activation of this receptor, which is normally associated
with survival, differentiation and proliferation of neuronal cells, leads to stimulation of signaling
pathways that promote both parasite invasion and host cell survival (de Melo-Jorge and PereiraPerrin,
2007).
Taken together, our results and others from the literature indicate that the T. cruzi-host cell
interplay is remarkably complex and that this intracellular parasite exploits a variety of host cell receptors
and signaling pathways to successfully invade, survive, proliferate, modulate immune responses and
ultimately, persist in the host.
In the second part of this dissertation, the development and evaluation of an improved method to
study in vitro models of host cell-parasite interaction and more specifically, T. cruzi infection and
intracellular proliferation, was described. This approach was based on high-content imaging and
automated analysis in a multiwell microplate format. It generated multiparametric data on a cell-by-cell
basis, which was further explored to precisely and quickly determine several parameters associated to in
vitro infection of host cells. Statistical analysis confirmed that there is substantial agreement between the
data acquired manually and that by automated analysis. This robust and efficient method greatly aided in
speeding up the research based on in vitro infection assays. Moreover, to further assess the applicability
of this novel methodology, the effects of specific compounds on T. cruzi intracellular proliferation were
evaluated. The results clearly demonstrated the potential of the tested compounds as anti-T. cruzi agents,
and importantly confirmed the usefulness and uniqueness of high-content imaging in the determination of
cytotoxic effects of the tested compounds as well as changes in T. cruzi infection rates and intracellular
proliferation in a single experiment. Notably, the assessment was performed in a drastically short period
when compared to manual counting. Thus, this novel automated approach may contribute to accelerate
the discovery of potential compounds in the critical search for more efficient and less toxic drugs against
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this parasite as well as the elucidation of molecular events related to host cell-pathogen interaction not
only in T. cruzi research but also in the study of other human intracellular pathogens.
Overall, the results from this dissertation provide novel insights in the molecular events during
the T. cruzi-host cell interplay as well as a novel and improved approach to facilitate this study in in vitro
models. Further elucidation of these molecular aspects may lead to a better understanding of the
mechanisms that underline the events regulating establishment of T. cruzi infection and the pathogenesis
of Chagas disease. The knowledge accumulated through these studies may eventually result in the
development of efficacious therapies against this parasite.

5.2.

Future directions

Synthetic tGPIs were used in the studies related to determination of the upstream molecules
implicated in their innate immune recognition. However, one particular structural trait lacking in these
synthetic tGPIs was the galactose branches along the glycan core (Almeida et al., 2000). The precise
structure of the GPI anchor glycan has not been determined yet largely due to heterogeneity and
limitations in quantity of GPIs purified from infective trypomastigote forms. This task will be undertaken
in our laboratory and upon chemical preparation of various tGPIs containing additional galactose residues
it would be relevant to assess the contribution of this feature in TLR recognition of tGPIs. Furthermore,
the results of this dissertation demonstrated that CD14 and CD36 cooperate with TLR2/6 heterodimer in
the innate immune sensing of stGPIs. However, the mechanisms underlying this effect remain unclear. It
would be interesting to evaluate whether the role of CD36 as a co-receptor is solely based on its
ectodomain (Jimenez-Dalmaroni et al., 2009) or whether CD36-induced Lyn kinase activation (Stewart et
al., 2010) modulates the responses to tGPIs.
On the other hand, based on our results demonstrating the role of CD36 in T. cruzi tGPI
recognition and recent findings demonstrating the involvement of CD36 in TLR2 ligand and pathogen
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internalization (Means et al., 2009, Shamsul et al., 2010, Stuart et al., 2005), it can be speculated that this
accessory molecule may participate in the upstream events leading to TLR2-dependent invasion. To test
this, non-phagocytic cells expressing TLR2/6 and CD14 but lacking CD36 expression, can be stably
transfected with CD36. These cells can be infected with trypomastigotes to determine whether CD36
expression can enhance T. cruzi invasion. Additionally, we are currently acquiring the CD36 knockout
mice to clarify the overall in vivo contribution of CD36 during T. cruzi infection.
The results presented here also provided initial insights into the downstream mechanisms related
to TLR2-mediated invasion. Cumulative evidence suggests that fast cellular responses upon TLR
activation such as cytoskeleton changes and enhancement in endocytic processes are dependent on TLRinduced MAP kinase pathways involving ERK and p38 (West et al., 2004, Zaru et al., 2007). Hence, to
initially investigate whether these MAP kinases are essential in TLR2-induced enhancement in T. cruzi
invasion, inhibitors that specifically target these kinases could be employed in infection assays.
Regarding the automated analysis of T. cruzi infection rate based on high-content imaging
described in the second part of this dissertation, efforts should be certainly taken to validate this
methodology for high-throughput screening. Moreover, during the assessment of the applicability of this
newly developed methodology, compounds demonstrating significant ability to inhibit T. cruzi
intracellular proliferation and high selectivity over mammalian cells were identified. In addition to
validate T. cruzi NMT as a molecular target and demonstrate that the compounds specifically inhibit Nmyristoylation in the parasite, the in vivo activity of compounds selected based on our in vitro inhibitory
effects will be evaluated by our group in a murine model of Chagas disease.
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Appendix

List of abbreviations

AAG

Alkylacylglycerol

α-Gal

Alpha-galactosyl

AEP

2-aminoethylphosphonate

BCS

Bovine calf serum

bp

Base pairs

BSA

Bovine serum albumin

CD14

Cluster of differentiation 14

CD36

Cluster of differentiation 36

cDNA

Complementary DNA

CFU

Colony-forming unit

CHO

Chinese hamster ovary

CL-ELISA

Chemiluminescent enzyme-linked immunosorbent assay

CpG

Cytosine-phosphate-guanosine

Ct

Threshold cycle

DAPI

4',6-diamidino-2-phenylindole

DC

Dendritic cell

DMEM

Dulbecco's modified Eagle's medium

DNA

Deoxyribonucleic acid

DMSO

Dimethyl sulfoxide

EDTA

Ethylenediaminetetraacetic acid

eGFP

Enhanced green fluorescent protein

eGPI

Epimastigote-derived glycosylphosphatidylinositol

ELAM

Endothelial leukocyte molecule

ELISA

Enzyme-linked immunosorbent assay

ER Ca+2ATPase

Endoplasmic reticulum calcium ATPase

ERK

Extracellular signal-regulated kinase

ESI-MS

Electrospray ionization-mass spectrometry

EtNP

Ethanolaminephosphate
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FBS

Fetal bovine serum

FITC

Fluorescein isothiocyanate

FSL

FSL-1 or Pam2CGDPKHPKSF or
S-(2,3-bispalmitoyloxypropyl)-Cys-Gly-Asp-Pro-Lys-His-Pro-Lys-Ser-Phe

Fura2-AM

Fura-2-acetoxymethyl ester

Gal

Galactose

GAPDH

Glyceraldehyde 3-phosphate dehydrogenase

GC-MS

Gas chromatography-mass spectrometry

GIPL

Glycoinositolphospholipid

Glc

Glucose

GlcN

Glucosamine

GPCR

G-protein coupled receptor

GPI

Glycosylphosphatidylinositol

GTP

Guanosine triphosphate

HA

Hemagglutinin

HBSS

Hank's Buffered Salt Solution

HEK293A

Human embryonic kidney cells

HIV

Human immunodeficiency virus

HPLC

High-performance liquid chromatography

IC50

Half maximal inhibitory concentration

IFN

Interferon

IL

Interleukin

IP3

Inositol 1,4,5-triphosphate

kV

Kilovolts

LacZ

β-Galactosidase

LAMP-1

Lysosomal-associated membrane protein 1

LBP

LPS-binding protein

LLC-MK2

Rhesus monkey kidney epithelial cells

LPG

Lipophosphoglycan

LPS

Lipopolysaccharide

LTA

Lipoteichoic acid

Luc/Ren luc

Ratio of NF-κB dependent firefly luciferase activity to Renilla luciferase activity

m/z

Mass-to-charge ratio

Man

Mannose
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MAPK

Mitogen-activated protein kinase

MD-2

Myeloid differentiation protein-2

m-Ins

myo-Inositol

mRNA

Messenger ribonucleic acid

MS

Mass spectrometry

MyD88

Myeloid differentiation primary response gene 88

NA

Numerical aperture

NF-kB

Nuclear factor-kappaB

NIH3T3

Mouse fibroblast cell line

NMT

N-myristoyltransferase

NO

Nitric oxide

OpdB

Oligopeptidase B

P3C

Pam3Cys-SKKKK or
N-Palmitoyl-S-[2,3-bis(palmitoyloxy)-propyl]-Cys-Ser-(Lys)4

PAMP

Pathogen-associated molecular pattern

PBS

Phosphate-buffered saline

PCR

Polymerase chain reaction

PGTF

Proteolytically generated trypomastigote factor

PI3K

Phosphoinositide 3-kinase

PIM

Phosphatidylinositol mannoside

PLC

Phospholipase C

PO4

-

Phosphate

PRR

Pattern-recognition receptor

Rac1

Ras-related C3 botulinum toxin substrate 1

RAW267.4

Mouse monocyte/macrophage cell line

RLU

Relative luminescence unit

RNA

Ribonucleic acid

ROI

Regions of interest

RT-PCR

Reverse transcription-polymerase chain reaction

shRNA

Short hairpin RNA

sn

Stereospecific numbering: it designates the configuration of derivatives or
substituent groups (i.e., acyl, alkyl chain, phosphate group, etc.) linked to
C-1 (sn-1), C-2 (sn-2), and C-3 (sn-3) of the glycerol moiety.

stGPI

Synthetic trypomastigote glycosylphosphatidylinositol
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tGPI

Glycosylphosphatidylinositol (GPI) moiety from trypomastigote-derived GPI-anchored
mucin

tGPI-mucin

Trypomastigote-derived glycosylphosphatidylinositol (GPI)-anchored mucin

TIR

Toll/interleukin-1 receptor-like domain

TLR

Toll-like receptor

TLR2/1

Toll-like receptor 2 and 1 heterodimer

TLR2/6

Toll-like receptor 2 and 6 heterodimer

TMS

Trimethylsilyl

TNF-α

Tumor necrosis factor-alpha

zeo

Zeocin resistance gene
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Abstract

23
24

Glucuronoxylomannan (GXM), the major capsular component in the Cryptococcus complex,

25

interacts with the immune system in multiple ways, which include activation of Toll-like receptors

26

(TLRs) and modulation of nitric oxide (NO) production by phagocytes. In this study, we analyzed

27

several structural parameters of GXM samples from C. neoformans (serotypes A and D) and C. gattii

28

(serotypes B and C) and correlated them with the production of NO by phagocytes and activation of

29

TLRs. GXM fractions were differentially recognized by TLR2/1 and TLR2/6 heterodimers expressed

30

on TLR-transfected HEK293A cells. Higher NF-kB luciferase reporter activity induced by GXM was

31

observed in cells expressing TLR2/1 than in cells transfected with TLR2/6 constructs. A serotype B

32

GXM from C. gattii was the most effective polysaccharide fraction activating the TLR-mediated

33

response. This serotype B polysaccharide, which was also highly efficient in eliciting the production

34

of NO by macrophages, was similar to the other GXM samples in monosaccharide composition, zeta

35

potential, and electrophoretic mobility. However, immunofluorescence with four different

36

monoclonal antibodies and dynamic light scattering analysis revealed that the serotype B GXM

37

showed particularities in serological reactivity and had the smallest effective diameter among the

38

GXM samples analyzed in this study. Fractionation of additional serotype B GXMs followed by

39

exposure of these fractions to macrophages revealed a correlation between NO production and

40

reduced effective diameters. Our results demonstrate a great functional diversity in GXM samples

41

from different isolates and establish their ability to differentially activate cellular responses. We

42

propose that serologic properties as well as physical chemical parameters such as the diameter of

43

polysaccharide molecules may potentially influence the inflammatory response against Cryptococcus

44

spp. and may contribute to the differences in granulomatous inflammation between cryptococcal

45

species.

46
47
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48

Introduction

49
50

Cryptococcus neoformans and C. gattii are the etiologic agents of the human and animal

51

fungal disease cryptococcosis. Infection is usually acquired by inhalation of environmental

52

basidiospores or desiccated yeasts. Cryptococcal disease in humans can involve every tissue,

53

including cutaneous and pulmonary sites, but the most serious manifestation is central nervous system

54

involvement with meningoencephalitis (Perfect et al., 2002). Despite the similarities of the clinical

55

syndromes in cryptococcosis caused by C. neoformans and C. gattii, these species differ in the types

56

of host where they cause disease. While C. neoformans preferentially causes disease in

57

immunosuppressed patients, C. gattii-related disease is relatively common in immunocompetent

58

individuals (Perfect et al., 2002, Speed et al., 1995, Mitchell et al., 1995). Mortality rates are still

59

high in different regions of the globe and the current therapeutic options are inefficient (Bicanic et al.,

60

2004). No vaccines are available for the prevention of cryptococcosis.

61

Glucuronoxylomannan (GXM) is the major component of the polysaccharide capsule, which

62

is the main virulence factor of Cryptococcus species (McClelland et al., 2005). GXM is an anionic

63

polysaccharide consisting of a α1-3 linked mannan that is O-acetylated at the carbon 6 of some of the

64

mannosyl units and substituted with β1,2 glucuronyl and β1,2 / β1,4 xylosyl residues (Doering,

65

2000). The polysaccharide is a capsular component of Cryptococcus species that is also abundant in

66

its soluble form in culture fluids or infected tissues (McFadden et al., 2006). Secreted and surface-

67

associated GXM are believed to modulate the immune response during cryptococcosis through

68

multiple mechanisms (Monari et al., 2006). In addition, administration of monoclonal antibodies

69

against GXM can modify the course of experimental cryptococcosis by prolonging host’s survival

70

(Casadevall et al., 1998). Four serotypes of GXM (A–D) have been defined by serological reactions.

71

This classification divides pathogenic Cryptococcus species with specific serotypes, such that C.

72

gattii consists of serotypes B and C isolates while C. neoformans varieties grubii and neoformans

147

73

correspond to serotypes A and D, respectively (Kwon-Chung et al., 2006, Perfect et al., 2002). Most

74

studies on the immunological functions of GXM have focused on the polysaccharide fractions from

75

serotype A C. neoformans isolates. Although it is generally assumed that the immunological

76

properties observed for the serotype A polysaccharide are applicable to the other serological groups,

77

this common assumption may not be correct given major structural differences among the four major

78

serotypes.

79

The ability of GXM to activate the innate immune response was previously reported in

80

several studies (Yauch et al., 2005, Monari et al., 2005a, Yauch et al., 2004, Shoham et al., 2001).

81

Serotype A GXM was reported to modulate the production of nitric oxide (NO) by phagocytes

82

(Chiapello et al., 2008). In addition, GXM activates Toll-like receptor (TLR) 4-mediated intracellular

83

signaling (Shoham et al., 2001), but the contribution of this event to the global innate response

84

against C. neoformans infections is uncertain (Nakamura et al., 2006, Biondo et al., 2005). GXM can

85

also interact with TLR2 (Shoham et al., 2001), which is believed to influence the response to

86

cryptococcal infection (Yauch et al., 2004). TLR2 recognizes a diverse set of pathogen-associated

87

molecular patterns, which requires heterodimerization with TLR 1 or 6 (Liang et al., 2009, Jin et al.,

88

2007, Gautam et al., 2006, Triantafilou et al., 2006, Kumar et al., 2009). The roles of TLR1 or TLR6

89

in the recognition of GXM by TLR2 have not been investigated yet.

90

In this study, we correlated the structural and physical chemical properties of five GXM

91

samples with their ability to stimulate NO production by macrophages and to activate nuclear factor

92

kB (NF-kB) in cells expressing either TLR2/TLR1 or TLR2/TLR6. Our results demonstrate that a

93

serotype B GXM sample is particularly efficient in activating these cellular responses. These

94

immunomodulatory properties correlate with specific serologic properties and to a reduced diameter

95

of polysaccharide molecules.

96
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97

Material and methods

98
99

Fungal strains

100

Cryptococcal isolates used in this study were selected from the culture collection available in our

101

laboratory. Strains that had previously been more extensively characterized according to their

102

phenotypic characteristics, such as capsule expression, serotype, growth rate and biochemical

103

properties (Collopy-Junior et al., 2006), were used for structural and immunological assays. These

104

samples included strains T1444, HEC3393 (serotype A, clinical isolates) and ATCC28938 (serotype

105

D, obtained from the American Type Culture Collection, Manassas, VA) of C. neoformans and

106

CN23/10.993 (serotype B, environmental isolate) and HEC40143 (serotype C, environmental isolate)

107

strains of C. gattii. Additional serotype B strains were included in this study based on the results

108

obtained during structural/immunological investigations. These isolates comprised the well

109

characterized strain R265 (Kidd et al., 2004) and strain ATCC56990 (American Type Culture

110

Collection). Stock cultures were maintained in Sabouraud dextrose agar under mineral oil and kept at

111

4 °C.

112
113

GXM purification

114

GXM was isolated as previously described by our group (Nimrichter et al., 2007). Briefly, C.

115

neoformans and C. gattii cells (4 x 109 cells) were suspended in 100 mL of a minimal medium

116

composed of glucose (15 mM), MgSO4 (10 mM), KH2PO4 (29.4 mM), glycine (13 mM), and

117

thiamine-HCl (3 µM); pH 5.5. For all experiments we used LPS-free water and glassware. This

118

suspension was then transferred to a 1000-mL Erlenmeyer flask and supplemented with 300 mL of

119

the same medium. Fungal cells were cultivated for four days at room temperature, with shaking and

120

separated from culture supernatants by centrifugation at 4,000 g (15 min, 4 oC). The supernatant

121

fluids were collected and again centrifuged at 15,000 g (15 min, 4 oC), to remove smaller debris. The

122

pellets were discarded and the resulting supernatant was concentrated approximately 20-fold using an
149

123

Amicon (Millipore, Danvers, MA) ultrafiltration cell (cutoff = 100 kDa, total capacity of 200 mL)

124

with stirring and Biomax polyethersulfone ultrafiltration discs (63.5 mm). Nitrogen (N2) stream was

125

used as the pressure gas. After supernatant concentration, the viscous layer formed was collected with

126

a cell scraper and transferred to graduated plastic tubes for measurement of gel volumes. The

127

procedure was repeated at least three times to ascertain average volumes. Alternatively, the

128

supernatant fraction passed through the 100 kDa membrane was again concentrated using a 10 kDa

129

filtration disc. The viscous layer was again collected and used for structural and functional

130

determinations.

131
132

ELISA for GXM quantification

133

The concentration of GXM in supernatants and concentrated films was determined by capture ELISA,

134

as previously described (Casadevall et al., 1992). Briefly, 96-well polystyrene plates were coated with

135

goat anti-mouse IgM. After removal of unbound antibodies, a solution of mAb 12A1, an IgM with

136

specificity for GXM, was added to the plate, and this step was followed by blocking with 1% bovine

137

serum albumin. Supernatants in different dilutions or purified GXM were added to the wells and the

138

plates were incubated for 1 h at 37 °C. The plates were then washed five times with a solution of tris-

139

buffered saline (TBS) supplemented with 0.1% Tween 20, followed by incubation with mAb 18B7 for

140

1 h. This antibody, is a well characterized IgG1 that protects mice against lethal challenges with C.

141

neoformans and binds to an epitope found in GXM from serotypes A, B, C and D (Casadevall et al.,

142

1998). The plate was again washed and incubated with an alkaline phosphatase-conjugated goat anti-

143

mouse IgG1 for 1 h. Reactions were developed after the addition of p-nitrophenyl phosphate disodium

144

hexahydrate, followed by measuring absorbance at 405 nm with a microplate reader (TP-reader,

145

Thermo Plate). The antibodies used in this assay were used at 1 µg/mL.

146
147
148
150

149

Monosaccharide analysis

150

Carbohydrate composition analysis was performed by gas chromatography-mass spectrometry (GC-

151

MS) analysis of the per-O-trimethylsilyl (TMS) derivatized monosaccharides from the polysaccharide

152

films, according to the methodology described by Merkle and Poppe (Merkle et al., 1994). Methyl

153

glycosides were first prepared from the dry sample (0.3 mg) by methanolysis in methanol-1 M HCl at

154

80 oC (18-22 h). The sample was then per-O-trimethylsilylated by treatment with Tri-Sil (Pierce) at

155

80 oC (0.5 h). GC-MS analysis of the per-O-TMS derivatives was performed on an HP 5890 gas-

156

chromatographer interfaced to a 5970 MSD mass spectrometer, using a Supelco DB-1 fused-silica

157

capillary column (30 m x 0.25 mm ID). Carbohydrate standards used were arabinose, rhamnose,

158

fucose, xylose, glucuronic acid, galacturonic acid, mannose, galactose, glucose, mannitol, dulcitol,

159

and sorbitol.

160
161

Transient transfection with TLRs

162

TLR constructs (Hajjar et al., 2001) as well as the β-actin Renilla luciferase (Sweetser et al., 1998)

163

and the reporter ELAM-1-firefly luciferase (Schindler et al., 1994) constructs were kindly provided

164

by Dr. Richard Darveau (University of Washington, Seattle, WA). All plasmids used in the

165

transfections were purified using the EndoFree Plasmid Purification Maxi Kit (Qiagen, Valencia, CA)

166

following the manufacturer’s instructions. HEK293A cells (ATCC, Manassas, VA) were cultured in

167

high glucose Dulbecco's Modified Eagle Medium (DMEM) (Sigma-Aldrich, St. Louis, MO)

168

supplemented with 10% heat-inactivated fetal bovine serum (FBS) (HyClone, Logan, UT) and the

169

confluent monolayer harvested by treatment with trypsin/EDTA (Sigma-Aldrich, St. Louis, MO).

170

Cells were seeded in 12-well plates the day before transfection. HEK293A cells were transiently

171

cotransfected with plasmids encoding mouse TLR2 and TLR1 or TLR2 and TLR6 together with the

172

reporter construct ELAM-1-firefly luciferase and β-actin Renilla luciferase using Lipofectamine 2000

173

(Invitrogen, Carlsbad, CA) according to the manufacturer’s recommendations. Total DNA per well
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174

was normalized to 2 µg by adding empty vector. In the following day, the transfected cells were

175

plated in 96-well plates.

176
177

Luciferase reporter assays for NF-κB activation

178

Forty-eight hours after transfection, cells were stimulated with purified GXM (1-100 µg/mL) for 4 h

179

in DMEM containing 10% FBS. Controls for TLR activation included stimulation of cells with ultra

180

pure lipopolysaccharide (LPS) from E. coli 0111:B4 strain (Invivogen, San Diego, CA), Pam3Cys-

181

SKKKK (P3C) or FSL-1 (EMC Microcollections, Tübingen, Germany). Then, cells were washed

182

once in phosphate buffered saline (PBS) and lysed in Passive Lysis Buffer (Promega, Madison, WI).

183

The luciferase activity was measured using the Dual-Luciferase Reporter Assay System (Promega,

184

Madison, WI) according to the manufacturer's instructions. The relative light-units (RLU) were

185

quantitated using a Luminoskan luminometer. NF-κB activation is expressed as the ratio of NF-κB-

186

dependent firefly luciferase activity to β-actin-dependent Renilla luciferase activity (Hajjar et al.,

187

2001). The results are shown as the means and standard deviations of values for triplicate wells.

188
189

Nitric oxide production by phagocytes

190

The murine macrophage-like cell line RAW 264.7 (ATCC) was cultured under LPS-free conditions in

191

complete DMEM supplemented with10% fetal calf serum (FCS), 2 mM L-glutamine, 1 mM sodium

192

pyruvate, 10 mg mL-1 gentamicin, MEM non-essential amino acids (Gibco- Invitrogen 11360), 10

193

mM HEPES and 50 mM 2- mercaptoethanol, at 37 °C in a 7.5% CO2 atmosphere. Murine cells were

194

washed twice in serum-free DMEM and incubated in fresh medium supplemented with varying

195

concentrations of GXM (1-100 µg/mL) for 16 h at 37oC (7.5% CO2 atmosphere). As a positive

196

control, macrophages were stimulated with 1 µg/mL LPS. Supernatants were then collected and

197

assayed for NO production by the method of Griess (Green et al., 1982). Negative controls consisted
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198

of supernatants of RAW cells cultivated in medium containing no GXM. All experiments were

199

performed in triplicate sets.

200
201

Immunofluorescence for GXM detection

202

Antibodies to GXM used in this assay included immunoglobulins (Ig) G and M. MAbs 12A1 and

203

13F1 are two clonally related IgMs that differ in fine specificity and protective efficacy (Mukherjee et

204

al., 1995, Mukherjee et al., 1992). MAb 12A1 is protective and produces annular

205

immunofluorescence (IF) on serotype D C. neoformans, while MAb 13F1 is not protective and

206

produces punctate IF. MAb 2D10 (IgM) is also protective in a murine model of cryptococcosis. This

207

antibody reacts with epitopes found through the cell wall and capsule of a serotype D strain of C.

208

neoformans (Garcia-Rivera et al., 2004). MAb 18B7 is a protective IgG1 that has been tested as a

209

therapeutic antibody in animals and humans (Casadevall et al., 1998, Larsen et al., 2005). This

210

antibody reacts with all GXM serotypes. C. neoformans cells (106) were fixed with 4%

211

paraformaldehyde. The cells were further blocked for 1 h in PBS-BSA and incubated with the mAbs

212

described above (1 µg / mL) for 1 h at room temperature, followed by fluorescein isothiocyanate

213

(FITC) labeled goat anti-mouse (IgG or IgM) antibodies (Sigma). Yeast cells were finally observed

214

with an Axioplan 2 (Zeiss, Germany) fluorescence microscope. Images were acquired using a Color

215

View SX digital camera and processed with the software system analySIS (Soft Image System). In

216

control conditions mAbs were replaced by isotype-matched irrelevant antibodies. Exposure times

217

were similar for all conditions.

218
219

Biophysical studies

220

Particle size and negative charge of GXM samples were inferred from dynamic light scattering and

221

zeta potential (ζ) determinations, respectively, following the methods described by Frases and

222

colleagues (Frases et al., 2009, Frases et al., 2008). For ζ determination, GXM solutions were
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223

adjusted to 1 mg/mL in water and analyzed in a Zeta potential analyzer (ZetaPlus, Brookhaven

224

Instruments Corp., Holtsville, NY). Final values were obtained from the equation ζ = (4πηm)/D,

225

where D is the dielectric constant of the medium, η is the viscosity, and m is the electrophoretic

226

mobility of the particle. For determination of GXM effective diameter, polysaccharide solutions

227

prepared as described above and measured by Quasi elastic light scattering in a 90Plus/BI-MAS Multi

228

Angle Particle Sizing analyzer (Brookhaven Instruments Corp., Holtsville, NY). Particle size values

229

were calculated as described recently (Frases et al., 2009). Multimodal size distribution analysis of

230

polysaccharides was calculated from the values of intensity weighted sizes obtained from the non-

231

negatively constrained least squared (NNLS) algorithm.

232
233

Statistics

234

The existence of significant differences between the different systems analyzed in this study was

235

ascertained using multiple statistical tests. Efficacy of TLR-mediated NF-kB activation, NO

236

production and correlation tests and biophysical tests were statistically evaluated using Student’s t test

237

when two different groups were compared, and analysis of variance for comparison of several groups.

238

Statistical tests were performed with GraphPad Prism (version 5.0).

239
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240

Results

241
242

GXM from all strains manifest aggregation characteristics. GXM aggregation resulting in the

243

production of purified gels of native polysaccharide was previously demonstrated for a serotype D

244

strain of C. neoformans (Frases et al., 2008, Nimrichter et al., 2007). However, it was unclear

245

whether formation of the viscous polysaccharide films was a strain-specific phenomenon or a general

246

property of cryptococcal strains. Therefore, we evaluated the ability of polysaccharide from two C.

247

neoformans var. grubii and C. gattii (serotypes B and C) to form gels after concentration by

248

ultrafiltration.

249

Supernatants were obtained from 400 mL-cultures containing an initial inoculum of 4 x 109

250

cells. The final number of cells in each culture varied according to the growth rate of each strain (not

251

shown). Supernatant concentration by ultrafiltration led to the deposition of viscous films on filters

252

for all isolates tested. The volumes of the films were normalized to the final cell numbers of each

253

culture. This procedure was repeated at least three times for each strain and different average values

254

of polysaccharide volume were generated (Figure 1A). Next, we analyzed the ability of each isolate to

255

produce extracellular GXM, normalizing the polysaccharide concentration found by ELISA to the

256

final cell number in the culture. The profile of GXM production by each strain, determined by ELISA

257

(Figure 1B), resembled very closely that observed for gel formation in the corresponding supernatant.

258

In fact, GXM concentrations in supernatants and gel formation were correlated (R2 = 0.7390; P =

259

0.0014), as demonstrated in Figure 1C.

260

The sugar composition of each polysaccharide fraction was analyzed by GC-MS (Figure 1D).

261

After methanolysis of the polysaccharides and per-O-trimethylsilylation of the corresponding

262

products, the resulting monosaccharides were initially identified by their retention times relative to

263

standards, followed by structural authentication using MS/MS (not shown). All polysaccharide

264

samples tested revealed xylose, mannose and glucuronic acid as major constituents, consistent with

265

the three sugar components of GXM. As previously reported (Frases et al., 2008, Fonseca et al.,
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266

2009), galactose was a trace component of all samples (data not shown). The levels of each GXM

267

building unit varied in polysaccharides from each isolate (Figure 1D), as normally observed during

268

analysis of different GXM samples. Strains HEC3393 (serotype A) and HEC40143 (serotype C)

269

contained particularly high proportions of xylose, while strains T1444 (serotype A), CN23/10993

270

(serotype B) and ATCC28938 (serotype D) had mannose as their major monosaccharide constituent.

271
272

NF-κB activation in cells expressing TLR2/1 or TLR2/6 heterodimer in response to GXM.

273

HEK293A cells expressing either TLR2/1 or TLR2/6 were stimulated with the control molecules

274

LPS, P3C, and FSL-1 or with five different GXM fractions obtained from C. neoformans and C. gattii

275

(Figure 2). Transfected cells showed efficient NF-kB activation in response to the synthetic

276

triacylated lipopeptide P3C and to the synthetic diacylated lipopeptide FSL-1, which were used as

277

positive controls for TLR2/1 and TLR2/6 activation, respectively (Krishnegowda et al., 2005). As

278

expected, TLR2/6- or TLR2/1-transfected cells responded very poorly to LPS, the classic TLR4

279

ligand (Jin et al., 2008). Also, HEK293A cells transfected with the reporter construct and plasmids

280

containing no TLR-coding sequences (vector) were unresponsive in all cases. All polysaccharide

281

samples induced a dose-dependent activation of NF-kB (Figure 2). NF-kB activation by GXM was

282

always more efficient in cells transfected with the TLR2/1 constructs. Translocation of NF-kB in

283

GXM-treated cells was also more efficient in cells expressing TLR2/1 than in cells transfected with

284

plasmids coding for TLR4/CD14 (data not shown), which were initially described as the receptors

285

involved in GXM-mediated TLR activation (Shoham et al., 2001).

286

A comparative analysis of the ability of each GXM sample to activate TLR-mediated cellular

287

responses revealed unexpected differences. Although all polysaccharide fractions had the capacity to

288

activate NF-kB in either TLR2/1- or TLR2/6-expressing cells at the concentration of 100 µg/mL, a C.

289

gattii polysaccharide sample (serotype B) was significantly more efficient at activating NF-kB than

290

all others (P<0.0001), with strong signals apparent at 1 and 10 µg/mL (Figure 3). At 1 µg/mL, NF-
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291

kB activation mediated by the serotype B GXM was at least 10-fold more efficient than all others for

292

TLR2/1-expressing cells and 6-fold higher for TLR2/6-expressing cells. At 10 µg/mL, the serotype B

293

sample was approximately 2-fold and 4-fold more effective than the other samples in TLR2/1- and

294

TLR2/6-expressing cells, respectively.

295
296

NO production in response to GXM stimulation. The GXM samples used for TLR activation were

297

also tested for their ability to stimulate the production of NO by macrophage-like cells. Exposure of

298

RAW cells to GXM from C. neoformans cultures resulted in the production of NO at the background

299

level (Figure 4). Treatment of the phagocytes with C. gattii GXM, however, resulted in a dose-

300

dependent production of NO. As observed in TLR-based assays, the GXM sample from strain

301

CN23/10993 was the most effective polysaccharide fraction in eliciting NO production.

302
303

Structural and serological properties of GXM from C. neoformans and C. gattii. The differences

304

in the TLR-activating ability of the various GXM samples led us to investigate the antigenic and

305

physical properties of this polysaccharide set in more detail. The differences in the monosaccharide

306

composition in each sample were not correlated with the ability of GXM to activate cellular

307

responses, since polysaccharide fractions with very similar compositions (strains CN23/10993 and

308

ATCC28938) manifested different efficacies in NO and TLR2/1- and TLR2/6-mediated NF-kB

309

activation (Figures 1-4).

310

The negative charge of GXM is an important determinant of function for the capsular

311

polysaccharide in C. neoformans (Nosanchuk et al., 1997, Nimrichter et al., 2007). Consequently, we

312

determined the zeta potential of the GXM from each C. neoformans and C. gattii isolates and these

313

were similar (Table 1). The electrophoretic mobility of each GXM preparation was also similar and

314

strictly correlated with zeta potential values (r² = 0.9992, P<0.0001). These results therefore

315

suggested that negative charge did not affect activation of NO production and TLR-mediated cellular

316

responses by GXM.
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317

Differences in GXM structure and functions can correlate with reactivity with monoclonal

318

antibodies (Nussbaum et al., 1997), which led us to evaluate whether the functional discrepancies

319

observed in Figures 2-4 would be related with specific serological patterns (Figure 5). Cells from

320

each of the five C. neoformans strains were similarly recognized by mAb 18B7, as demonstrated by

321

immunofluorescence analysis. For all strains, there was comparable intensity and the binding pattern

322

was annular. MAbs 2D10, 12A1 and 13F1 produced punctate patterns of reactivity with similar

323

intensities after incubation with strains T1444, HEC3393, HEC40143 and ATCC28938. When strain

324

CN23/10993 was used, however, very strong serologic reactions were observed with mAb 12A1. In

325

contrast, these cells were not recognized by mAb 13F1.

326
327

GXM effective diameter. Epitope accessibility in GXM may vary according to the diameter of the

328

molecule (Frases et al., 2008). In addition, polysaccharide size is a parameter known to influence

329

activation of TLR2-mediated innate responses (Lee et al., 2008). We therefore investigated the

330

relationship between NF-kB activation and GXM effective diameter as measured by dynamic light

331

scattering (Figure 6). The polysaccharide molecules with the largest diameters came from isolates

332

T1444 and ATCC28938 (serotypes A and D, respectively). GXM from strains HEC3393 and

333

HEC40143 (serotypes A and C, respectively) showed smaller diameter values, which were still higher

334

than that obtained for the polysaccharide isolated from strain CN23/10993 (serotype B). All strains

335

produced polysaccharides with diameters higher than 2 µm, except for strain CN23/10993. Effective

336

diameter determination in ten different analyses showed that GXM fractions from the CN23/10993

337

isolate were significantly shorter (P<0.0001) than any other polysaccharide. Therefore, the GXM

338

sample containing molecules of the smallest diameter was the most potent one in activating the

339

cellular responses in this study.

340
341

Smaller GXM fractions from serotype B C. gattii strains are more effective in eliciting NO

342

production. In an attempt to establish a correlation between the effective diameter of GXM samples
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343

and their ability to stimulate cellular responses, we fractionated culture supernatants of different

344

cryptococcal isolates. GXM samples were isolated from different strains, including: i) T1444, due to

345

its ability to abundantly produce extracellular polysaccharides with high-diameter (Figures 1 and 6),

346

and ii) CN23/10993, which was selected based on its ability to produce GXM with apparently higher

347

immunogenicity (Figures 2-4). Two additional serotype B GXMs, from strains R265 and

348

ATCC56990, were included in this assay for comparative purposes. GXM fractions with molecular

349

masses higher than 100 kDa and in the range of 10-100 kDa were obtained by supernatant filtration

350

and the prototype assay used to analyze the relationship between the size of GXM samples and their

351

ability to stimulate cellular responses was NO production by macrophages, since it includes

352

straightforward procedures and simple data interpretation. Fractionation of the T1444 supernatant

353

revealed that the high molecular mass sample (>100 kDa) induced NO production by the phagocytes

354

more efficiently (P < 0.001) than the polysaccharide fraction in the 10-100 kDa mass range (Figure

355

7A). An opposite pattern was observed for the C. gattii samples. All GXM fractions of lower

356

molecular masses were significantly more effective in stimulating the production of NO than the high

357

molecular weight polysaccharides (P < 0.0001 for all samples). Again, GXM fractions from strain

358

CN23/10993 were the most effective samples inducing NO production. Measurements of

359

polysaccharide effective diameter in these fractions were performed by dynamic light scattering,

360

which confirmed that samples with higher molecular masses consisted of molecules of increased

361

dimensions (Figure 7B). Analysis of serotype B GXM samples in the 10-100 kDa molecular mass

362

range revealed a direct correlation between their ability to induce NO and reduced effective diameters

363

(Figure 7C).

364
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365

Discussion

366
367

Recent studies indicate that the structure of GXM and, consequently, its biological functions

368

vary according to parameters that include molecular mass and effective diameter (Frases et al., 2009,

369

Frases et al., 2008, Nimrichter et al., 2007). The functional diversity in cryptococcal polysaccharides

370

is not exclusive to GXM. In fact, it has been recently described that galactoxylomannan (GalXM)

371

samples from C. neoformans are structurally and antigenically variable (De Jesus et al.). Therefore,

372

establishing general functions for cryptococcal polysaccharides is complex, since very different

373

characteristics of supposedly similar samples have been repeatedly observed in independent studies

374

(Frases et al., 2008, Nimrichter et al., 2007, De Jesus et al.), that presumably reflect differences in

375

polysaccharide structure. GXM, for instance, has been classically defined as deleterious to the

376

immune system (Vecchiarelli, 2007), although it can also activate the host defense (Shoham et al.,

377

2001).

378

Fungal polysaccharides are potential candidates to activate TLR2-mediated cellular

379

responses. In Histoplasma capsulatum, β-glucan-induced formation of lipid bodies, which are

380

multifunctional organelles with critical roles in inflammation, was inhibited in TLR2-deficient mice

381

(Sorgi et al., 2009). Chitin, a cell wall structural polysaccharide, has been consistently characterized

382

as a stimulator of TLR2-dependent production of IL-17 by macrophages, resulting in the induction of

383

acute inflammation (Da Silva et al., 2008).

384

The ability of C. neoformans GXM to activate TLR-mediated innate responses was

385

demonstrated in a number of previous studies (Biondo et al., 2005, Levitz, 2004, Levitz, 2002,

386

Monari et al., 2005b, Nakamura et al., 2006, Shoham et al., 2001, Yauch et al., 2004), but

387

comparable studies have not been carried out for C. gattii polysaccharides. TLRs and the CD14

388

receptor function as pattern recognition receptors for GXM (Monari et al., 2005b, Yauch et al., 2004,

389

Levitz, 2004, Roeder et al., 2004, Levitz, 2002, Shoham et al., 2001). The binding of GXM to TLR4

390

was reported to result in translocation of NF-kB to the nucleus in an incomplete process that does not
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391

induce activation of mitogen-activated protein kinase pathways or release of TNF-α (Shoham et al.,

392

2001). TLR4 was also implicated as a receptor involved in cellular uptake (Monari et al., 2005a), and

393

tissue distribution (Yauch et al., 2005) of GXM. However, the roles of TLR2 and other TLRs in the

394

immune response to GXM remain poorly understood. In the present study, we determined that

395

distinct structural and physical chemical properties of GXM polysaccharide fractions are correlated

396

with their ability to stimulate NO production by macrophages and to activate NF-kB in a TLR2-

397

dependent manner.

398

GXM fractions tested in this study were isolated by a recently described aggregation-based

399

method that allows the purification of native serotype D GXM (Nimrichter et al., 2007). Our current

400

results indicate that the ability of GXM to self-aggregate with gel formation after concentration by

401

ultrafiltration was a property of all serotypes of pathogenic cryptococci. Since the serological

402

classification of GXM is a consequence of structural differences, the ability of each isolate to

403

produce GXM capable of self-aggregation could be a consequence of differences in polysaccharide

404

structure and / or composition. We initially suspected that the efficacy of gel formation was not

405

directly associated with serotype-related structural aspects, since supernatants from two different

406

serotype A isolates (strains T1444 and HEC3393) produced very different gel volumes. We therefore

407

considered the possibility that gel formation was influenced by the individual ability of each strain to

408

produce extracellular GXM. The ability of each strain to form GXM gels was correlated with their

409

individual efficiency to produce and secrete the polysaccharide, suggesting that a necessary amount

410

of mass is needed for efficient aggregation into gels. Our results imply that GXM aggregation, and

411

consequent formation of polysaccharide films, is not an exclusive property of any cryptococcal

412

serogroup, but rather it reflects structural properties common to GXM from all strains. Consistent

413

with this inference we found that GXM-containing supernatants with very different gel formation

414

capacity had similar monosaccharide compositions (e.g. strains T1444 and HEC3393). Therefore,

415

equivalent sugar composition is not a predictor of the gel-forming capacity of GXM preparations.
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416

In our study, all GXM fractions stimulated activation of NF-kB in HEK293A cells transiently

417

transfected with TLR2 and TLR6, or TLR2 and TLR1 constructs. This response was always more

418

intense in cells expressing the TLR2/1 association than in those expressing the TLR2/6 construct. In

419

all systems, the highest levels of NF-kB activation were obtained when transfected HEK293A cells

420

were exposed to a serotype B GXM from the C. gattii strain.

421

To understand the structural characteristics responsible for NO and TLR activation we

422

evaluated several GXM parameters. Although sugar composition varied in different strains, GXM

423

samples with similar ratios of Man-Xyl-GlcA constitution produced very different levels of NF-kB

424

activation (e.g. strains CN23/10993 and ATCC28938). The dissociation was further illustrated by the

425

fact that differences in sugar ratio were associated with similar efficacies in activating NF-kB nuclear

426

translocation (e.g. strains HEC40143 and T1444). The ability of GXM to induce NO production and

427

the TLR-mediated response in transfected HEK293A cells was not an intra-species property, since

428

GXM from the C. gattii strain CN23/10993 produced cellular responses significantly more efficiently

429

than the polysaccharide sample from the C. gattii isolate HEC40143.

430

Differences in antibody reactivity can imply differences in GXM structure (Frases et al.,

431

2008), which also denote functional specificity (Kozel et al., 2003). However, in this study we found

432

that the serologic characteristics revealed by the binding of mAbs were similar in all strains, except

433

for the C. gattii strain CN23/10993. Those cells showed strong reactivity with the protective IgM

434

12A1, but did not react with the clonally-related, non-protective mAb 13F1. This observation is

435

consistent and reflective of the fact that mAbs 12A1 and 13F1 bind to different epitopes. In a recent

436

study, it has been suggested that antibody reactivity is influenced by the diameter of GXM (10),

437

which led us to the inference that the effective diameter of the polysaccharide samples used in this

438

study could also be related to the functionality of GXM.

439

Immunological studies with chitin have shown that large polysaccharide polymers are

440

biologically inert, while their fragments are efficient regulators of TLR2-mediated innate immune

441

responses (Lee, 2009, Lee et al., 2008, Da Silva et al., 2008). Human cryptococcosis caused by C.
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442

gattii is known to produce strong inflammatory responses in the lung, whereas the C. neoformans

443

varieties often trigger little or no inflammation (49). Consequently, the result that serotype B GXMs

444

were more potent activators of cellular responses raises the tantalizing possibility that a correlation

445

might exist between activation of host cells and the type of granulomatous response made. In our

446

model, the most effective GXM sample in activating cellular responses had the smallest effective

447

diameter, a result that echoed previous findings with chitin (Lee, 2009, Lee et al., 2008, Da Silva et

448

al., 2008). Using the model of NO production by macrophages after exposure to the serotype B

449

GXM, we observed that polysaccharides with reduced dimensions induced a stronger cellular

450

response, a property that was exclusive to serotype B GXM samples. NO production by macrophages

451

is involved in both antimicrobial responses and mediation of inflammation, illustrating the complex

452

effects of the GXM on host immune function. Given that our studies compared GXM preparations

453

standardized by mass/volume and that smaller fibers have lower molecular masses, it is possible that

454

the effects measured here reflect differences in the molarity of the GXM. Nevertheless, we urge

455

caution in attributing these effects to simple differences in molarity since interactions between

456

polysaccharides and their receptors are likely to involve repeating structural motifs in polysaccharide

457

molecules such that avidity considerations could be dominant. Furthermore, we note that

458

immunological studies routinely measure effects using polysaccharide concentrations standardized by

459

mass/volume and consequently this approach is experimentally relevant, especially for literature

460

comparisons.

461

The cryptococcal capsule enlarges during infection, which is essential for virulence

462

(Zaragoza et al., 2009). A linear correlation between the effective diameter of GXM and microscopic

463

capsular diameter was recently demonstrated (Frases et al., 2009), suggesting that the synthesis of

464

high-diameter polysaccharides is essential for capsule enlargement. In our model, strain CN23/10993

465

produced GXM molecules with the lowest values of effective diameter and had the smallest capsular

466

dimension (data not shown). The combination of the ability of GXM to modulate cellular responses

467

and the capacity of C. neoformans to produce large GXMs and capsules may have a direct impact on
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468

fungal virulence. C. neoformans isolates producing large GXM molecules would be more efficient in

469

producing capsules with increased dimensions, which is generally associated with pathogenic

470

potential (Zaragoza et al., 2009). On the other hand, isolates producing smaller GXMs, according to

471

our current results, would manifest a potentially enhanced ability to activate some mechanisms of the

472

immune response. Considering that the cryptococcal capsule also protects the fungus against a

473

number of antifungal mechanisms of the host, a combination of smaller GXMs and formation of a

474

capsular network with reduced dimensions would favor the host defense by multiple mechanisms. We

475

therefore suggest that synthesis of capsular structures with reduced dimensions could have protean

476

effects on the pathogenic capacity of cryptococcal strains ranging from increased susceptibility to

477

oxidative fluxes and phagocytosis, to producing molecules with an enhanced ability to activate host

478

defenses. These observations suggest a mechanistic explanation for the consistent observation that

479

strains with small capsules elicit more inflammation than those with large capsules (Perfect et al.,

480

2002). Furthermore, the higher NO-inducing activity associated with C. gattii polysaccharides, which

481

correlates with smaller GXM diameters, suggests an explanation for the consistent observation of

482

stronger granulomatous responses in cryptococcosis caused by this species (Perfect et al., 2002,

483

Speed et al., 1995, Mitchell et al., 1995).

484
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A

B

D

C

505
506

Figure 1. Quantitative and structural analyses of GXMs from five Cryptococcus isolates. GXM

507

was isolated by formation of polysaccharide gels after concentration of culture supernatants of five

508

different isolates of C. neoformans and C. gattii. The volume of gel formation in normalized cultures

509

(A) apparently correlates with the ability of each strain to produce and secrete GXM to the

510

extracellular medium (B). Results are expressed as means + standard deviations of three different

511

experiments. Correlation properties are shown in C. D. Monosaccharide composition of

512

polysaccharides obtained from the five different isolates of C. neoformans and C. gattii.

513

Monosaccharides were identified by GC-MS; the relative amount of each sugar residue in the

514

polysaccharides is shown as molar percentage. Serotypes are indicated for each strain.
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515
516

Figure 2. NF-κ
κB activation in cells expressing TLRs by GXM. A. Control systems. Pam3CSK4

517

(P3C) and FSL-1, but not LPS, activated NF-kB nuclear translocation in cells expressing either

518

TLR2/1 or TLR2/6, as expected. Transfection of HEK293A cells with a plasmid containing no TLR-

519

coding sequences (vector) resulted in unresponsiveness. B-E. Stimulation of HEK293A cells

520

expressing TLR2/1 (inverted triangles) or TLR2/6 (triangles) to GXM samples resulted in dose-

521

dependent NF-kB activation. Cryptococcus strains and serotypes from which each GXM sample was

522

isolated are indicated in each panel.
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A

B
TLR2/6

TLR2/1

523

Figure 3. Comparative analysis of the efficacy of GXM samples in the activation of TLR-

524

mediated NF-κB nuclear translocation. Treatment of HEK293A cells expressing either TLR2/6 (A)

525

or TLR2/1 (B) with GXM revealed that polysaccharide fractions from strain CN23/10993 were

526

significantly more efficient than all others (P<0.0001) at 1 and 10 µg/mL (asterisks). No significant

527

differences were observed at a higher concentration (100 µg/mL). Strains T1444, HEC3393,

528

HEC40143 and ATCC28938 (serotypes indicated) manifested similar efficacies in activating NF-kB

529

nuclear translocation. Strain serotypes are indicated.

530
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531

Figure 4. Comparative analysis of the efficacy of GXM samples in the induction of NO

532

production by macrophages. Polysaccharide fractions from strain CN23/10993 were significantly

533

more efficient in induction of NO production than all others (P<0.0001) at 1, 10 and 100 µg/mL. LPS

534

was used as positive control of NO production by macrophage-like cells; incubation of the

535

phagocytes in the medium alone (no stimulation) was the negative control. Serotypes are indicated for

536

each strain.

537
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538

Figure 5. Reactivity of C. neoformans and C. gattii isolates with four monoclonal antibodies to

539

GXM. Fungal strains and serotypes are indicated on the top panels; antibodies are shown on the left.

540

Differential interferential contrast (gray) and fluorescence (red) images are shown. Overreaction of

541

CN23/10993 cells with antibody 12A1 (single asterisk) and lack of reactivity with antibody 13F1

542

(double asterisks) are highlighted.
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543

Figure 6. Diameter of GXM fractions of different isolates of C. neoformans and C. gattii.

544

Effective diameter distribution of GXM (A) and related average values (B) are shown. Serotypes are

545

indicated for each strain.

546
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547
548

Figure 7. NO induction by GXM fractions of different molecular masses and effective

549

diameters. A. Stimulation of macrophage-like cells with the GXM fractions results in differential

550

production of NO. Asterisks denote significant differences after stimulation of phagocytes with GXM

551

fractions (P<0.0001). B. Effective diameter determination of fractions obtained by sequential

552

ultrafiltration through 100 kDa and 10 kDa cut-off filtration discs. Asterisks denote statistical

553

significance after comparison of the differences in effective diameter (P<0.0001). C. Correlation

554

analysis of effective diameter of serotype B GXM samples in the 10-100 kDa range and their ability

555

to induce NO. Serotypes are indicated for each strain.
172

556
557
558
559
560
561

Table 1. Electronegativity of polysaccharides from five different strains of

562

C. neoformans and C. gattii.

563
Strain

Serotype

Zeta Potential (mV)

Mobility (µ/s)/(V/cm)

T1444

A

-34.50 ±0.32

-2.70±0.02

HEC3393

A

-33.36±0.51

-2.61±0.04

CN23/10993

B

-33.34±0.21

-2.60±0.02

HEC40143

C

-38.15±0.41

-2.98±0.03

ATCC28938

D

-34.62±0.45

-2.71±0.04

564
565
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